,molecule_name,test_type,test_text,opsin_smiles,line_idx,in_house_namescore,in_house_precision,in_house_recall,in_house_f1,in_house_smiles_sim
0,(1-Aminocyclohexyl)methanol,IR,"(film): 3320, 3210 3305 (br), 3210, 2980, 1562, 1409, 1203,
1142, 987, 857, 831",NC1(CO)CCCCC1,940,1.0,1.0,0.18,0.31,1.0
1,(1-Aminocyclohexyl)methanol,1H NMR,"(500 MHz, CDCl3) δ 3.31 (s, 2H, H-1), 1.64 – 1.26 (m, 10H, H-3, H-4 and
H-5)",NC1(CO)CCCCC1,941,1.0,1.0,1.0,1.0,1.0
2,(1-Aminocyclohexyl)methanol,13C NMR,"(126 MHz, CDCl3) δ 70.3, 52.0, 35.5, 26.1, 21.9",NC1(CO)CCCCC1,942,1.0,0.0,0.0,0.0,1.0
3,"2,2-Diethyl-3-oxa-1-azaspiro[4.5]decane",IR,"(film): 2965,
2929, 2854, 1450, 1350, 1196, 1055, 920, 815, 759, 668",CCC1(CC)NC2(CCCCC2)CO1,943,1.0,1.0,1.0,1.0,0.9565217391304348
4,"2,2-Diethyl-3-oxa-1-azaspiro[4.5]decane",1H NMR,"(500 MHz, CDCl3) δ 3.63 (s, 2H, H-
4), 1.88 – 1.18 (m, 14H, H-2, H-6, H-7 and H-8), 0.91 (t, J = 7.5 Hz, 6H, H-1)",CCC1(CC)NC2(CCCCC2)CO1,944,1.0,1.0,1.0,1.0,0.9565217391304348
5,"2,2-Diethyl-3-oxa-1-azaspiro[4.5]decane",13C NMR,"(126 MHz,
CDCl3) δ 98.8, 74.5, 62.0, 38.1, 30.5, 25.4, 24.0, 8.7",CCC1(CC)NC2(CCCCC2)CO1,945,1.0,1.0,1.0,1.0,0.9565217391304348
6,"2,2-Diethyl-3-oxa-1-azaspiro[4.5]decane",MS,"(ESI) found [M+H]+ 198.1852,
C12H24NO requires 198.1852",CCC1(CC)NC2(CCCCC2)CO1,946,1.0,1.0,1.0,1.0,0.9565217391304348
7,"2,2-Diethyl-3-oxa-1-azaspiro[4.5]decane",IR,"(film): 2972, 2929,
2854, 1450, 1371, 1283, 1209, 1114, 1086, 866, 810, 748",CCC1(CC)NC2(CCCCC2)CO1,953,1.0,0.27,0.25,0.26,0.9565217391304348
8,"2,2-Diethyl-3-oxa-1-azaspiro[4.5]decane",1H NMR,"(500 MHz, CDCl3) δ 3.66 (d, J = 8.3
Hz, 1H, H-5), 3.58 (d, J = 8.3 Hz, 1H, H-5), 1.73 – 1.40 (m, 10H, H-2, H-7 and H-8), 1.38 – 1.29 (m, 2H,
H-9), 1.30 (s, 3H, H-4), 0.93 (t, J = 7.5 Hz, 3H, H-1)",CCC1(CC)NC2(CCCCC2)CO1,954,1.0,0.0,0.0,0.0,0.9565217391304348
9,"2,2-Diethyl-3-oxa-1-azaspiro[4.5]decane",13C NMR,"(126 MHz, CDCl3) δ 96.6, 74.4, 62.2,
38.1, 37.8, 33.9, 25.9, 25.4, 24.0, 23.9, 9.0",CCC1(CC)NC2(CCCCC2)CO1,955,1.0,0.38,0.27,0.32,0.9565217391304348
10,"2,2-Diethyl-3-oxa-1-azaspiro[4.5]decane",MS,"(ESI) found [M+H]+ 184.1693, C11H21NO
requires 184.1696",CCC1(CC)NC2(CCCCC2)CO1,956,1.0,0.0,0.0,0.0,0.9565217391304348
11,"Trinuclear N,O-ketal palladacycle",IR,"(film): 2971, 2292, 1738, 1566, 1366, 1217, 1045, 661",,947,1.0,1.0,1.0,1.0,
12,"Trinuclear N,O-ketal palladacycle",1H NMR,"(500 MHz, CDCl3) δ 3.63 (s, 2H, H-4), 1.88 – 1.18 (m, 14H, H-2, H-6, H-7 and H-8), 0.91 (t, J =
7.5 Hz, 6H, H-1)",,948,,,,,
13,"Trinuclear N,O-ketal palladacycle",13C NMR,"(126 MHz, CDCl3) δ 98.8, 74.5, 62.0, 38.1, 30.5, 25.4, 24.0, 8.7",,949,1.0,1.0,1.0,1.0,
14,"2,2-Diethyl-4,4-dimethyloxazolidine",IR,"2967, 2939, 2879, 1460, 1381, 1364, 1198, 1056, 999, 918, 825, 757",CCC1(CC)NC(C)(C)CO1,950,1.0,1.0,1.0,1.0,0.95
15,"2,2-Diethyl-4,4-dimethyloxazolidine",1H NMR,"(500 MHz, CDCl3) δ 3.58 (s, 2H, H-4), 1.64 (q, 4H, J = 7.5 Hz, H-2), 1.26 (s, 6H, H-6), 0.92 (t, J =
7.5 Hz, 6H, H-1)",CCC1(CC)NC(C)(C)CO1,951,,,,,
16,"2,2-Diethyl-4,4-dimethyloxazolidine",13C NMR,"(126 MHz, CDCl3) δ 99.7, 76.8, 58.8, 30.4, 28.5, 8.7",CCC1(CC)NC(C)(C)CO1,952,1.0,1.0,1.0,1.0,0.95
17,"2-Ethyl-2,4,4-trimethyloxazolidine",IR,"(film): 2967, 2931, 1463, 1372, 1201, 1057, 804",CCC1(C)NC(C)(C)CO1,957,1.0,1.0,1.0,1.0,0.5454545454545454
18,"2-Ethyl-2,4,4-trimethyloxazolidine",1H NMR,"(500 MHz, CDCl3) δ 3.61 (d, J =
8.1 Hz, 1H, H-5), 3.53 (d, J = 8.1 Hz, 1H, H-5), 1.61 (apparent septet, J = 6.3 Hz, 2H, H-2), 1.32 (s, 3H,
H-4), 1.26 (s, 3H, H-8), 1.23 (s, 3H, H-8), 0.94 (t, J = 7.5 Hz, 3H, H-1)",CCC1(C)NC(C)(C)CO1,958,1.0,1.0,1.0,1.0,0.5454545454545454
19,"2-Ethyl-2,4,4-trimethyloxazolidine",13C NMR,"(126 MHz, CDCl3) δ
97.5, 76.9, 59.1, 34.0, 28.4, 28.1, 25.7, 9.0",CCC1(C)NC(C)(C)CO1,959,1.0,1.0,1.0,1.0,0.5454545454545454
20,"2-Ethyl-2,4,4-trimethyloxazolidine",MS,"(ESI) found [M+H]+ 144.1380, C8H17NO requires
144.1383",CCC1(C)NC(C)(C)CO1,960,1.0,1.0,1.0,1.0,0.5454545454545454
21,2-Isopropyl-2-methyl-3-oxa-1-azaspiro[4.5]decane,IR,"(film):
2971, 2929, 2853, 1739, 1448, 1366, 1229, 1217, 1055, 891, 860, 806, 784",CC(C)C1(C)NC2(CCCCC2)CO1,961,1.0,1.0,1.0,1.0,0.9795918367346939
22,2-Isopropyl-2-methyl-3-oxa-1-azaspiro[4.5]decane,1H NMR,"(500 MHz, CDCl3)
δ 3.66 (d, J = 8.3 Hz, 1H, H-5), 3.57 (d, J = 8.3 Hz, 1H, H-5), 1.76 (septet, J = 7.0 Hz 1H, H-2), 1.72 –
1.25 (m, 10H, H-7, H-8 and H-9), 1.22 (s, 3H, H-4), 0.95 (d, J = 7.0 Hz, 3H, H-1), 0.93 (d, J = 7.0 Hz,
3H, H-1)",CC(C)C1(C)NC2(CCCCC2)CO1,962,1.0,1.0,1.0,1.0,0.9795918367346939
23,2-Isopropyl-2-methyl-3-oxa-1-azaspiro[4.5]decane,13C NMR,"(126 MHz, CDCl3) δ 98.9, 74.3, 62.1, 38.2, 37.8, 37.8, 25.4, 24.1, 23.9, 22.1, 18.1,
18.0",CC(C)C1(C)NC2(CCCCC2)CO1,963,1.0,0.92,0.92,0.92,0.9795918367346939
24,2-Isopropyl-2-methyl-3-oxa-1-azaspiro[4.5]decane,MS,"(ESI) found [M+H]+ 198.1851, C12H23NO requires 198.1852",CC(C)C1(C)NC2(CCCCC2)CO1,964,1.0,1.0,1.0,1.0,0.9795918367346939
25,"2-Isopropyl-2,4,4-trimethyloxazolidine",IR,"(film): 2962, 2872, 1466, 1371, 1194, 1056, 907, 856, 789",CC(C)C1(C)NC(C)(C)CO1,965,1.0,1.0,1.0,1.0,0.9545454545454546
26,"2-Isopropyl-2,4,4-trimethyloxazolidine",1H NMR,"(500
MHz, CDCl3) δ 3.62 (d, J = 8.0 Hz, 1H, H-5), 3.51 (d, J = 8.0 Hz, 1H, H-5), 1.82 (septet, J = 6.8 Hz, 1H,
H-2), 1.27 (s, 3H, H-4), 1.24 (s, 3H, H-8), 1.22 (s, 3H, H-8), 0.96 (d, J = 6.8 Hz, 3H, H-1), 0.94 (d, J =
6.9 Hz, 3H, H-1)",CC(C)C1(C)NC(C)(C)CO1,966,1.0,1.0,1.0,1.0,0.9545454545454546
27,"2-Isopropyl-2,4,4-trimethyloxazolidine",13C NMR,"(126 MHz, CDCl3) δ 99.8, 76.9, 59.0, 37.9, 28.5, 28.2, 21.9, 18.1, 18.0",CC(C)C1(C)NC(C)(C)CO1,967,1.0,1.0,1.0,1.0,0.9545454545454546
28,"2-Isopropyl-2,4,4-trimethyloxazolidine",MS,"(ESI) found [M+H]+ 158.1536, C9H19NO requires 158.1539",CC(C)C1(C)NC(C)(C)CO1,968,1.0,1.0,1.0,1.0,0.9545454545454546
29,2-Ethyl-2-propyl-3-oxa-1-azaspiro[4.5]decane,Rf,"(ethyl acetate in petroleum ether, 20%): 0.21",CCCC1(CC)NC2(CCCCC2)CO1,969,1.0,1.0,1.0,1.0,0.8
30,2-Ethyl-2-propyl-3-oxa-1-azaspiro[4.5]decane,IR,"(film):
2929, 2854, 1450, 1376, 1251, 1192, 1175, 1055, 947, 930, 899, 817, 739",CCCC1(CC)NC2(CCCCC2)CO1,970,1.0,0.0,0.0,0.0,0.8
31,2-Ethyl-2-propyl-3-oxa-1-azaspiro[4.5]decane,1H NMR,"(500 MHz, CDCl3) δ
3.61 (d, J = 8.4 Hz, 1H), 3.60 (d, J = 8.4 Hz, 1H), 1.72 – 1.41 (m, 11H, H-2, H-4, H-10, H-11 and H-12),
1.40 – 1.24 (m, 5H, H-5, H-10 and H-11), 0.91 (t, J = 7.3 Hz, 3H, H-6), 0.88 (t, J = 7.5 Hz, 3H, H-1)",CCCC1(CC)NC2(CCCCC2)CO1,971,1.0,0.12,0.12,0.12,0.8
32,2-Ethyl-2-propyl-3-oxa-1-azaspiro[4.5]decane,13C NMR,"(126 MHz, CDCl3) δ 98.5, 74.4, 62.0, 40.5, 38.1, 38.1, 31.1, 25.4, 24.0, 24.0, 17.7, 14.5, 8.8",CCCC1(CC)NC2(CCCCC2)CO1,972,1.0,0.0,0.0,0.0,0.8
33,2-Ethyl-2-propyl-3-oxa-1-azaspiro[4.5]decane,MS,"(ESI) found [M+H]+ 212.2007, C13H26NO requires 212.2007",CCCC1(CC)NC2(CCCCC2)CO1,973,1.0,0.0,0.0,0.0,0.8
34,2-Ethyl-2-propyl-3-oxa-1-azaspiro[4.5]decane,Rf,"(ethyl acetate in petroleum ether, 20%): 0.21",CCCC1(CC)NC2(CCCCC2)CO1,974,1.0,1.0,1.0,1.0,0.8
35,2-Ethyl-2-propyl-3-oxa-1-azaspiro[4.5]decane,IR,"(film): 2936, 2925, 2858, 1428,
1364, 1198, 1127, 1056, 1001, 918, 825",CCCC1(CC)NC2(CCCCC2)CO1,975,1.0,1.0,1.0,1.0,0.8
36,2-Ethyl-2-propyl-3-oxa-1-azaspiro[4.5]decane,1H NMR,"(400 MHz, CDCl3) δ 3.54 (s, 2H, H-7), 1.67 – 1.48
(m, 4H, H-2 and H-4), 1.34 (apparent sextet, J = 7.5 Hz, 2H, H-5), 1.23 (s, 3H, H-10), 1.21 (s, 3H, H-10),
0.91 (t, J = 7.3 Hz, 3H, H-6), 0.89 (t, J = 7.5 Hz, 3H, H-1)",CCCC1(CC)NC2(CCCCC2)CO1,976,1.0,1.0,1.0,1.0,0.8
37,2-Ethyl-2-propyl-3-oxa-1-azaspiro[4.5]decane,13C NMR,"(101 MHz, CDCl3) δ 99.8, 77.2,
59.2, 40.7, 31.4, 28.9, 28.9, 18.1, 14.9, 9.2",CCCC1(CC)NC2(CCCCC2)CO1,977,1.0,0.9,0.9,0.9,0.8
38,2-Ethyl-2-propyl-3-oxa-1-azaspiro[4.5]decane,MS,"(ESI) found [M+H]+ 172.1625, C10H22NO
requires 172.1623",CCCC1(CC)NC2(CCCCC2)CO1,978,1.0,1.0,1.0,1.0,0.8
39,2-Cyclohexyl-2-ethyl-3-oxa-1-azaspiro[4.5]decane,IR,"(film):
2971, 2929, 2855, 1739, 1481, 1449, 1366, 1229, 1217, 1110, 1033, 910, 820, 663",CCC1(C2CCCCC2)NC2(CCCCC2)CO1,979,0.73,1.0,1.0,1.0,0.6666666666666666
40,2-Cyclohexyl-2-ethyl-3-oxa-1-azaspiro[4.5]decane,1H NMR,"(500 MHz,
CDCl3) δ 4.21 (s, 1H, H-3), 3.61 (d, J = 7.7 Hz, 1H, H-4), 3.27 (d, J = 7.7 Hz, 1H, H-4), 1.98 – 1.13 (m,
10H, H-6, H-7 and H-8), 0.92 (s, 9H, H-1)",CCC1(C2CCCCC2)NC2(CCCCC2)CO1,980,0.73,1.0,1.0,1.0,0.6666666666666666
41,2-Cyclohexyl-2-ethyl-3-oxa-1-azaspiro[4.5]decane,13C NMR,"(126 MHz, CDCl3) δ 97.6, 75.0, 62.0, 36.7, 35.0,
33.4, 25.7, 25.2, 24.2, 23.0",CCC1(C2CCCCC2)NC2(CCCCC2)CO1,981,0.73,1.0,1.0,1.0,0.6666666666666666
42,2-Cyclohexyl-2-ethyl-3-oxa-1-azaspiro[4.5]decane,MS,"(ESI) ) found [M+H]+ 198.1850, C12H23NO requires 198.1852",CCC1(C2CCCCC2)NC2(CCCCC2)CO1,982,0.73,1.0,1.0,1.0,0.6666666666666666
43,6-Chlorohexan-3-one,IR,"(film): 2970, 1819, 1710, 1412, 1376,
1309, 1115, 1036, 979, 867, 787, 729",CCC(=O)CCCCl,983,1.0,1.0,1.0,1.0,0.8
44,6-Chlorohexan-3-one,1H NMR,"(400 MHz, CDCl3) δ 3.57 (t, J = 6.3 Hz, 1H), 2.61 (t, J =
7.0 Hz, 2H, H-6), 2.45 (q, J = 7.3 Hz, 2H, H-2), 2.12 – 1.99 (m, 2H, H-5), 1.07 (t, J = 7.3 Hz, 3H, H-1)",CCC(=O)CCCCl,984,1.0,1.0,1.0,1.0,0.8
45,6-Chlorohexan-3-one,13C NMR,"(101 MHz, CDCl3) δ 210.3, 44.5, 38.8, 36.0, 26.3, 7.8",CCC(=O)CCCCl,985,1.0,1.0,1.0,1.0,0.8
46,"2-(4-Oxohexyl)isoindoline-1,3-dione",Rf,"(ethyl acetate in petroleum ether, 25%): 0.38",CCC(=O)CCCN1C(=O)c2ccccc2C1=O,986,1.0,1.0,1.0,1.0,0.3582089552238806
47,"2-(4-Oxohexyl)isoindoline-1,3-dione",IR,"(film): 2939, 1772, 1705, 1467, 1438, 1395, 1362, 1188, 1112, 1055, 1000, 888, 795, 719",CCC(=O)CCCN1C(=O)c2ccccc2C1=O,987,1.0,1.0,1.0,1.0,0.3582089552238806
48,"2-(4-Oxohexyl)isoindoline-1,3-dione",1H NMR,"(400 MHz, CDCl3) δ 7.83 (dd, J = 5.4, 3.0 Hz, 2H, H-9), 7.70 (dd, J = 5.4, 3.0 Hz, 2H, H-10), 3.70
(t, J = 6.9 Hz, 2H, H-6), 2.46 (t, J = 7.2 Hz, 2H, H-4), 2.41 (q, J = 7.3 Hz, 2H, H-2), 1.96 (quint, J = 6.9
Hz, 2H, H-5), 1.02 (t, J = 7.3 Hz, 3H, H-1)",CCC(=O)CCCN1C(=O)c2ccccc2C1=O,988,,,,,
49,"2-(4-Oxohexyl)isoindoline-1,3-dione",13C NMR,"(101 MHz, CDCl3) δ 210.1, 168.4, 133.9, 132.1,
123.2, 39.2, 37.3, 35.9, 22.7, 7.8",CCC(=O)CCCN1C(=O)c2ccccc2C1=O,989,1.0,1.0,1.0,1.0,0.3582089552238806
50,"2-(4-Oxohexyl)isoindoline-1,3-dione",MS,"(ESI) found [M+H]+ 246.1125, C14H16NO3 requires
246.1125",CCC(=O)CCCN1C(=O)c2ccccc2C1=O,990,1.0,1.0,1.0,1.0,0.3582089552238806
51,"2-{3-(2-Ethyl-4,4-dimethyloxazolidin-2-yl)propyl}isoindoline-1,3-dione",Rf,"(ethyl acetate in petroleum ether, 25%):
0.28",CCC1(CCCN2C(=O)c3ccccc3C2=O)NC(C)(C)CO1,996,1.0,1.0,1.0,1.0,0.40476190476190477
52,"2-{3-(2-Ethyl-4,4-dimethyloxazolidin-2-yl)propyl}isoindoline-1,3-dione",IR,"(film): 2966, 2769, 1709, 1617, 1396, 1361, 1260, 1189, 1056, 913, 796, 720",CCC1(CCCN2C(=O)c3ccccc3C2=O)NC(C)(C)CO1,997,1.0,1.0,1.0,1.0,0.40476190476190477
53,"2-{3-(2-Ethyl-4,4-dimethyloxazolidin-2-yl)propyl}isoindoline-1,3-dione",1H NMR,"(500 MHz, CDCl3) δ 7.84 (dd, J = 5.4, 3.0 Hz, 2H, H-9), 7.71 (dd, J = 5.4, 3.0 Hz, 2H, H-10), 3.71
(t, J = 6.5 Hz, 2H, H-6), 3.57 (d, J = 8.1 Hz, 1H, H-11), 3.53 (d, J = 8.1 Hz, 1H, H-11), 1.80 – 1.71 (m,
2H, H-5), 1.68 – 1.56 (m, 4H, H-4 and H-2), 1.23 (s, 3H, H-14), 1.23 (s, 3H, H-14), 0.88 (t, J = 7.5 Hz,
3H, H-1)",CCC1(CCCN2C(=O)c3ccccc3C2=O)NC(C)(C)CO1,998,,,,,
54,"2-{3-(2-Ethyl-4,4-dimethyloxazolidin-2-yl)propyl}isoindoline-1,3-dione",13C NMR,"(126 MHz, CDCl3) δ 168.4, 133.9, 132.1, 123.2, 99.0, 76.8, 58.9, 38.2, 35.1, 30.9,
28.5, 28.4, 23.8, 8.7",CCC1(CCCN2C(=O)c3ccccc3C2=O)NC(C)(C)CO1,999,1.0,1.0,1.0,1.0,0.40476190476190477
55,"2-{3-(2-Ethyl-4,4-dimethyloxazolidin-2-yl)propyl}isoindoline-1,3-dione",MS,"(ESI) found [M+H]+ 317.1863, C18H25N2O3 requires 317.1865",CCC1(CCCN2C(=O)c3ccccc3C2=O)NC(C)(C)CO1,1000,1.0,1.0,1.0,1.0,0.40476190476190477
56,2-(Benzyloxy)-N-methoxy-N-methylacetamide,Rf,"(ethyl acetate in petroleum ether, 20%): 0.28",CON(C)C(=O)COCc1ccccc1,1001,1.0,1.0,1.0,1.0,0.8205128205128205
57,2-(Benzyloxy)-N-methoxy-N-methylacetamide,IR,"(film):. 2938, 2899, 1676, 1454, 1392, 1328, 1177, 1138, 1086, 991, 916, 739, 699",CON(C)C(=O)COCc1ccccc1,1002,1.0,1.0,1.0,1.0,0.8205128205128205
58,2-(Benzyloxy)-N-methoxy-N-methylacetamide,1H NMR,"(500 MHz, CDCl3) δ 7.53 – 7.27 (m, 5H, Ar-H), 4.67 (s, 2H, H-5), 4.28 (s, 2H, H-6), 3.63 (s, 3H, H-8),
3.19 (s, 3H, H-9)",CON(C)C(=O)COCc1ccccc1,1003,1.0,1.0,1.0,1.0,0.8205128205128205
59,2-(Benzyloxy)-N-methoxy-N-methylacetamide,13C NMR,"(126 MHz, CDCl3) δ 171.0, 137.5, 128.4, 128.1, 127.8, 73.3, 67.1, 61.4,
32.3",CON(C)C(=O)COCc1ccccc1,1004,1.0,1.0,1.0,1.0,0.8205128205128205
60,1-(Benzyloxy)butan-2-one,IR,"(film): 2977,
2881, 1717, 1455, 1340, 1103, 1028, 96, 737, 697",CCC(=O)COCc1ccccc1,1005,1.0,1.0,1.0,1.0,0.972972972972973
61,1-(Benzyloxy)butan-2-one,1H NMR,"(500 MHz, CDCl3) δ 7.42 – 7.28 (m, 5H,
Ar-H), 4.59 (s, 2H, H-5), 4.07 (s, 2H, H-4), 2.50 (q, J = 7.3 Hz, 2H, H-2), 1.07 (t, J = 7.3 Hz, 3H, H-1)",CCC(=O)COCc1ccccc1,1006,1.0,1.0,1.0,1.0,0.972972972972973
62,1-(Benzyloxy)butan-2-one,13C NMR,"(126 MHz, CDCl3) δ 209.37, 137.25, 128.52, 128.00, 127.88, 74.80, 73.36, 32.27, 7.22",CCC(=O)COCc1ccccc1,1007,1.0,1.0,1.0,1.0,0.972972972972973
63,2-((Benzyloxy)methyl)-2-ethyl-3-oxa-1-azaspiro[4.5]decane,Rf,"(ethyl acetate in petroleum ether, 20%):
0.28",CCC1(COCc2ccccc2)NC2(CCCCC2)CO1,1008,1.0,1.0,1.0,1.0,1.0
64,2-((Benzyloxy)methyl)-2-ethyl-3-oxa-1-azaspiro[4.5]decane,IR,"(film): 2968, 2869, 1454, 1382, 1363, 1253, 1201, 1099, 1055, 914, 824, 734, 697",CCC1(COCc2ccccc2)NC2(CCCCC2)CO1,1009,1.0,1.0,1.0,1.0,1.0
65,2-((Benzyloxy)methyl)-2-ethyl-3-oxa-1-azaspiro[4.5]decane,1H NMR,"(500 MHz, CDCl3) δ 7.36 – 7.31 (m, 4H, Ar-H), 7.30 – 7.25 (m, 1H, Ar-H), 4.61 (d, J = 12.2 Hz,
1H, H-5), 4.58 (d, J = 12.2 Hz, 1H, H-5), 3.65 (d, J = 8.1 Hz, 1H, H-10), 3.62 (d, J = 8.1 Hz, 1H, H-10),
3.43 (d, J = 10.1 Hz, 1H, H-4), 3.38 (d, J = 10.1 Hz, 1H, H-4), 1.70 (q, J = 7.5 Hz, 2H, H-2), 1.68 – 1.26
(m, 10H, H-13, H-14 and H-15), 0.88 (t, J = 7.5 Hz, 3H, H-1)",CCC1(COCc2ccccc2)NC2(CCCCC2)CO1,1010,,,,,
66,2-((Benzyloxy)methyl)-2-ethyl-3-oxa-1-azaspiro[4.5]decane,13C NMR,"(126 MHz, CDCl3) δ 138.3,
128.3, 127.6, 127.5, 97.6, 75.2, 73.4, 73.0, 62.1, 37.7, 37.6, 30.3, 28.4, 25.5, 23.9, 8.5",CCC1(COCc2ccccc2)NC2(CCCCC2)CO1,1011,1.0,1.0,1.0,1.0,1.0
67,2-((Benzyloxy)methyl)-2-ethyl-3-oxa-1-azaspiro[4.5]decane,MS,"(ESI)
found [M+H]+ 290.2113, C18H28NO2 requires 290.2115",CCC1(COCc2ccccc2)NC2(CCCCC2)CO1,1012,1.0,1.0,1.0,1.0,1.0
68,2-((Benzyloxy)methyl)-2-ethyl-3-oxa-1-azaspiro[4.5]decane,Rf,"(ethyl acetate in petroleum ether, 20%):
0.28",CCC1(COCc2ccccc2)NC2(CCCCC2)CO1,1013,1.0,1.0,1.0,1.0,1.0
69,2-((Benzyloxy)methyl)-2-ethyl-3-oxa-1-azaspiro[4.5]decane,IR,"(film): 2968, 2869, 1454, 1382, 1363, 1253, 1201, 1099, 1055, 914, 824, 734, 697",CCC1(COCc2ccccc2)NC2(CCCCC2)CO1,1014,1.0,1.0,1.0,1.0,1.0
70,2-((Benzyloxy)methyl)-2-ethyl-3-oxa-1-azaspiro[4.5]decane,1H NMR,"(500 MHz, CDCl3) δ 7.36 – 7.31 (m, 4H, Ar-H), 7.30 – 7.25 (m, 1H, Ar-H), 4.61 (d, J = 12.2 Hz,
1H, H-5), 4.58 (d, J = 12.2 Hz, 1H, H-5), 3.65 (d, J = 8.1 Hz, 1H, H-10), 3.62 (d, J = 8.1 Hz, 1H, H-10),
3.43 (d, J = 10.1 Hz, 1H, H-4), 3.38 (d, J = 10.1 Hz, 1H, H-4), 1.70 (q, J = 7.5 Hz, 2H, H-2), 1.68 – 1.26
(m, 10H, H-13, H-14 and H-15), 0.88 (t, J = 7.5 Hz, 3H, H-1)",CCC1(COCc2ccccc2)NC2(CCCCC2)CO1,1015,,,,,
71,2-((Benzyloxy)methyl)-2-ethyl-3-oxa-1-azaspiro[4.5]decane,13C NMR,"(126 MHz, CDCl3) δ 138.3,
128.3, 127.6, 127.5, 97.6, 75.2, 73.4, 73.0, 62.1, 37.7, 37.6, 30.3, 28.4, 25.5, 23.9, 8.5",CCC1(COCc2ccccc2)NC2(CCCCC2)CO1,1016,1.0,1.0,1.0,1.0,1.0
72,2-((Benzyloxy)methyl)-2-ethyl-3-oxa-1-azaspiro[4.5]decane,MS,"(ESI)
found [M+H]+ 290.2113, C18H28NO2 requires 290.2115",CCC1(COCc2ccccc2)NC2(CCCCC2)CO1,1017,1.0,1.0,1.0,1.0,1.0
73,"2-{(Benzyloxy)methyl}-2-ethyl-4,4-dimethyloxazolidine",Rf,"(ethyl acetate in petroleum ether, 20%):
0.35",CCC1(COCc2ccccc2)NC(C)(C)CO1,1018,1.0,1.0,1.0,1.0,0.8484848484848485
74,"2-{(Benzyloxy)methyl}-2-ethyl-4,4-dimethyloxazolidine",IR,"(film): 2968, 2869, 1454, 1382, 1363, 1253, 1201, 1099, 1055, 914, 824, 734, 697",CCC1(COCc2ccccc2)NC(C)(C)CO1,1019,1.0,1.0,1.0,1.0,0.8484848484848485
75,"2-{(Benzyloxy)methyl}-2-ethyl-4,4-dimethyloxazolidine",1H NMR,"(500 MHz, CDCl3) δ 7.37 – 7.26 (m, 5H, Ar-H), 4.62 (d, J = 12.2 Hz, 1H, H-5), 4.57 (d, J = 12.2
Hz, 1H, H-5), 3.60 (d, J = 7.8 Hz, 1H, H-10), 3.58 (d, J = 7.8 Hz, 1H, H-10), 3.45 (d, J = 10.1 Hz, 1H, H-
4), 3.42 (d, J = 10.1 Hz, 1H, H-4), 1.72 (qd, J = 7.5, 1.4 Hz, 2H, H-2), 1.25 (s, 3H, H-13), 1.23 (s, 3H, H-
13), 0.89 (t, J = 7.6 Hz, 3H, H-1)",CCC1(COCc2ccccc2)NC(C)(C)CO1,1020,,,,,
76,"2-{(Benzyloxy)methyl}-2-ethyl-4,4-dimethyloxazolidine",13C NMR,"(126 MHz, CDCl3) δ 138.3, 128.3, 127.6, 127.5, 98.4, 77.5,
73.4, 72.9, 59.0, 30.4, 28.3, 27.8, 8.6",CCC1(COCc2ccccc2)NC(C)(C)CO1,1021,1.0,1.0,1.0,1.0,0.8484848484848485
77,"2-{(Benzyloxy)methyl}-2-ethyl-4,4-dimethyloxazolidine",MS,"(ESI) found [M+H]+ 250.1796, C15H23NO2 requires
250.1801",CCC1(COCc2ccccc2)NC(C)(C)CO1,1022,1.0,1.0,1.0,1.0,0.8484848484848485
78,N-Methoxy-N-methyl-4-(1-tosylpiperidin-4-yl)butanamide,Rf,"(ethyl acetate
in petroleum ether, 50%): 0.39",CON(C)C(=O)CCCC1CCN(S(=O)(=O)c2ccc(C)cc2)CC1,1023,1.0,1.0,1.0,1.0,
79,N-Methoxy-N-methyl-4-(1-tosylpiperidin-4-yl)butanamide,IR,"2935, 1663, 1417, 1385, 1334, 1306, 1248, 1157,
1095, 1048, 989, 928, 854, 817, 724",CON(C)C(=O)CCCC1CCN(S(=O)(=O)c2ccc(C)cc2)CC1,1024,1.0,1.0,1.0,1.0,
80,N-Methoxy-N-methyl-4-(1-tosylpiperidin-4-yl)butanamide,1H NMR,"(500 MHz, CDCl3) δ 7.63 (d, J = 8.3 Hz, 2H, H-11), 7.31
(d, J = 7.9 Hz, 2H, H-12), 3.75 (d, J = 11.7 Hz, 2H, H-9), 3.65 (s, 3H, H-2), 3.15 (s, 3H, H-1), 2.43 (s,
3H, H-14), 2.37 (t, J = 7.4 Hz, 2H, H-4), 2.20 (td, J = 11.8, 2.4 Hz, 2H, H-9), 1.73 (dd, J = 12.8, 1.9 Hz,
2H, H-8), 1.66 – 1.51 (m, 2H, H-5), 1.40 – 1.21 (m, 4H, H-6 and H-8), 1.19 – 1.05 (m, 1H, H-7)",CON(C)C(=O)CCCC1CCN(S(=O)(=O)c2ccc(C)cc2)CC1,1025,1.0,1.0,1.0,1.0,
81,N-Methoxy-N-methyl-4-(1-tosylpiperidin-4-yl)butanamide,13C NMR,"(126 MHz, CDCl3) δ 174.4, 143.3, 133.2, 129.5, 127.7, 61.2, 46.4, 35.8, 35.1, 32.1, 31.8, 31.5,
21.7, 21.5",CON(C)C(=O)CCCC1CCN(S(=O)(=O)c2ccc(C)cc2)CC1,1026,1.0,1.0,1.0,1.0,
82,N-Methoxy-N-methyl-4-(1-tosylpiperidin-4-yl)butanamide,MS,"(ESI) found [M+H]+ 369.1848, C18H29N2O4S requires 369.1843",CON(C)C(=O)CCCC1CCN(S(=O)(=O)c2ccc(C)cc2)CC1,1027,1.0,1.0,1.0,1.0,
83,6-(1-Tosylpiperidin-4-yl)hexan-3-one,Rf,"(ethyl acetate in petroleum
ether, 20%): 0.30",CCC(=O)CCCC1CCN(S(=O)(=O)c2ccc(C)cc2)CC1,1028,0.41,1.0,1.0,1.0,0.4470588235294118
84,6-(1-Tosylpiperidin-4-yl)hexan-3-one,IR,"(film): 2922, 2852, 1714, 1597, 1465, 1338, 1305, 1247, 1161, 1108,
1087, 1046, 975, 928, 849, 814, 728",CCC(=O)CCCC1CCN(S(=O)(=O)c2ccc(C)cc2)CC1,1029,0.41,1.0,1.0,1.0,0.4470588235294118
85,6-(1-Tosylpiperidin-4-yl)hexan-3-one,1H NMR,"(500 MHz, CDCl3) δ 7.63 (d, J = 8.3 Hz, 2H, H-11), 7.31
(dd, J = 8.3 Hz, 2H, H-12), 3.75 (d, J = 11.6 Hz, 2H, H-9), 2.43 (s, 3H, H-14), 2.38 (q, J = 7.3 Hz, 2H, H-
2), 2.35 (t, J = 7.3 Hz, 2H, H-4), 2.19 (td, J = 11.8, 2.4 Hz, 2H, H-9), 1.71 (ddd, J = 14.3, 11.8, 3.1 Hz,
2H, H-8), 1.57 – 1.48 (m, 2H, H-5), 1.27 (ddd, J = 14.3, 12.4, 4.0 Hz, 2H, H-8), 1.21 – 1.08 (m, 3H, H-6
and H-7), 1.03 (t, J = 7.3 Hz, 3H, H-1)",CCC(=O)CCCC1CCN(S(=O)(=O)c2ccc(C)cc2)CC1,1030,0.41,1.0,1.0,1.0,0.4470588235294118
86,6-(1-Tosylpiperidin-4-yl)hexan-3-one,13C NMR,"(126 MHz, CDCl3) δ 211.5, 143.3, 133.2, 129.5, 127.7,
46.4, 42.3, 35.9, 35.6, 35.1, 31.4, 21.5, 20.9, 7.8",CCC(=O)CCCC1CCN(S(=O)(=O)c2ccc(C)cc2)CC1,1031,0.41,1.0,1.0,1.0,0.4470588235294118
87,6-(1-Tosylpiperidin-4-yl)hexan-3-one,MS,"(ESI) found [M+H]+ 338.1787, C18H28NO3S
requires 338.1789",CCC(=O)CCCC1CCN(S(=O)(=O)c2ccc(C)cc2)CC1,1032,0.41,1.0,1.0,1.0,0.4470588235294118
88,2-Ethyl-2-(3-[1-tosylpiperidin-4-yl]propyl)-3-oxa-1-azaspiro[4.5]decane,Rf,"(ethyl acetate in petroleum ether,
50%): 0.43",CCC1(CCCC2CCN(S(=O)(=O)c3ccc(C)cc3)CC2)NC2(CCCCC2)CO1,1033,1.0,1.0,1.0,1.0,0.9541284403669725
89,2-Ethyl-2-(3-[1-tosylpiperidin-4-yl]propyl)-3-oxa-1-azaspiro[4.5]decane,IR,"(film): 2925, 2850, 1598, 1449, 1339, 1251, 1163, 1094, 1049, 931, 815, 724",CCC1(CCCC2CCN(S(=O)(=O)c3ccc(C)cc3)CC2)NC2(CCCCC2)CO1,1034,1.0,1.0,1.0,1.0,0.9541284403669725
90,2-Ethyl-2-(3-[1-tosylpiperidin-4-yl]propyl)-3-oxa-1-azaspiro[4.5]decane,1H NMR,"(400 MHz, CDCl3) δ 7.63 (d, J = 8.2 Hz, 2H, H-11), 7.31 (d, J = 8.2 Hz, 2H, H-12), 3.75 (d, J =
11.6 Hz, 2H, H-9), 3.60 (d, J = 8.3 Hz, 1H, H-15), 3.57 (d, J = 8.3 Hz, 1H, H-15), 2.43 (s, 3H, H-14),
2.28 – 2.13 (m, 2H, H-9), 1.77 – 1.40 (m, 12H, H-2, H-3, H-8, H-18 and H-19), 1.39 – 1.11 (m, 11H, H-5, H-6, H-7, H-8, H-18 and H-19), 0.86 (t, J = 7.5 Hz, 3H, H-1)",CCC1(CCCC2CCN(S(=O)(=O)c3ccc(C)cc3)CC2)NC2(CCCCC2)CO1,1035,1.0,1.0,1.0,1.0,0.9541284403669725
91,2-Ethyl-2-(3-[1-tosylpiperidin-4-yl]propyl)-3-oxa-1-azaspiro[4.5]decane,13C NMR,"(126 MHz, CDCl3) δ 143.3,
133.2, 129.5, 127.7, 98.4, 74.5, 62.0, 46.5, 38.2, 38.2, 38.1, 36.4, 35.1, 31.5, 31.5, 31.0, 25.4, 24.0, 21.5,
21.5, 8.7",CCC1(CCCC2CCN(S(=O)(=O)c3ccc(C)cc3)CC2)NC2(CCCCC2)CO1,1036,1.0,0.86,0.86,0.86,0.9541284403669725
92,2-Ethyl-2-(3-[1-tosylpiperidin-4-yl]propyl)-3-oxa-1-azaspiro[4.5]decane,MS,"(ESI) found [M+H]+ 449.2822, C25H41N2O3S requires 449.2819",CCC1(CCCC2CCN(S(=O)(=O)c3ccc(C)cc3)CC2)NC2(CCCCC2)CO1,1037,1.0,1.0,1.0,1.0,0.9541284403669725
93,"2-Ethyl-4,4-dimethyl-2-(3-[1-tosylpiperidin-4-yl]propyl)oxazolidine",Rf,"(ethyl acetate in petroleum ether,
50%): 0.33",CCC1(CCCC2CCN(S(=O)(=O)c3ccc(C)cc3)CC2)NC(C)(C)CO1,1038,1.0,1.0,1.0,1.0,
94,"2-Ethyl-4,4-dimethyl-2-(3-[1-tosylpiperidin-4-yl]propyl)oxazolidine",IR,"(film): 2935, 2848, 1598, 1461, 1339, 1163, 1094, 1050, 931, 816, 725",CCC1(CCCC2CCN(S(=O)(=O)c3ccc(C)cc3)CC2)NC(C)(C)CO1,1039,1.0,1.0,1.0,1.0,
95,"2-Ethyl-4,4-dimethyl-2-(3-[1-tosylpiperidin-4-yl]propyl)oxazolidine",1H NMR,"(400 MHz, CDCl3) δ 7.63 (d, J = 8.2 Hz, 2H, H-11), 7.31 (d, J = 8.1 Hz, 2H, H-12), 3.75 (d, J =
11.6 Hz, 2H, H-9), 3.55 (d, J = 8.1 Hz, 1H, H-15), 3.52 (d, J = 8.1 Hz, 1H, H-15), 2.43 (s, 3H, H-14),
2.19 (d, J = 11.6, 2H, H-9), 1.71 (d, J = 10.8 Hz, 2H, H-8), 1.64 – 1.47 (m, 4H, H-2 and H-4), 1.36 – 1.05
(m, 7H, H-5, H-6, H-7 and H-8), 1.23 (s, 3H, H-18), 1.22 (s, 3H, H-18), 0.87 (t, J = 7.5 Hz, 3H)",CCC1(CCCC2CCN(S(=O)(=O)c3ccc(C)cc3)CC2)NC(C)(C)CO1,1040,,,,,
96,"2-Ethyl-4,4-dimethyl-2-(3-[1-tosylpiperidin-4-yl]propyl)oxazolidine",13C NMR,"(126 MHz, CDCl3) δ 143.3, 133.2, 129.5, 127.7, 99.3, 76.7, 58.8, 46.5, 38.1, 36.4, 35.2, 31.5, 30.8,
28.6, 28.4, 21.5, 21.5, 8.8",CCC1(CCCC2CCN(S(=O)(=O)c3ccc(C)cc3)CC2)NC(C)(C)CO1,1041,1.0,0.94,0.94,0.94,
97,"2-Ethyl-4,4-dimethyl-2-(3-[1-tosylpiperidin-4-yl]propyl)oxazolidine",MS,"(ESI) found [M+H]+ 409.2512, C22H37N2O3S requires 409.2514",CCC1(CCCC2CCN(S(=O)(=O)c3ccc(C)cc3)CC2)NC(C)(C)CO1,1042,1.0,1.0,1.0,1.0,
98,"2-(2-Ethyl-1,3-dithian-2-yl)propan-2-ol",Rf,"(ethyl acetate in petroleum
ether, 10%): 0.33",CCC1(C(C)(C)O)SCCCS1,1043,1.0,1.0,1.0,1.0,0.6486486486486487
99,"2-(2-Ethyl-1,3-dithian-2-yl)propan-2-ol",IR,"(film): 3463 (br), 2978, 2932, 1452, 1365, 1278, 1240, 1177, 1131, 998, 959, 907, 861, 816, 798",CCC1(C(C)(C)O)SCCCS1,1044,1.0,1.0,0.07,0.13,0.6486486486486487
100,"2-(2-Ethyl-1,3-dithian-2-yl)propan-2-ol",1H NMR,"(400 MHz, CDCl3) δ 2.99 – 2.87 (m, 2H, H-7), 2.86 – 2.73 (m, 2H, H-
7), 2.52 (s, 1H, OH), 2.01 – 1.86 (m, 4H, H-2 and H-8), 1.41 (s, 6H, H-5), 1.18 (t, J = 7.3 Hz, 3H, H-1)",CCC1(C(C)(C)O)SCCCS1,1045,1.0,1.0,1.0,1.0,0.6486486486486487
101,"2-(2-Ethyl-1,3-dithian-2-yl)propan-2-ol",13C NMR,"(101 MHz, CDCl3) δ 78.8, 64.7, 30.8, 27.1, 26.2, 23.6, 11.3",CCC1(C(C)(C)O)SCCCS1,1046,1.0,1.0,1.0,1.0,0.6486486486486487
102,"2-(2-Ethyl-1,3-dithian-2-yl)propan-2-ol",MS,"(ESI) found
[M+NH4]+ 224.1132, C9H22NOS2 requires 224.1129",CCC1(C(C)(C)O)SCCCS1,1047,1.0,1.0,1.0,1.0,0.6486486486486487
103,2-Hydroxy-2-methylpentan-3-one,IR,"(film): 3469 (br), 2925, 2855, 1718, 1458, 1230, 1090, 968, 863, 735",CCC(=O)C(C)(C)O,1048,1.0,1.0,0.1,0.18,0.5454545454545454
104,2-Hydroxy-2-methylpentan-3-one,1H NMR,"(400
MHz, CDCl3) δ 2.60 (q, J = 7.3 Hz, 2H, H-2), 2.42 (s, 1H, OH), 1.41 (s, 6H, H-5), 1.14 (t, J = 7.3 Hz, 3H,
H-1)",CCC(=O)C(C)(C)O,1049,1.0,1.0,1.0,1.0,0.5454545454545454
105,2-Hydroxy-2-methylpentan-3-one,13C NMR,"(400 MHz, CDCl3) δ 215.0, 28.7, 26.6, 26.4, 7.9",CCC(=O)C(C)(C)O,1050,1.0,1.0,1.0,1.0,0.5454545454545454
106,2-(2-Ethyl-3-oxa-1-azaspiro[4.5]decan-2-yl)propan-2-ol,Rf,"(ethyl acetate in petroleum ether, 20%):
0.23",CCC1(C(C)(C)O)NC2(CCCCC2)CO1,1051,1.0,1.0,1.0,1.0,0.9824561403508771
107,2-(2-Ethyl-3-oxa-1-azaspiro[4.5]decan-2-yl)propan-2-ol,IR,"(film): 3469 (br), 2928, 2855, 1450, 1367, 1164, 1049, 946, 843, 703",CCC1(C(C)(C)O)NC2(CCCCC2)CO1,1052,1.0,1.0,0.1,0.18,0.9824561403508771
108,2-(2-Ethyl-3-oxa-1-azaspiro[4.5]decan-2-yl)propan-2-ol,1H NMR,"(500
MHz, CDCl3) δ 3.76 (d, J = 8.1 Hz, 1H, H-6), 3.69 (d, J = 8.1 Hz, 1H, H-6), 1.77 – 1.50 (m, 8H, H-2, H-
9, H-10), 1.47 – 1.29 (m, 4H, H-10 and H-11), 1.27 (s, 3H, H-5), 1.17 (s, 3H, H-5), 0.97 (t, J = 7.6 Hz,
3H, H-1)",CCC1(C(C)(C)O)NC2(CCCCC2)CO1,1053,1.0,1.0,1.0,1.0,0.9824561403508771
109,2-(2-Ethyl-3-oxa-1-azaspiro[4.5]decan-2-yl)propan-2-ol,13C NMR,"(126 MHz, CDCl3) δ 102.0, 74.3, 61.9, 38.4, 37.9, 28.6, 26.4, 26.1, 25.3, 24.6, 24.1,
24.0, 9.6",CCC1(C(C)(C)O)NC2(CCCCC2)CO1,1054,1.0,1.0,1.0,1.0,0.9824561403508771
110,2-(2-Ethyl-3-oxa-1-azaspiro[4.5]decan-2-yl)propan-2-ol,MS,"(ESI) found [M+H]+ 228.1956, C13H26NO2 requires 228.1958",CCC1(C(C)(C)O)NC2(CCCCC2)CO1,1055,1.0,1.0,1.0,1.0,0.9824561403508771
111,Methyl 4-oxohexanoate,Rf,"(ethyl acetate in petroleum ether, 20%): 0.31",CCC(=O)CCC(=O)OC,1056,1.0,1.0,1.0,1.0,0.9696969696969697
112,Methyl 4-oxohexanoate,IR,"(film):
1915, 1736, 1714, 1550, 1438, 1359, 1263, 1206, 1170, 1115, 842, 785",CCC(=O)CCC(=O)OC,1057,1.0,1.0,1.0,1.0,0.9696969696969697
113,Methyl 4-oxohexanoate,1H NMR,"(500 MHz, CDCl3) δ
3.67 (s, 3H, H-7), 2.72 (t, J = 6.5 Hz, 2H, H-4), 2.59 (t, J = 6.6 Hz, 2H, H-5), 2.48 (q, J = 7.3 Hz, 2H, H-
2), 1.07 (t, J = 7.3 Hz, 3H, H-1)",CCC(=O)CCC(=O)OC,1058,1.0,1.0,1.0,1.0,0.9696969696969697
114,Methyl 4-oxohexanoate,13C NMR,"(126 MHz, CDCl3) δ 209.4, 173.3, 51.8, 36.6, 35.9, 27.8, 7.8",CCC(=O)CCC(=O)OC,1059,1.0,1.0,1.0,1.0,0.9696969696969697
115,Methyl 3-(2-ethyl-3-oxa-1-azaspiro[4.5]decan-2-yl)propanoate,Rf,"(ethyl acetate in petroleum ether, 20%):
0.24",CCC1(CCC(=O)OC)NC2(CCCCC2)CO1,1060,1.0,1.0,1.0,1.0,1.0
116,Methyl 3-(2-ethyl-3-oxa-1-azaspiro[4.5]decan-2-yl)propanoate,IR,"(film): 2929, 2859, 1737, 1437, 1258, 1168, 1101, 1053, 923, 815, 715",CCC1(CCC(=O)OC)NC2(CCCCC2)CO1,1061,1.0,1.0,1.0,1.0,1.0
117,Methyl 3-(2-ethyl-3-oxa-1-azaspiro[4.5]decan-2-yl)propanoate,1H NMR,"(500
MHz, CDCl3) δ 3.67 (s, 3H, H-7), 3.63 (d, J = 8.3 Hz, 1H, H-8), 3.59 (d, J = 8.3 Hz, 1H, H-8), 2.41 –
2.33 (m, 2H, H-5), 1.96 – 1.88 (m, 2H, H-4), 1.70 – 1.27 (m, 12H, H-2, H-11, H-12 and H-13), 0.91 (t, J
= 7.5 Hz, 3H, H-1)",CCC1(CCC(=O)OC)NC2(CCCCC2)CO1,1062,1.0,1.0,1.0,1.0,1.0
118,Methyl 3-(2-ethyl-3-oxa-1-azaspiro[4.5]decan-2-yl)propanoate,13C NMR,"(126 MHz, CDCl3) δ 174.3, 97.6, 74.8, 62.0, 51.6, 38.1, 38.1, 32.9, 31.1,
29.7, 25.4, 24.0, 23.8, 8.5",CCC1(CCC(=O)OC)NC2(CCCCC2)CO1,1063,1.0,0.93,0.93,0.93,1.0
119,Methyl 3-(2-ethyl-3-oxa-1-azaspiro[4.5]decan-2-yl)propanoate,MS,"(ESI) found [M+H]+ 256.1910, C14H26NO3 requires 256.1907",CCC1(CCC(=O)OC)NC2(CCCCC2)CO1,1064,1.0,1.0,1.0,1.0,1.0
120,"Methyl 3-(2-ethyl-4,4-dimethyloxazolidin-2-yl)propanoate",Rf,"(ethyl acetate in petroleum ether, 25%):
0.21",CCC1(CCC(=O)OC)NC(C)(C)CO1,1065,1.0,1.0,1.0,1.0,0.8666666666666667
121,"Methyl 3-(2-ethyl-4,4-dimethyloxazolidin-2-yl)propanoate",IR,"(film): 2964, 2866, 1736, 1437, 1365, 1258, 1195, 1167, 1053, 992, 904, 834",CCC1(CCC(=O)OC)NC(C)(C)CO1,1066,1.0,1.0,1.0,1.0,0.8666666666666667
122,"Methyl 3-(2-ethyl-4,4-dimethyloxazolidin-2-yl)propanoate",1H NMR,"(500 MHz, CDCl3) δ 3.67 (s, 3H, H-7), 3.59 (d, J = 8.1 Hz, 1H, H-8), 3.54 (d, J = 8.1 Hz, 1H, H-
8), 2.42 – 2.33 (m, 2H, H-5), 2.00 – 1.87 (m, 2H, H-4), 1.65 – 1.55 (q, J = 7.5 Hz, 2H, H-2), 1.25 (s, 3H,
H-11), 1.24 (s, 3H, H-11), 0.92 (t, J = 7.5 Hz, 3H, H-1)",CCC1(CCC(=O)OC)NC(C)(C)CO1,1067,,,,,
123,"Methyl 3-(2-ethyl-4,4-dimethyloxazolidin-2-yl)propanoate",13C NMR,"(126 MHz, CDCl3) δ 174.3, 98.5,
76.8, 58.9, 51.6, 32.7, 31.0, 29.7, 28.5, 28.5, 8.6",CCC1(CCC(=O)OC)NC(C)(C)CO1,1068,1.0,0.91,0.91,0.91,0.8666666666666667
124,"Methyl 3-(2-ethyl-4,4-dimethyloxazolidin-2-yl)propanoate",MS,"(ESI) found [M+H]+ 216.1593,
C11H22NO3 requires 216.1594",CCC1(CCC(=O)OC)NC(C)(C)CO1,1069,1.0,1.0,1.0,1.0,0.8666666666666667
125,"(E)-2-(Butan-2-ylidene)-1,1-dimethylhydrazine",IR,"(film): 2974, 2951, 2854, 2817, 1638, 1466, 1359, 1196, 1155, 1074,
1022, 975, 947, 848, 731",CC/C(C)=N/N(C)C,1070,1.0,1.0,1.0,1.0,
126,"(E)-2-(Butan-2-ylidene)-1,1-dimethylhydrazine",1H NMR,"(400 MHz, CDCl3) δ 2.47 (q, J = 7.7 Hz, 2H, H-3; minor), 2.44 (s,
6H, H-5; major), 2.42 (s, 6H, H-5; minor), 2.22 (q, J = 7.6 Hz, 2H, H-3; major), 1.95 (s, 3H, H-1; major),
1.92 (s, 3H, H-1; minor), 1.10 (t, J = 7.7 Hz, 3H, H-4; minor), 1.09 (t, J = 7.6 Hz, 3H, H-4; major)",CC/C(C)=N/N(C)C,1071,1.0,1.0,1.0,1.0,
127,"(E)-2-(Butan-2-ylidene)-1,1-dimethylhydrazine",13C NMR,"(101 MHz, CDCl3) δ 170.8 (minor), 169.2 (major), 48.0 (minor), 47.4 (major), 32.6 (major), 24.9
(minor), 22.5 (minor), 16.4 (major), 11.9 (major), 11.4 (minor)",CC/C(C)=N/N(C)C,1072,1.0,1.0,1.0,1.0,
128,(E)-6-Bromohex-2-ene,IR,"(film): 2920, 2851, 1739, 1464, 1375,
1242, 1017, 803",C/C=C/CCCBr,1073,1.0,1.0,1.0,1.0,0.6206896551724138
129,(E)-6-Bromohex-2-ene,1H NMR,"(400 MHz, CDCl3) δ 5.59 – 5.42 (m, 1H, H-2), 5.42 – 5.30 (m, 1H, H-3), 3.40
(t, J = 6.8 Hz, 2H, H-6), 2.17 – 2.09 (m, 2H, H-4), 1.90 (quint, J = 7.0 Hz, 2H, H-5), 1.65 (ddd, J = 6.3,
2.6, 1.2 Hz, 3H, H-1)",C/C=C/CCCBr,1074,1.0,0.89,0.89,0.89,0.6206896551724138
130,(E)-6-Bromohex-2-ene,13C NMR,"(101 MHz, CDCl3) δ 129.2, 126.5, 33.3, 32.5, 30.9, 17.9",C/C=C/CCCBr,1075,1.0,1.0,1.0,1.0,0.6206896551724138
131,(E)-Dec-8-en-3-one,Rf,"(ethyl acetate in petroleum ether, 20%): 0.32",C/C=C/CCCCC(=O)CC,1076,1.0,1.0,1.0,1.0,0.45161290322580644
132,(E)-Dec-8-en-3-one,IR,"(film): 2935,
2856, 1714, 1454, 1413, 1376, 1111, 965, 732",C/C=C/CCCCC(=O)CC,1077,1.0,1.0,1.0,1.0,0.45161290322580644
133,(E)-Dec-8-en-3-one,1H NMR,"(500 MHz, CDCl3) δ 5.49 – 5.30 (m, 2H, H-2
and H-3), 2.44 – 2.36 (m, 4H, H-7 and H-9), 2.02 – 1.94 (m, 2H, H-4), 1.65 – 1.62 (m, 3H, H-1), 1.61 –
1.52 (m, 2H, H-6), 1.39 – 1.27 (m, 2H, H-5), 1.04 (t, J = 7.3 Hz, 3H, H-10)",C/C=C/CCCCC(=O)CC,1078,1.0,1.0,1.0,1.0,0.45161290322580644
134,(E)-Dec-8-en-3-one,13C NMR,"(126 MHz, CDCl3)
δ 211.9, 131.0, 125.1, 42.3, 35.9, 32.3, 29.2, 23.4, 17.9, 7.8",C/C=C/CCCCC(=O)CC,1079,1.0,0.71,1.0,0.83,0.45161290322580644
135,(E)-2-Ethyl-2-(hept-5-en-1-yl)-3-oxa-1-azaspiro[4.5]decane,Rf,"(ethyl acetate in petroleum ether, 25%):
0.41",C/C=C/CCCCC1(CC)NC2(CCCCC2)CO1,1080,1.0,1.0,1.0,1.0,0.7936507936507936
136,(E)-2-Ethyl-2-(hept-5-en-1-yl)-3-oxa-1-azaspiro[4.5]decane,IR,"(film): 2928, 2853, 2191, 1450, 1195, 1114, 1055, 965, 813, 738",C/C=C/CCCCC1(CC)NC2(CCCCC2)CO1,1081,1.0,1.0,1.0,1.0,0.7936507936507936
137,(E)-2-Ethyl-2-(hept-5-en-1-yl)-3-oxa-1-azaspiro[4.5]decane,1H NMR,"(500 MHz,
CDCl3) δ 5.44 – 5.37 (m, 2H, H-8 and H-9), 3.62 (d, J = 8.4 Hz, 1H, H-11), 3.60 (d, J = 8.4 Hz, 1H, H-
11), 2.01 – 1.95 (m, 2H, H-7), 1.71 – 1.43 (m, 15H, H-2, H-4, H-14 and H-15), 1.39 – 1.26 (m, 6H, H-5,
H-6 and H-16), 0.89 (t, J = 7.5 Hz, 3H, H-1)",C/C=C/CCCCC1(CC)NC2(CCCCC2)CO1,1082,1.0,1.0,1.0,1.0,0.7936507936507936
138,(E)-2-Ethyl-2-(hept-5-en-1-yl)-3-oxa-1-azaspiro[4.5]decane,13C NMR,"(126 MHz, CDCl3) δ 131.4, 124.8, 98.6, 74.4,
62.0, 38.1, 38.1, 37.9, 32.5, 31.0, 30.0, 25.4, 24.1, 24.0, 23.9, 17.9, 8.8",C/C=C/CCCCC1(CC)NC2(CCCCC2)CO1,1083,1.0,0.94,0.94,0.94,0.7936507936507936
139,(E)-2-Ethyl-2-(hept-5-en-1-yl)-3-oxa-1-azaspiro[4.5]decane,MS,"(ESI) found [M+H]+
266.2475, C17H32NO requires 266.2478",C/C=C/CCCCC1(CC)NC2(CCCCC2)CO1,1084,1.0,1.0,1.0,1.0,0.7936507936507936
140,"(E)-2-Ethyl-2-(hept-5-en-1-yl)-4,4-dimethyloxazolidine",Rf,"(ethyl acetate in petroleum ether, 25%): 0.31",C/C=C/CCCCC1(CC)NC(C)(C)CO1,1085,1.0,1.0,1.0,1.0,0.7586206896551724
141,"(E)-2-Ethyl-2-(hept-5-en-1-yl)-4,4-dimethyloxazolidine",IR,"(film): 2963, 2933, 2856, 1460, 1381, 1364, 1199, 1056, 964, 827, 769",C/C=C/CCCCC1(CC)NC(C)(C)CO1,1086,1.0,1.0,1.0,1.0,0.7586206896551724
142,"(E)-2-Ethyl-2-(hept-5-en-1-yl)-4,4-dimethyloxazolidine",1H NMR,"(500 MHz, CDCl3) δ
5.48 – 5.32 (m, 2H, H-8 and H-9), 3.56 (d, J = 8.3 Hz, 1H, H-11), 3.54 (d, J = 8.3 Hz, 1H, H-11), 2.05 –
1.92 (m, 2H, H-7), 1.65 – 1.51 (m, 7H, H-2, H-4 and H-10), 1.40 – 1.27 (m, 4H, H-5 and H-6), 1.24 (s,
3H, H-14), 1.24 (s, 3H, H-14), 0.89 (t, J = 7.5 Hz, 3H, H-1)",C/C=C/CCCCC1(CC)NC(C)(C)CO1,1087,1.0,0.92,0.92,0.92,0.7586206896551724
143,"(E)-2-Ethyl-2-(hept-5-en-1-yl)-4,4-dimethyloxazolidine",13C NMR,"(126 MHz, CDCl3) δ 131.3, 124.8,
99.5, 76.8, 58.8, 37.8, 32.5, 30.9, 29.9, 28.5, 28.4, 23.9, 17.9, 8.8",C/C=C/CCCCC1(CC)NC(C)(C)CO1,1088,1.0,1.0,1.0,1.0,0.7586206896551724
144,"(E)-2-Ethyl-2-(hept-5-en-1-yl)-4,4-dimethyloxazolidine",MS,"(ESI) found [M+H]+
226.2162, C14H28NO requires 226.2165",C/C=C/CCCCC1(CC)NC(C)(C)CO1,1089,1.0,1.0,1.0,1.0,0.7586206896551724
145,Hept-6-en-3-one,Rf,"(ethyl acetate in petroleum ether, 10%): 0.29",C=CCCC(=O)CC,1090,1.0,1.0,1.0,1.0,0.4782608695652174
146,Hept-6-en-3-one,IR,"(film): 2971, 1936, 1716,
1658, 1407, 1272, 1177, 1114, 773",C=CCCC(=O)CC,1091,1.0,1.0,1.0,1.0,0.4782608695652174
147,Hept-6-en-3-one,1H NMR,"(500 MHz, CDCl3) δ 5.80 (ddt, J = 17.1, 10.2, 6.5 Hz, 1H,
H-7), 5.02 (apparent dq, J = 17.1, 1.7 Hz, 1H, H-9), 4.97 (apparent ddd, J = 10.2, 2.9, 1.7 Hz, 1H, H-10),
2.50 (t, J = 7.4 Hz, 2H, H-4), 2.42 (q, J = 7.3 Hz, 2H, H-2), 2.35 – 2.29 (m, 2H, H-5), 1.05 (t, J = 7.3 Hz,
3H, H-1)",C=CCCC(=O)CC,1092,1.0,1.0,1.0,1.0,0.4782608695652174
148,Hept-6-en-3-one,13C NMR,"(126 MHz, CDCl3) δ 210.8, 137.2, 115.1, 41.4, 36.0, 27.8, 7.8",C=CCCC(=O)CC,1093,1.0,1.0,1.0,1.0,0.4782608695652174
149,"2-(But-3-en-1-yl)-2-ethyl-4,4-dimethyloxazolidine",Rf,"(ethyl acetate in petroleum ether, 20%): 0.32",C=CCCC1(CC)NC(C)(C)CO1,1094,0.22,1.0,1.0,1.0,0.676923076923077
150,"2-(But-3-en-1-yl)-2-ethyl-4,4-dimethyloxazolidine",IR,"(film):
2966, 2937, 2362, 1641, 1450, 1382, 1365, 1196, 1056, 907, 831, 774",C=CCCC1(CC)NC(C)(C)CO1,1095,0.22,1.0,1.0,1.0,0.676923076923077
151,"2-(But-3-en-1-yl)-2-ethyl-4,4-dimethyloxazolidine",1H NMR,"(500 MHz, CDCl3) δ
5.84 (ddt, J = 16.8, 10.2, 6.5 Hz, 1H, H-6), 5.03 (apparent dq, J = 16.8, 1.7 Hz, 1H, H-9), 4.95 (apparent
ddd, J = 10.2, 3.2, 1.7 Hz, 1H, H-8), 3.58 (d, J = 8.1 Hz, 1H, H-10), 3.56 (d, J = 8.1 Hz, 1H, H-10), 2.16 –
2.05 (m, 2H, H-5), 1.76 – 1.54 (m, 4H, H-4 and H-2), 1.25 (s, 3H, H-13), 1.25 (s, 3H, H-13), 0.91 (t, J =
7.5 Hz, 3H, H-1)",C=CCCC1(CC)NC(C)(C)CO1,1096,0.22,0.92,0.92,0.92,0.676923076923077
152,"2-(But-3-en-1-yl)-2-ethyl-4,4-dimethyloxazolidine",13C NMR,"(126 MHz, CDCl3) δ 138.7, 114.3, 99.2, 76.9, 58.9, 37.0, 31.0, 28.8, 28.5,
28.5, 8.7",C=CCCC1(CC)NC(C)(C)CO1,1097,0.22,0.91,0.91,0.91,0.676923076923077
153,"2-(But-3-en-1-yl)-2-ethyl-4,4-dimethyloxazolidine",MS,"(ESI) found [M+H]+ 184.1693, C11H21NO requires 184.1696",C=CCCC1(CC)NC(C)(C)CO1,1098,0.22,1.0,1.0,1.0,0.676923076923077
154,"Ethyl 2-(2-ethyl-4,4-dimethyloxazolidin-2-yl)acetate",Rf,"(ethyl acetate in petroleum ether, 20%):
0.22",CCOC(=O)CC1(CC)NC(C)(C)CO1,1104,1.0,1.0,1.0,1.0,1.0
155,"Ethyl 2-(2-ethyl-4,4-dimethyloxazolidin-2-yl)acetate",IR,"(film): 2970, 2934, 1723, 1464, 1367, 1198, 1096, 1049, 917, 815, 779",CCOC(=O)CC1(CC)NC(C)(C)CO1,1105,1.0,1.0,1.0,1.0,1.0
156,"Ethyl 2-(2-ethyl-4,4-dimethyloxazolidin-2-yl)acetate",1H NMR,"(500
MHz, CDCl3) δ 4.14 (q, J = 7.1 Hz, 2H, H-6), 3.59 (d, J = 8.0 Hz, 1H, H-8), 3.55 (d, J = 8.0 Hz, 1H, H-
8), 2.64 (d, J = 14.0 Hz, 1H, H-4), 2.61 (d, J = 14.0 Hz, 1H, H-4), 1.77 (tt, J = 7.6, 4.0 Hz, 2H, H-2), 1.27
(s, 3H, H-10), 1.27 (t, J = 7.1 Hz, 3H, H-7), 1.24 (s, 3H, H-10)",CCOC(=O)CC1(CC)NC(C)(C)CO1,1106,1.0,0.89,0.89,0.89,1.0
157,"Ethyl 2-(2-ethyl-4,4-dimethyloxazolidin-2-yl)acetate",13C NMR,"(126 MHz, CDCl3) δ 170.9,
97.8, 77.3, 60.6, 59.1, 42.4, 32.9, 28.6, 27.9, 14.2, 8.8",CCOC(=O)CC1(CC)NC(C)(C)CO1,1107,1.0,1.0,1.0,1.0,1.0
158,"Ethyl 2-(2-ethyl-4,4-dimethyloxazolidin-2-yl)acetate",MS,"(ESI) found [M+H]+ 216.1588,
C11H22NO3 requires 216.1588",CCOC(=O)CC1(CC)NC(C)(C)CO1,1108,1.0,1.0,1.0,1.0,1.0
159,2-Ethyl-2-(trifluoromethyl)-3-oxa-1-azaspiro[4.5]decane,Rf,"(ethyl acetate in petroleum ether, 25%): 0.24",CCC1(C(F)(F)F)NC2(CCCCC2)CO1,1109,1.0,1.0,1.0,1.0,0.9824561403508771
160,2-Ethyl-2-(trifluoromethyl)-3-oxa-1-azaspiro[4.5]decane,IR,"(film): 2931, 2858, 1453, 1382, 1300, 1153, 1082, 1045, 945, 814, 714",CCC1(C(F)(F)F)NC2(CCCCC2)CO1,1110,1.0,1.0,1.0,1.0,0.9824561403508771
161,2-Ethyl-2-(trifluoromethyl)-3-oxa-1-azaspiro[4.5]decane,1H NMR,"(500 MHz,
CDCl3) δ 3.92 – 3.76 (m, 2H, H-5), 2.00 – 1.84 (m, 2H, H-2), 1.80 – 1.24 (m, 10H, H-8, H-9 and H-10),
1.00 (td, J = 7.5, 0.7 Hz, 3H, H-1)",CCC1(C(F)(F)F)NC2(CCCCC2)CO1,1111,1.0,1.0,1.0,1.0,0.9824561403508771
162,2-Ethyl-2-(trifluoromethyl)-3-oxa-1-azaspiro[4.5]decane,13C NMR,"(126 MHz, CDCl3) δ 125.1 (q, J = 289.1 Hz), 95.5 (q, J =
28.9 Hz), 77.3, 62.3, 38.1, 37.2, 26.1, 25.1, 24.2, 23.8, 6.7",CCC1(C(F)(F)F)NC2(CCCCC2)CO1,1112,1.0,1.0,1.0,1.0,0.9824561403508771
163,2-Ethyl-2-(trifluoromethyl)-3-oxa-1-azaspiro[4.5]decane,19F NMR,"(376 MHz, MeOD) δ -86.15",CCC1(C(F)(F)F)NC2(CCCCC2)CO1,1113,,,,,
164,2-Ethyl-2-(trifluoromethyl)-3-oxa-1-azaspiro[4.5]decane,MS,"(ESI) found [M+H]+ 238.1412, C11H19F3NO requires 238.1411",CCC1(C(F)(F)F)NC2(CCCCC2)CO1,1114,1.0,1.0,1.0,1.0,0.9824561403508771
165,2-Ethyl-2-phenyl-3-oxa-1-azaspiro[4.5]decane,Rf,"(ethyl acetate in petroleum ether, 25%): 0.34",CCC1(c2ccccc2)NC2(CCCCC2)CO1,1115,1.0,1.0,1.0,1.0,0.9824561403508771
166,2-Ethyl-2-phenyl-3-oxa-1-azaspiro[4.5]decane,IR,"(film): 2927, 2854, 1602, 1448, 1196, 1173,
1045, 919, 814, 757, 702",CCC1(c2ccccc2)NC2(CCCCC2)CO1,1116,1.0,1.0,1.0,1.0,0.9824561403508771
167,2-Ethyl-2-phenyl-3-oxa-1-azaspiro[4.5]decane,1H NMR,"(500 MHz, CDCl3) δ 7.56 – 7.51 (m, 2H, H-5), 7.34 – 7.27 (m, 2H,
H-6), 7.25 – 7.20 (m, 1H, H-7), 3.66 (d, J = 8.0 Hz, 1H, H-8), 3.46 (d, J = 8.0 Hz, 1H, H-8), 1.92 – 1.75
(m, 2H, H-2), 1.74 – 1.49 (m, 4H, H-10, H-11), 1.45 – 1.29 (m, 3H, H-11, H-12), 1.24 – 1.04 (m, 3H, H-
10, H-12), 0.81 (t, J = 7.5 Hz, 3H, H-1)",CCC1(c2ccccc2)NC2(CCCCC2)CO1,1117,1.0,1.0,1.0,1.0,0.9824561403508771
168,2-Ethyl-2-phenyl-3-oxa-1-azaspiro[4.5]decane,13C NMR,"(101 MHz, CDCl3) δ 145.17, 127.63, 126.89, 126.43,
99.24, 75.20, 62.68, 38.16, 36.96, 35.96, 25.45, 24.17, 23.39, 8.56",CCC1(c2ccccc2)NC2(CCCCC2)CO1,1118,1.0,1.0,1.0,1.0,0.9824561403508771
169,2-Ethyl-2-phenyl-3-oxa-1-azaspiro[4.5]decane,MS,"(ESI) found [M+H]+
246.1846, C16H24NO requires 246.1852",CCC1(c2ccccc2)NC2(CCCCC2)CO1,1119,1.0,1.0,1.0,1.0,0.9824561403508771
170,N-Methoxy-N-methyl-4-nitrobenzamide,IR,"(film): 2953, 2854, 1685, 1543, 1390, 1362, 1177, 1071, 991, 914, 756",CON(C)C(=O)c1ccc([N+](=O)[O-])cc1,1120,1.0,1.0,1.0,1.0,0.16216216216216217
171,N-Methoxy-N-methyl-4-nitrobenzamide,1H NMR,"(400 MHz,
CDCl3) δ 8.26 (d, J = 8.9 Hz, 2H, H-2), 7.84 (d, J = 8.9 Hz, 2H, H-3), 3.53 (s, 3H, H-7), 3.39 (s, 3H, H-
6)",CON(C)C(=O)c1ccc([N+](=O)[O-])cc1,1121,1.0,1.0,1.0,1.0,0.16216216216216217
172,N-Methoxy-N-methyl-4-nitrobenzamide,13C NMR,"(101 MHz, CDCl3) δ 167.7, 148.9, 140.1, 129.2, 123.2, 61.4, 33.2",CON(C)C(=O)c1ccc([N+](=O)[O-])cc1,1122,1.0,1.0,1.0,1.0,0.16216216216216217
173,1-(4-Nitrophenyl)propan-1-one,Rf,"(ethyl acetate in
petroleum ether, 10%): 0.30",CCC(=O)c1ccc([N+](=O)[O-])cc1,1123,0.23,1.0,1.0,1.0,0.8888888888888888
174,1-(4-Nitrophenyl)propan-1-one,IR,"(film): 2985, 1686, 1602, 1519, 1341, 1320, 1211, 953, 852,
804, 740, 682",CCC(=O)c1ccc([N+](=O)[O-])cc1,1124,0.23,1.0,1.0,1.0,0.8888888888888888
175,1-(4-Nitrophenyl)propan-1-one,1H NMR,"(400 MHz, CDCl3) δ 8.31 (d, J = 9.0 Hz, 2H, H-2), 8.11 (d, J = 9.0 Hz, 1H, H-
3), 3.06 (q, J = 7.2 Hz, 1H, H-6), 1.26 (t, J = 7.2 Hz, 2H, H-7)",CCC(=O)c1ccc([N+](=O)[O-])cc1,1125,0.23,1.0,1.0,1.0,0.8888888888888888
176,1-(4-Nitrophenyl)propan-1-one,13C NMR,"(101 MHz, CDCl3) δ 199.1,
150.3, 141.3, 129.0, 123.9, 32.5, 7.9",CCC(=O)c1ccc([N+](=O)[O-])cc1,1126,0.23,0.0,0.0,0.0,0.8888888888888888
177,2-Ethyl-2-phenethyl-3-oxa-1-azaspiro[4.5]decane,Rf,"(ethyl acetate in petroleum ether, 20%):
0.26",CCC1(CCc2ccccc2)NC2(CCCCC2)CO1,1132,1.0,1.0,1.0,1.0,1.0
178,2-Ethyl-2-phenethyl-3-oxa-1-azaspiro[4.5]decane,IR,"(film): 2928, 2854, 1604, 1496, 1451, 1054, 814, 746, 698",CCC1(CCc2ccccc2)NC2(CCCCC2)CO1,1133,1.0,1.0,1.0,1.0,1.0
179,2-Ethyl-2-phenethyl-3-oxa-1-azaspiro[4.5]decane,1H NMR,"(500 MHz,
CDCl3) δ 7.28 (t, J = 6.6 Hz, 2H, H-8), 7.22 – 7.14 (m, 2H, H-7 and H-9), 3.67 (d, J = 8.3 Hz, 1H, H-10),
3.64 (d, J = 8.3 Hz, 1H, H-10), 2.77 – 2.59 (m, 2H, H-5), 1.93 – 1.84 (m, 2H, H-4), 1.74 – 1.26 (m, 13H,
H-2, H-13, H-14 and H-15), 0.95 (t, J = 7.5 Hz, 3H, H-1)",CCC1(CCc2ccccc2)NC2(CCCCC2)CO1,1134,1.0,1.0,1.0,1.0,1.0
180,2-Ethyl-2-phenethyl-3-oxa-1-azaspiro[4.5]decane,13C NMR,"(126 MHz, CDCl3) δ 142.5,
128.4(x2), 128.3(x2), 125.7, 98.3, 74.7, 62.1, 39.9, 38.2, 38.1, 31.1, 31.0, 25.4, 24.0, 23.9, 8.7",CCC1(CCc2ccccc2)NC2(CCCCC2)CO1,1135,1.0,1.0,1.0,1.0,1.0
181,2-Ethyl-2-phenethyl-3-oxa-1-azaspiro[4.5]decane,MS,"(ESI) found [M+H]+ 274.2161, C18H27NO requires 274.2165",CCC1(CCc2ccccc2)NC2(CCCCC2)CO1,1136,1.0,1.0,1.0,1.0,1.0
182,"2-Ethyl-4,4-dimethyl-2-phenethyloxazolidine",Rf,"(ethyl acetate in petroleum ether, 25%): 0.23",CCC1(CCc2ccccc2)NC(C)(C)CO1,1137,1.0,1.0,1.0,1.0,0.7605633802816901
183,"2-Ethyl-4,4-dimethyl-2-phenethyloxazolidine",IR,"(film): 2964, 2891, 1496, 1455, 1364, 1200, 1054, 900, 841, 746",CCC1(CCc2ccccc2)NC(C)(C)CO1,1138,1.0,1.0,1.0,1.0,0.7605633802816901
184,"2-Ethyl-4,4-dimethyl-2-phenethyloxazolidine",1H NMR,"(500 MHz, CDCl3) δ 7.30 –
7.26 (m, 2H, H-8), 7.22 – 7.16 (m, 3H, H-7 and H-9), 3.62 (d, J = 8.1 Hz, 1H, H-10), 3.60 (d, J = 8.1 Hz,
1H, H-10), 2.75 – 2.61 (m, 2H, H-5), 1.91 (dd, J = 12.9, 4.8 Hz, 2H, H-4), 1.78 – 1.65 (m, 2H, H-2), 1.27
(s, 3H, H-13), 1.26 (s, 3H, H-13), 0.97 (t, J = 7.5 Hz, 3H, H-1)",CCC1(CCc2ccccc2)NC(C)(C)CO1,1139,1.0,1.0,1.0,1.0,0.7605633802816901
185,"2-Ethyl-4,4-dimethyl-2-phenethyloxazolidine",13C NMR,"(126 MHz, CDCl3) δ 142.5, 128.5, 128.4, 125.9, 99.3, 77.1, 59.1, 39.9, 31.2, 31.1, 28.7, 28.7, 8.9",CCC1(CCc2ccccc2)NC(C)(C)CO1,1140,1.0,0.85,0.85,0.85,0.7605633802816901
186,"2-Ethyl-4,4-dimethyl-2-phenethyloxazolidine",MS,"(ESI) found [M+H]+
234.1846, C15H24NO requires 234.1851",CCC1(CCc2ccccc2)NC(C)(C)CO1,1141,1.0,1.0,1.0,1.0,0.7605633802816901
187,2-Cyclopropyl-N-methoxy-N-methylacetamide,Rf,"(ethyl acetate in petroleum ether, 25%): 0.27",CON(C)C(=O)CC1CC1,1142,0.16,1.0,1.0,1.0,1.0
188,2-Cyclopropyl-N-methoxy-N-methylacetamide,IR,"(film): 3003, 2942, 1659, 1463, 1414, 1367, 1176, 1008, 979, 951, 832, 805, 772, 670",CON(C)C(=O)CC1CC1,1143,0.16,1.0,1.0,1.0,1.0
189,2-Cyclopropyl-N-methoxy-N-methylacetamide,1H NMR,"(400 MHz, CDCl3) δ 3.66 (s, 3H, H-6), 3.19 (s, 3H, H-5), 2.34 (d, J = 6.9 Hz, 2H, H-3), 1.16 – 0.99
(m, 1H, H-2), 0.60 – 0.49 (m, 2H, H-1), 0.20 – 0.12 (m, 2H, H-1)",CON(C)C(=O)CC1CC1,1144,,,,,
190,2-Cyclopropyl-N-methoxy-N-methylacetamide,13C NMR,"(101 MHz, CDCl3) δ 182.8,
61.5, 37.4, 32.2, 6.7, 4.4",CON(C)C(=O)CC1CC1,1145,0.16,1.0,1.0,1.0,1.0
191,1-Cyclopropylbutan-2-one,IR,"(film): 2965,
2924, 1714, 1460, 1378, 1259, 1095, 1017, 954, 867, 798",CCC(=O)CC1CC1,1146,1.0,1.0,1.0,1.0,0.9629629629629629
192,1-Cyclopropylbutan-2-one,1H NMR,"(400 MHz, CDCl3) δ 2.48 (q, J = 7.3 Hz, 2H, H-5), 2.28 (d, J = 7.0 Hz, 2H, H-3), 1.06 (t, J = 7.3 Hz, 3H, H-6), 1.03 – 0.93 (m, 1H, H-2), 0.62
– 0.51 (m, 2H, H-1), 0.16 – 0.07 (m, 2H, H-1)",CCC(=O)CC1CC1,1147,1.0,1.0,1.0,1.0,0.9629629629629629
193,1-Cyclopropylbutan-2-one,13C NMR,"(101 MHz, CDCl3) δ 212.0, 48.1, 35.9, 8.1, 6.9,
4.9",CCC(=O)CC1CC1,1148,1.0,1.0,1.0,1.0,0.9629629629629629
194,2-(Cyclopropylmethyl)-2-ethyl-3-oxa-1-azaspiro[4.5]decane,Rf,"(ethyl acetate in petroleum ether, 25%): 0.34",CCC1(CC2CC2)NC2(CCCCC2)CO1,1149,1.0,1.0,1.0,1.0,0.9811320754716981
195,2-(Cyclopropylmethyl)-2-ethyl-3-oxa-1-azaspiro[4.5]decane,IR,"(film): 2927, 2853, 1450, 1261, 1176, 1112, 1052, 1017, 936, 822, 765",CCC1(CC2CC2)NC2(CCCCC2)CO1,1150,1.0,1.0,1.0,1.0,0.9811320754716981
196,2-(Cyclopropylmethyl)-2-ethyl-3-oxa-1-azaspiro[4.5]decane,1H NMR,"(500 MHz,
CDCl3) δ 3.65 (d, J = 8.2 Hz, 1H, H-7), 3.62 (d, J = 8.2 Hz, 1H, H-7), 1.98 (s, 1H, NH), 1.78 – 1.25 (m,
14H, H-2, H-4, H-10, H-11 and H-12), 0.89 (t, J = 7.5 Hz, 3H, H-1), 0.83 – 0.70 (m, 1H, H-5), 0.55 –
0.41 (m, 2H, H-6), 0.15 – 0.03 (m, 2H, H-6)",CCC1(CC2CC2)NC2(CCCCC2)CO1,1151,1.0,1.0,1.0,1.0,0.9811320754716981
197,2-(Cyclopropylmethyl)-2-ethyl-3-oxa-1-azaspiro[4.5]decane,13C NMR,"(126 MHz, CDCl3) δ 99.1, 74.6, 62.2, 42.2, 38.2,
38.1, 31.7, 25.4, 24.1, 23.9, 8.9, 6.2, 4.8, 3.9",CCC1(CC2CC2)NC2(CCCCC2)CO1,1152,1.0,1.0,1.0,1.0,0.9811320754716981
198,2-(Cyclopropylmethyl)-2-ethyl-3-oxa-1-azaspiro[4.5]decane,MS,"(ESI) found [M+H]+ 224.2009, C14H26NO
requires 224.2009",CCC1(CC2CC2)NC2(CCCCC2)CO1,1153,1.0,1.0,1.0,1.0,0.9811320754716981
199,"2-(Cyclopropylmethyl)-2-ethyl-4,4-dimethyloxazolidine",IR,"(film): 2966, 2958, 1463, 1364, 1196, 1054, 1040, 987, 824,
753",CCC1(CC2CC2)NC(C)(C)CO1,1154,1.0,1.0,1.0,1.0,0.9787234042553191
200,"2-(Cyclopropylmethyl)-2-ethyl-4,4-dimethyloxazolidine",1H NMR,"(500 MHz, CDCl3) δ 3.60 (d, J = 8.0 Hz, 1H, H-7), 3.57 (d, J = 8.0 Hz, 1H, H-7), 2.08 (s,
1H, NH), 1.80 – 1.63 (m, 3H, H-2 and H-4), 1.41 (dd, J = 14.4, 7.6 Hz, 1H, H-4), 1.26 (s, 3H, H-10), 1.25
(s, 3H, H-10), 0.90 (t, J = 7.5 Hz, 3H, H-1), 0.82 – 0.69 (m, 1H, H-5), 0.55 – 0.39 (m, 2H, H-6), 0.16 –
0.03 (m, 2H, H-6)",CCC1(CC2CC2)NC(C)(C)CO1,1155,1.0,1.0,1.0,1.0,0.9787234042553191
201,"2-(Cyclopropylmethyl)-2-ethyl-4,4-dimethyloxazolidine",13C NMR,"(126 MHz, CDCl3) δ 100.0, 77.3, 59.0, 42.1, 31.6, 28.6, 28.5, 8.9, 6.2, 4.8,
3.9",CCC1(CC2CC2)NC(C)(C)CO1,1156,1.0,1.0,1.0,1.0,0.9787234042553191
202,"2-(Cyclopropylmethyl)-2-ethyl-4,4-dimethyloxazolidine",MS,"(ESI) found [M+H]+ 184.1696, C11H22NO requires 184.1696",CCC1(CC2CC2)NC(C)(C)CO1,1157,1.0,1.0,1.0,1.0,0.9787234042553191
203,"7a'-Ethyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",Rf,"(ethyl acetate in petroleum ether, 25%): 0.22",CCC12CCC(=O)N1C1(CCCCC1)CO2,1158,0.62,0.0,0.0,0.0,0.9642857142857143
204,"7a'-Ethyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",IR,"(film): 2943, 1683, 1453, 1385, 1263, 131,
963, 920, 805, 657",CCC12CCC(=O)N1C1(CCCCC1)CO2,1159,0.62,0.0,0.0,0.0,0.9642857142857143
205,"7a'-Ethyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",1H NMR,"(500 MHz, CDCl3) δ 4.24 (d, J = 9.0 Hz, 1H, H-7), 3.95 (dd, J = 9.0, 2.0
Hz, 1H, H-7), 2.79 – 2.70 (m, 1H, H-9), 2.67 (ddd, J = 17.0, 9.4, 6.1 Hz), 2.50 (ddd, J = 17.0, 9.7, 0.9 Hz,
1H, H-5), 2.20 (ddd, J = 12.3, 8.1, 0.9 Hz, 1H, H-4), 2.15 – 2.02 (m, 1H, H-9), 1.95 – 1.88 (m, 1H, H-4),
1.87 – 1.78 (m, 2H, H-2 and H-10), 1.76 – 1.63 (m, 3H, H-2, H-9 and H-11), 1.61 – 1.56 (m, 1H, H-10),
1.46 (dd, J = 10.4, 2.6 Hz, 1H, H-9), 1.33 – 1.18 (m, 2H, H-10), 1.09 – 1.00 (m, 1H, H-11), 0.96 (t, J = 7.5 Hz, 3H, H-1)",CCC12CCC(=O)N1C1(CCCCC1)CO2,1160,0.62,0.14,0.13,0.13,0.9642857142857143
206,"7a'-Ethyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",13C NMR,"(126 MHz, CDCl3) δ 173.0, 102.9, 77.4, 61.4, 36.8, 36.2, 32.0, 30.9, 28.8,
24.5, 24.5, 23.7, 8.3",CCC12CCC(=O)N1C1(CCCCC1)CO2,1161,0.62,0.0,0.0,0.0,0.9642857142857143
207,"7a'-Ethyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",MS,"(ESI) found [M+H]+ 224.1644, C13H22NO2 requires 224.1645",CCC12CCC(=O)N1C1(CCCCC1)CO2,1162,0.62,0.5,0.5,0.5,0.9642857142857143
208,"7a-Ethyl-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",Rf,"(ethyl acetate in petroleum ether, 20%): 0.11",CCC12CCC(=O)N1C(C)(C)CO2,1168,0.93,1.0,1.0,1.0,0.8275862068965517
209,"7a-Ethyl-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",IR,"(film): 2972, 2935, 1696,
1460, 1367, 1268, 1230, 1125, 1043, 1002, 961, 809, 683, 667",CCC12CCC(=O)N1C(C)(C)CO2,1169,0.93,1.0,1.0,1.0,0.8275862068965517
210,"7a-Ethyl-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",1H NMR,"500 MHz, CDCl3) δ 3.99 (d, J
= 8.8 Hz, 1H, H-7), 3.95 (d, J = 8.8 Hz, 1H, H-7), 2.65 (ddd, J = 17.0, 12.0, 8.2 Hz, 1H, H-5), 2.49 (ddd,
J = 17.0, 9.7, 0.8 Hz, 1H, H-5), 2.22 (ddd, J = 12.4, 8.1, 0.9 Hz, 1H, H-4), 1.99 – 1.89 (m, 1H, H-4), 1.89
– 1.80 (m, 1H, H-2), 1.74 – 1.65 (m, 1H, H-2), 1.57 (s, 3H, H-8 or H-9), 1.40 (s, 3H, H-8 or H-9), 0.97 (t,
J = 7.5 Hz, 3H, H-1)",CCC12CCC(=O)N1C(C)(C)CO2,1170,0.93,0.86,0.8,0.83,0.8275862068965517
211,"7a-Ethyl-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",13C NMR,"(126 MHz, CDCl3) δ 173.7, 103.5, 81.5, 57.9, 35.6, 32.0, 28.6, 26.6,
24.6, 8.3",CCC12CCC(=O)N1C(C)(C)CO2,1171,0.93,1.0,1.0,1.0,0.8275862068965517
212,"7a-Ethyl-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",MS,"(ESI) found [M+H]+ 184.1331, C10H18NO2 requires 184.1332",CCC12CCC(=O)N1C(C)(C)CO2,1172,0.93,1.0,1.0,1.0,0.8275862068965517
213,"7a'-Methyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",Rf,"(ethyl acetate in petroleum ether, 25%): 0.21",CC12CCC(=O)N1C1(CCCCC1)CO2,1173,1.0,1.0,1.0,1.0,1.0
214,"7a'-Methyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",IR,"(film): 2930, 2860, 2163,
2026, 1695, 1455, 1369, 1250, 1191, 1085, 1030, 993, 899, 841, 809, 690, 667",CC12CCC(=O)N1C1(CCCCC1)CO2,1174,1.0,1.0,1.0,1.0,1.0
215,"7a'-Methyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",1H NMR,"(500 MHz,
CDCl3) δ 4.26 (d, J = 9.0 Hz, 1H, H-6), 4.03 (dd, J = 9.0, 1.9 Hz, 1H, H-6), 2.79 – 2.62 (m, 2H, H-4 and
H-8), 2.51 (ddd, J = 16.8, 9.0, 0.9 Hz, 1H, H-4), 2.17 – 1.99 (m, 3H, H-3, H-8 and H-9), 1.90 – 1.79 (m,
1H, H-8), 1.78 – 1.68 (m, 2H, H-3 and H-10), 1.65 – 1.54 (m, 1H, H-9), 1.48 (s, 3H, H-1), 1.46 – 1.43 (m,
1H, H-8), 1.34 – 1.18 (m, 2H, H-2 and H-9), 1.11 – 0.99 (m, 1H, H-10)",CC12CCC(=O)N1C1(CCCCC1)CO2,1175,1.0,1.0,1.0,1.0,1.0
216,"7a'-Methyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",13C NMR,"(126 MHz, CDCl3) δ
172.5, 100.6, 77.8, 77.4, 61.5, 36.7, 36.3, 36.2, 31.0, 24.6, 23.8, 23.7",CC12CCC(=O)N1C1(CCCCC1)CO2,1176,1.0,1.0,1.0,1.0,1.0
217,"7a'-Methyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",MS,"(ESI) found [M+H]+
210.1486, C12H20NO2 requires 210.1489",CC12CCC(=O)N1C1(CCCCC1)CO2,1177,1.0,1.0,1.0,1.0,1.0
218,"3,3,7a-Trimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",Rf,"(ethyl acetate in petroleum ether, 25%): 0.15",CC1(C)COC2(C)CCC(=O)N12,1178,0.92,1.0,1.0,1.0,1.0
219,"3,3,7a-Trimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",IR,"(film): 2975, 2876, 1693,
1457, 1365, 1258, 1201, 1131, 1085, 1036, 1002, 824, 810, 672",CC1(C)COC2(C)CCC(=O)N12,1179,0.92,1.0,1.0,1.0,1.0
220,"3,3,7a-Trimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",1H NMR,"(500 MHz, CDCl3) δ 4.05 (dd,
J = 8.8, 0.5 Hz, 1H, H-6), 3.97 (d, J = 8.8 Hz, 1H, H-6), 2.70 (ddd, J = 16.8, 12.3, 8.0 Hz, 1H, H-4), 2.49
(ddd, J = 16.8, 8.8, 1.2 Hz, 1H, H-4), 2.15 – 2.00 (m, 2H, H-3), 1.56 (s, 3H, H-1), 1.49 (s, 3H, H-8), 1.41
(s, 3H, H-8)",CC1(C)COC2(C)CCC(=O)N12,1180,0.92,1.0,1.0,1.0,1.0
221,"3,3,7a-Trimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",13C NMR,"(126 MHz, CDCl3) δ 173.0, 101.0, 81.7, 57.9, 36.1, 35.6, 26.5, 24.3, 23.4",CC1(C)COC2(C)CCC(=O)N12,1181,0.92,1.0,1.0,1.0,1.0
222,"3,3,7a-Trimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",MS,"(ESI) found [M+H]+ 170.1175, C9H16NO2 requires 170.1176",CC1(C)COC2(C)CCC(=O)N12,1182,0.92,1.0,1.0,1.0,1.0
223,"3,3,7a-Trimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",Rf,"(ethyl acetate in petroleum ether, 20%): 0.14",CC1(C)COC2(C)CCC(=O)N12,1198,0.92,1.0,1.0,1.0,1.0
224,"3,3,7a-Trimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",IR,"(film): 2952, 2915, 1665, 1459, 1368, 1281, 1232, 1125, 1043, 1014, 961, 809, 683",CC1(C)COC2(C)CCC(=O)N12,1199,0.92,0.0,0.0,0.0,1.0
225,"3,3,7a-Trimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",1H NMR,"(500 MHz, CDCl3) δ 4.00 (dd, J = 8.8, 0.6 Hz, 1H, H-8), 3.95 (d, J = 8.8 Hz, 1H, H-8), 2.65 (ddd, J =
17.0, 12.1, 8.1 Hz, 1H, H-6), 2.48 (ddd, J = 12.4, 9.7, 0.9 Hz, 1H, H-6), 2.23 (ddd, J = 12.4, 8.1, 0.9 Hz,
1H, H-5), 2.00 – 1.90 (m, 1H, H-5), 1.85 – 1.75 (m, 1H, H-3), 1.69 – 1.60 (m, 1H, H-3), 1.56 (s, 3H, H-
10), 1.50 – 1.34 (m, 2H, H-2), 1.41 (s, 3H, H-10), 0.97 (t, J = 7.4 Hz, 3H, H-1)",CC1(C)COC2(C)CCC(=O)N12,1200,0.92,0.33,0.19,0.24,1.0
226,"3,3,7a-Trimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",13C NMR,"(126 MHz,
CDCl3) δ 173.6, 103.1, 81.6, 57.9, 38.1, 35.6, 32.7, 26.7, 24.6, 17.4, 14.3",CC1(C)COC2(C)CCC(=O)N12,1201,0.92,0.22,0.18,0.2,1.0
227,"3,3,7a-Trimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",MS,"(ESI) found
[M+H]+ 198.1490, C11H20NO2 requires 198.1494",CC1(C)COC2(C)CCC(=O)N12,1202,0.92,0.0,0.0,0.0,1.0
228,"7',7a'-Dimethyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",Rf,"(ethyl acetate in petroleum ether, 25%): 0.21",CC1CC(=O)N2C3(CCCCC3)COC12C,1183,0.12,1.0,1.0,1.0,0.9152542372881356
229,"7',7a'-Dimethyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",IR,"(film): 2928, 2860, 1693, 1453, 1368, 1214, 1190, 1031, 993, 921, 810, 689",CC1CC(=O)N2C3(CCCCC3)COC12C,1184,0.12,0.92,0.92,0.92,0.9152542372881356
230,"7',7a'-Dimethyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",MS,"(ESI) found [M+H]+ 224.1641, C13H22NO2 requires
224.1645",CC1CC(=O)N2C3(CCCCC3)COC12C,1185,0.12,1.0,1.0,1.0,0.9152542372881356
231,"7',7a'-Dimethyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",1H NMR,"(500 MHz, CDCl3) δ 4.29 – 4.22 (m, 1H, H-7), 4.08 – 4.02
(m, 1H, H-7), 2.69 – 2.59 (m, 1H, H-9), 2.57 – 2.47 (m, 1H, H-5), 2.40 – 2.25 (m, 2H, H-3 and H-5), 2.17
– 2.03 (m, 1H, H-9), 1.87 – 1.78 (m, 1H, H-10), 1.77 – 1.68 (m, 2H, H-9 and H-11), 1.59 (ddd, J = 6.2,
3.3, 1.5 Hz, 1H, H-10), 1.46 – 1.43 (m, 1H, H-9), 1.31 (s, 3H, H-1), 1.30 – 1.18 (m, 2H, H-10), 1.09 –
1.00 (m, 1H, H-11), 1.05 (d, J = 6.7 Hz, 3H, H-4)",CC1CC(=O)N2C3(CCCCC3)COC12C,1186,0.12,1.0,1.0,1.0,0.9152542372881356
232,"7',7a'-Dimethyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",13C NMR,"(126 MHz, CDCl3) δ 171.3, 101.70, 77.79,
61.49, 44.07, 42.69, 36.61, 30.87, 24.49, 24.45, 23.74, 18.39, 13.42",CC1CC(=O)N2C3(CCCCC3)COC12C,1187,0.12,0.0,0.0,0.0,0.9152542372881356
233,"3,3,7,7a-Tetramethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",Rf,"(ethyl acetate in petroleum ether, 25%): 0.15",CC1CC(=O)N2C(C)(C)COC12C,1188,0.93,1.0,1.0,1.0,0.4067796610169492
234,"3,3,7,7a-Tetramethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",IR,"(film): 2972, 2875, 1694, 1458, 1366, 1263,
1170, 1052, 989, 923, 826, 664, 654",CC1CC(=O)N2C(C)(C)COC12C,1189,0.93,1.0,1.0,1.0,0.4067796610169492
235,"3,3,7,7a-Tetramethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",MS,"(ESI) found [M+H]+ 184.1331, C10H18NO2 requires
184.1332",CC1CC(=O)N2C(C)(C)COC12C,1190,0.93,1.0,1.0,1.0,0.4067796610169492
236,"3,3,7,7a-Tetramethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",1H NMR,"(500 MHz, CDCl3) δ 4.10 – 4.03 (m, 1H, H-7), 3.99 – 3.94
(m, 1H, H-7), 2.51 (dd, J = 14.5, 6.5 Hz, 1H, H-5), 2.43 – 2.26 (m, 2H, H-3 and H-5), 1.54 (s, 3H, H-9),
1.41 (s, 3H, H-9), 1.33 (s, 3H, H-1), 1.07 (d, J = 6.5 Hz, 3H, H-4)",CC1CC(=O)N2C(C)(C)COC12C,1191,0.93,1.0,1.0,1.0,0.4067796610169492
237,"3,3,7,7a-Tetramethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",13C NMR,"(126 MHz, CDCl3) δ 172.0,
102.3, 81.9, 58.1, 43.5, 42.7, 26.4, 24.2, 18.3, 13.5",CC1CC(=O)N2C(C)(C)COC12C,1192,0.93,0.1,0.1,0.1,0.4067796610169492
238,"7a'-Propyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",Rf,"(ethyl acetate in petroleum ether, 20%): 0.29",CCCC12CCC(=O)N1C1(CCCCC1)CO2,1193,1.0,1.0,1.0,1.0,0.9824561403508771
239,"7a'-Propyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",IR,"(film): 2929, 2856, 1698,
1452, 1377, 1250, 1190, 1136, 1085, 1052, 995, 905, 807, 657",CCCC12CCC(=O)N1C1(CCCCC1)CO2,1194,1.0,1.0,1.0,1.0,0.9824561403508771
240,"7a'-Propyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",1H NMR,"(500 MHz, CDCl3) δ 4.24 (d, J
= 9.0 Hz, 1H, H-8), 3.97 (dd, J = 9.0, 2.0 Hz, 1H, H-8), 2.79 – 2.69 (m, 1H, H-10), 2.64 (ddd, J = 16.9,
9.4, 6.1 Hz, 1H, H-6), 2.50 (ddd, J = 16.9, 9.7, 0.8 Hz, 1H, H-6), 2.21 (ddd, J = 12.3, 8.0, 0.8 Hz, 1H, H-
5), 2.14 – 2.06 (m, 1H, H-10), 1.98 – 1.69 (m, 5H, H-5, H-10 and H-11 and H-12), 1.67 – 1.59 (m, 1H, H-
3), 1.51 – 1.16 (m, 6H, H-2, H-10 and H-11), 1.10 – 1.00 (m, 1H, H-12), 0.97 (t, J = 7.4 Hz, 3H, H-1)",CCCC12CCC(=O)N1C1(CCCCC1)CO2,1195,1.0,1.0,1.0,1.0,0.9824561403508771
241,"7a'-Propyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",13C NMR,"(126 MHz, CDCl3) δ 172.9, 102.5, 77.4, 61.4, 38.3, 36.8, 36.1, 32.6, 30.9, 24.6, 24.5, 23.7,
17.4, 14.4",CCCC12CCC(=O)N1C1(CCCCC1)CO2,1196,1.0,1.0,1.0,1.0,0.9824561403508771
242,"7a'-Propyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",MS,"(ESI) found [M+H]+ 238.1802, C14H24NO2 requires 238.1802",CCCC12CCC(=O)N1C1(CCCCC1)CO2,1197,1.0,1.0,1.0,1.0,0.9824561403508771
243,"7a'-Cyclohexyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",Rf,"(ethyl acetate in petroleum ether, 20%): 0.24",O=C1CCC2(C3CCCCC3)OCC3(CCCCC3)N12,1203,1.0,1.0,1.0,1.0,1.0
244,"7a'-Cyclohexyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",IR,"(film): 2927, 2855, 1693,
1454, 1383, 1357, 1184, 1029, 1003, 894, 729",O=C1CCC2(C3CCCCC3)OCC3(CCCCC3)N12,1204,1.0,1.0,1.0,1.0,1.0
245,"7a'-Cyclohexyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",1H NMR,"(500 MHz, CDCl3) δ 4.19 (d, J = 9.0 Hz, 1H, H-
9), 3.97 (dd, J = 9.0, 2.0 Hz, 1H, H-9), 2.97 – 2.73 (m, 1H, H-11), 2.66 – 2.44 (m, 2H, H-7), 2.34 – 2.22
(m, 1H, H-6), 2.17 – 2.02 (m, 1H, H-11), 1.95 – 1.54 (m, 11H, H-2, H-3, H-4, H-6 and H-11), 1.48 – 1.36
(m, 1H, H-11), 1.34 – 0.91 (m, 8H, H-1, H-12 and H-13)",O=C1CCC2(C3CCCCC3)OCC3(CCCCC3)N12,1205,1.0,1.0,1.0,1.0,1.0
246,"7a'-Cyclohexyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",13C NMR,"(126 MHz, CDCl3) δ 174.0, 104.9,
77.0, 61.7, 43.8, 37.3, 36.7, 31.1, 28.7, 26.9, 26.9, 26.5, 26.4, 26.1, 24.7, 24.5, 23.7",O=C1CCC2(C3CCCCC3)OCC3(CCCCC3)N12,1206,1.0,0.94,0.94,0.94,1.0
247,"7a'-Cyclohexyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",MS,"(ESI)
found [M+H]+ 278.2117, C17H28NO2 requires 278.2115",O=C1CCC2(C3CCCCC3)OCC3(CCCCC3)N12,1207,1.0,1.0,1.0,1.0,1.0
248,"7a-Cyclohexyl-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",Rf,"(ethyl acetate in petroleum ether, 20%): 0.14",CC1(C)COC2(C3CCCCC3)CCC(=O)N12,1208,0.94,1.0,1.0,1.0,0.8285714285714286
249,"7a-Cyclohexyl-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",IR,"(film): 2931, 2158, 1740,
1703, 1450, 1365, 1358, 1233, 1006",CC1(C)COC2(C3CCCCC3)CCC(=O)N12,1209,0.94,1.0,1.0,1.0,0.8285714285714286
250,"7a-Cyclohexyl-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",1H NMR,"(500 MHz, CDCl3) δ 4.01 (d, J = 8.8 Hz, 1H, H-9), 3.94
(d, J = 8.8 Hz, 1H, H-9), 2.63 – 2.44 (m, 2H, H-7), 2.30 (ddd, J = 12.9, 8.4, 1.4 Hz, 1H, H-6), 1.92 – 1.67
(m, 6H, H-1, H-2, H-3, H-4, H-6), 1.59 (s, 3H, H-11), 1.41 (s, 3H, H-11), 1.28 – 0.96 (m, 6H, H-1, H-2
and H-3)",CC1(C)COC2(C3CCCCC3)CCC(=O)N12,1210,0.94,1.0,1.0,1.0,0.8285714285714286
251,"7a-Cyclohexyl-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",13C NMR,"(126 MHz, CDCl3) δ 174.7, 105.5, 81.3, 58.1, 43.5, 36.1, 28.8, 27.2, 26.9, 26.9, 26.6,
26.4, 26.1, 24.9",CC1(C)COC2(C3CCCCC3)CCC(=O)N12,1211,0.94,0.93,0.93,0.93,0.8285714285714286
252,"7a-Cyclohexyl-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",MS,"(ESI) found [M+H]+ 238.1796, C14H24NO2 requires 238.1800",CC1(C)COC2(C3CCCCC3)CCC(=O)N12,1212,0.94,1.0,1.0,1.0,0.8285714285714286
253,"2-{3-(5'-Oxotetrahydro-2'H-spiro[cyclohexane-1,3'-pyrrolo[2,1-b]oxazol]-7a'-
yl)propyl}isoindoline-1,3-dione",Rf,"(ethyl acetate in petroleum ether, 25%): 0.31",O=C1c2ccccc2C(=O)N1CCCC12CCC(=O)N1C1(CCCCC1)CO2,1213,0.44,1.0,1.0,1.0,1.0
254,"2-{3-(5'-Oxotetrahydro-2'H-spiro[cyclohexane-1,3'-pyrrolo[2,1-b]oxazol]-7a'-
yl)propyl}isoindoline-1,3-dione",IR,"(film): 2932, 2860, 1773,
1706, 1395, 1360, 1228, 1188, 1063, 1030, 998, 914, 720",O=C1c2ccccc2C(=O)N1CCCC12CCC(=O)N1C1(CCCCC1)CO2,1214,0.44,1.0,1.0,1.0,1.0
255,"2-{3-(5'-Oxotetrahydro-2'H-spiro[cyclohexane-1,3'-pyrrolo[2,1-b]oxazol]-7a'-
yl)propyl}isoindoline-1,3-dione",1H NMR,"(500 MHz, CDCl3) δ 7.85 (dd, J =
5.5, 3.0 Hz, 2H, H-2), 7.73 (dd, J = 5.5, 3.0 Hz, 2H, H-1), 4.23 (d, J = 9.1 Hz, 1H, H-12), 3.97 (dd, J =
9.1, 1.9 Hz, 1H, H-12), 3.81 – 3.63 (m, 2H, H-5), 2.74 – 2.68 (m, 1H, H-14), 2.51 (ddd, J = 17.1, 9.8, 2.5
Hz, 1H, H-10), 2.51 (dd, J = 17.1, 9.5 Hz, 1H, H-10), 2.23 – 2.14 (m, 1H, H-9), 2.14 – 2.03 (m, 1H, H-
14), 1.97 – 1.65 (m, 8H, H-6, H-7, H-9, H-14, H-15 and H-16), 1.64 – 1.53 (m, 1H, H-15), 1.48 – 1.38
(m, 1H, H-14), 1.32 – 1.16 (m, 2H, H-15), 1.09 – 0.96 (m, 1H, H-16)",O=C1c2ccccc2C(=O)N1CCCC12CCC(=O)N1C1(CCCCC1)CO2,1215,0.44,0.92,0.92,0.92,1.0
256,"2-{3-(5'-Oxotetrahydro-2'H-spiro[cyclohexane-1,3'-pyrrolo[2,1-b]oxazol]-7a'-
yl)propyl}isoindoline-1,3-dione",13C NMR,"(126 MHz, CDCl3) δ
172.8, 168.3, 134.0, 132.0, 123.3, 102.0, 77.5, 61.6, 37.9, 36.8, 36.0, 33.2, 32.5, 30.9, 24.5, 24.4, 23.7,
23.5",O=C1c2ccccc2C(=O)N1CCCC12CCC(=O)N1C1(CCCCC1)CO2,1216,0.44,1.0,1.0,1.0,1.0
257,"2-{3-(5'-Oxotetrahydro-2'H-spiro[cyclohexane-1,3'-pyrrolo[2,1-b]oxazol]-7a'-
yl)propyl}isoindoline-1,3-dione",MS,"(ESI) found [M+H]+ 383.1969, C22H27N2O4 requires 383.1970",O=C1c2ccccc2C(=O)N1CCCC12CCC(=O)N1C1(CCCCC1)CO2,1217,0.44,1.0,1.0,1.0,1.0
258,"2-{3-(3,3-Dimethyl-5-oxohexahydropyrrolo[2,1-b]oxazol-7a-yl)propyl}isoindoline-1,3-dione",Rf,"(ethyl acetate in petroleum ether, 25%): 0.23",CC1(C)COC2(CCCN3C(=O)c4ccccc4C3=O)CCC(=O)N12,1218,1.0,1.0,1.0,1.0,0.8686868686868687
259,"2-{3-(3,3-Dimethyl-5-oxohexahydropyrrolo[2,1-b]oxazol-7a-yl)propyl}isoindoline-1,3-dione",IR,"(film): 2976, 2952, 1773,
1704, 1466, 1396, 1366, 1273, 1124, 1058, 1002, 882, 721, 667",CC1(C)COC2(CCCN3C(=O)c4ccccc4C3=O)CCC(=O)N12,1219,1.0,1.0,1.0,1.0,0.8686868686868687
260,"2-{3-(3,3-Dimethyl-5-oxohexahydropyrrolo[2,1-b]oxazol-7a-yl)propyl}isoindoline-1,3-dione",1H NMR,"(500 MHz, CDCl3) δ 7.85 (dd,
J = 5.5, 3.0 Hz, 2H, H-2), 7.73 (dd, J = 5.5, 3.0 Hz, 2H, H-1), 4.00 (d, J = 9.2 Hz, 1H, H-12), 3.94 (d, J =
8.9 Hz, 1H, H-12), 3.81 – 3.64 (m, 2H, H-5), 2.63 (ddd, J = 17.0, 12.3, 8.0 Hz, 1H, H-10), 2.51 (dd, 1H, J
= 17.0, 11.9 Hz, H-10), 2.20 (ddd, J = 12.3, 8.0, 0.8 Hz, 1H, H-9), 2.02 – 1.66 (m, 5H, H-6, H-7 and H-9),
1.55 (s, 3H, H-14), 1.40 (s, 3H, H-14)",CC1(C)COC2(CCCN3C(=O)c4ccccc4C3=O)CCC(=O)N12,1220,1.0,1.0,1.0,1.0,0.8686868686868687
261,"2-{3-(3,3-Dimethyl-5-oxohexahydropyrrolo[2,1-b]oxazol-7a-yl)propyl}isoindoline-1,3-dione",13C NMR,"(126 MHz, CDCl3) δ 173.5, 168.3, 134.1, 132.0, 123.3, 102.6, 81.6, 58.1, 37.9, 35.4, 33.0, 32.5, 26.7, 24.5, 23.5",CC1(C)COC2(CCCN3C(=O)c4ccccc4C3=O)CCC(=O)N12,1221,1.0,0.93,0.93,0.93,0.8686868686868687
262,"2-{3-(3,3-Dimethyl-5-oxohexahydropyrrolo[2,1-b]oxazol-7a-yl)propyl}isoindoline-1,3-dione",MS,"(ESI) found [M+H]+ 343.1656,
C20H25N2O4 requires 343.1652",CC1(C)COC2(CCCN3C(=O)c4ccccc4C3=O)CCC(=O)N12,1222,1.0,1.0,1.0,1.0,0.8686868686868687
263,"7a'-{(Benzyloxy)methyl}dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-
one",Rf,"(ethyl acetate in petroleum ether, 20%): 0.31",O=C1CCC2(COCc3ccccc3)OCC3(CCCCC3)N12,1223,0.99,1.0,1.0,1.0,1.0
264,"7a'-{(Benzyloxy)methyl}dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-
one",IR,"(film): 2928, 2858, 1695,
1453, 1367, 1272, 1108. 1028, 991, 738, 699",O=C1CCC2(COCc3ccccc3)OCC3(CCCCC3)N12,1224,0.99,1.0,1.0,1.0,1.0
265,"7a'-{(Benzyloxy)methyl}dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-
one",1H NMR,"(500 MHz, CDCl3) δ 7.41 – 7.27 (m, 5H, H-1, H-
2 and H-3), 4.63 (d, J = 12.2 Hz, 1H, H-5), 4.56 (d, J = 12.2 Hz, 1H, H-5), 4.25 (d, J = 9.0 Hz, 1H, H-11),
4.00 (dd, J = 9.0, 1.9 Hz, 1H, H-11), 3.59 (d, J = 10.1 Hz, 1H, H-6), 3.46 (d, J = 10.1 Hz, 1H, H-6), 2.78
– 2.67 (m, 2H, H-9 and H-13), 2.52 (dd, J = 15.0, 8.8 Hz, 1H, H-9), 2.39 (dd, J = 11.9, 8.8, Hz, 2H, H-8),
2.12 – 1.99 (m, 1H, H-13), 1.92 (apparent q, J = 6.2, 1H, H-8), 1.88 – 1.80 (m, 1H, H-14), 1.72 – 1.56 (m,
3H, H-13, H-14 and H-15), 1.51 – 1.42 (m, 1H, H-13), 1.30 – 1.17 (m, 2H, H-14), 1.06 – 0.90 (m, 1H, H-
15)",O=C1CCC2(COCc3ccccc3)OCC3(CCCCC3)N12,1225,0.99,1.0,1.0,1.0,1.0
266,"7a'-{(Benzyloxy)methyl}dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-
one",13C NMR,"(126 MHz, CDCl3) δ 174.0, 137.7, 128.5, 127.8, 127.7, 101.1, 78.5, 73.6, 71.1, 61.8, 36.6,
36.3, 31.9, 31.1, 24.6, 24.5, 23.7",O=C1CCC2(COCc3ccccc3)OCC3(CCCCC3)N12,1226,0.99,1.0,1.0,1.0,1.0
267,"7a'-{(Benzyloxy)methyl}dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-
one",MS,"(ESI) found [M+H]+ 316.1908, C19H26NO2 requires
316.1907",O=C1CCC2(COCc3ccccc3)OCC3(CCCCC3)N12,1227,0.99,1.0,1.0,1.0,1.0
268,"7a-{(Benzyloxy)methyl}-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",Rf,"(ethyl acetate in petroleum ether, 20%): 0.23",CC1(C)COC2(COCc3ccccc3)CCC(=O)N12,1228,0.94,1.0,1.0,1.0,0.49056603773584906
269,"7a-{(Benzyloxy)methyl}-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",IR,"(film): 2973, 2870, 1698,
1454, 1365, 1264, 1199, 1104, 1071, 1029, 1001, 738, 698, 618",CC1(C)COC2(COCc3ccccc3)CCC(=O)N12,1229,0.94,1.0,1.0,1.0,0.49056603773584906
270,"7a-{(Benzyloxy)methyl}-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",1H NMR,"(500 MHz, CDCl3) δ 7.43 –
7.29 (m, 5H, Ar-H), 4.63 (d, J = 12.2 Hz, 1H, H-5), 4.56 (d, J = 12.2 Hz, 1H, H-5), 4.04 (d, J = 8.7 Hz,
1H, H-11), 3.97 (d, J = 8.7 Hz, 1H, H-11), 3.60 (dd, J = 10.1, 0.6 Hz, 1H, H-6), 3.49 (d, J = 10.1 Hz, 1H,
H-6), 2.72 (ddd, J = 16.8, 12.0, 8.0 Hz, 1H, H-9), 2.51 – 2.32 (m, 2H, H-8 and H-9), 1.96 (td, J = 12.2, 9.8 Hz, 1H, H-8), 1.57 (s, 3H, H-13), 1.36 (s, 3H, H-13)",CC1(C)COC2(COCc3ccccc3)CCC(=O)N12,1230,0.94,1.0,1.0,1.0,0.49056603773584906
271,"7a-{(Benzyloxy)methyl}-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",13C NMR,"(126 MHz, CDCl3) δ 174.6, 137.7,
128.5, 127.9, 127.7, 101.6, 82.6, 73.6, 71.2, 58.4, 35.7, 32.0, 26.5, 24.5",CC1(C)COC2(COCc3ccccc3)CCC(=O)N12,1231,0.94,1.0,1.0,1.0,0.49056603773584906
272,"7a-{(Benzyloxy)methyl}-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",MS,"(ESI) found [M+H]+
276.1589, C16H22NO3 requires 276.1593",CC1(C)COC2(COCc3ccccc3)CCC(=O)N12,1232,0.94,1.0,1.0,1.0,0.49056603773584906
273,"7a'-{3-(1-Tosylpiperidin-4-yl)propyl}dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-
b]oxazol)-5'(6'H)-one",Rf,"(ethyl acetate in petroleum ether, 40%): 0.33",Cc1ccc(S(=O)(=O)N2CCC(CCCC34CCC(=O)N3C3(CCCCC3)CO4)CC2)cc1,1233,0.33,1.0,1.0,1.0,1.0
274,"7a'-{3-(1-Tosylpiperidin-4-yl)propyl}dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-
b]oxazol)-5'(6'H)-one",IR,"(film): 2930, 1694, 1598,
1462, 1395, 1340, 1165, 1059, 986, 933, 769, 728",Cc1ccc(S(=O)(=O)N2CCC(CCCC34CCC(=O)N3C3(CCCCC3)CO4)CC2)cc1,1234,0.33,1.0,1.0,1.0,1.0
275,"7a'-{3-(1-Tosylpiperidin-4-yl)propyl}dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-
b]oxazol)-5'(6'H)-one",1H NMR,"(500 MHz, CDCl3) δ 7.64 (d, J = 8.2 Hz,
2H, H-4), 7.32 (d, J = 8.2 Hz, 2H, H-3), 4.22 (d, J = 9.0 Hz, 1H, H-16), 3.92 (dd, J = 9.1, 1.8 Hz, 1H, H-
16), 3.81 – 3.73 (m, 2H, H-6), 2.76 – 2.57 (m, 2H, H-18 and H-14), 2.49 (dd, J = 17.0, 9.1 Hz, 1H, H-14),
2.43 (s, 3H, H-1), 2.26 – 2.13 (m, 3H, H-6 and H-13), 2.10 – 2.00 (m, 1H, H-11), 1.95 – 1.80 (m, 2H, H-
10 and H-13), 1.79 – 1.63 (m, 5H, H-10, H-11, H-18, H-19 and H-20), 1.48 – 1.35 (m, 2H, H-10 and H-
18), 1.35 – 1.09 (m, 10H, H-7, H-8, H9, H-18 and H-19), 1.07 – 0.94 (m, 1H, H-20)",Cc1ccc(S(=O)(=O)N2CCC(CCCC34CCC(=O)N3C3(CCCCC3)CO4)CC2)cc1,1235,0.33,0.96,0.96,0.96,1.0
276,"7a'-{3-(1-Tosylpiperidin-4-yl)propyl}dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-
b]oxazol)-5'(6'H)-one",13C NMR,"(126
MHz, CDCl3) δ 172.8, 143.4, 133.2, 129.6, 127.7, 102.3, 61.5, 46.4, 36.8, 36.3, 36.2, 36.0, 35.2, 32.6,
31.6, 31.5, 30.9, 29.7, 24.5, 24.4, 23.7, 23.0, 21.5, 21.3",Cc1ccc(S(=O)(=O)N2CCC(CCCC34CCC(=O)N3C3(CCCCC3)CO4)CC2)cc1,1236,0.33,1.0,1.0,1.0,1.0
277,"7a'-{3-(1-Tosylpiperidin-4-yl)propyl}dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-
b]oxazol)-5'(6'H)-one",MS,"(ESI) found [M+H]+ 475.2615,
C26H39N2O4S requires 475.2612",Cc1ccc(S(=O)(=O)N2CCC(CCCC34CCC(=O)N3C3(CCCCC3)CO4)CC2)cc1,1237,0.33,1.0,1.0,1.0,1.0
278,"3,3-Dimethyl-7a-{3-(1-tosylpiperidin-4-yl)propyl}tetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",Rf,"(ethyl acetate in petroleum ether, 40%): 0.21",Cc1ccc(S(=O)(=O)N2CCC(CCCC34CCC(=O)N3C(C)(C)CO4)CC2)cc1,1238,0.95,1.0,1.0,1.0,0.9565217391304348
279,"3,3-Dimethyl-7a-{3-(1-tosylpiperidin-4-yl)propyl}tetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",IR,"(film): 2934, 1694, 1461,
1338, 1164, 1093, 1034, 1002, 930, 816, 729, 670",Cc1ccc(S(=O)(=O)N2CCC(CCCC34CCC(=O)N3C(C)(C)CO4)CC2)cc1,1239,0.95,1.0,1.0,1.0,0.9565217391304348
280,"3,3-Dimethyl-7a-{3-(1-tosylpiperidin-4-yl)propyl}tetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",1H NMR,"(500 MHz, CDCl3) δ 7.64 (d, J = 8.2 Hz,
2H, H-4), 7.32 (d, J = 7.9 Hz, 2H, H-3), 3.96 (d, J = 9.0 Hz, 1H, H-16), 3.93 (d, J = 9.0 Hz, 1H, H-16), 3.77 (d, J = 11.6 Hz, 2H, H-6), 2.61 (ddd, J = 17.0, 12.1, 8.0 Hz, 1H, H-14), 2.52 – 2.45 (m, 1H, H-14),
2.43 (s, 3H, H-1), 2.24 – 2.14 (m, 3H, H-6 and H-13), 1.92 (dd, J = 17.1, 12.1 Hz, 1H, H-13), 1.80 – 1.67
(m, 2H, H-8 and H-11), 1.63 – 1.56 (m, 2H, H-9), 1.55 (s, 3H, H-18), 1.38 (s, 3H, H-18), 1.33 – 1.12 (m,
6H, H-7, H-9 and H-11)",Cc1ccc(S(=O)(=O)N2CCC(CCCC34CCC(=O)N3C(C)(C)CO4)CC2)cc1,1240,0.95,0.95,0.95,0.95,0.9565217391304348
281,"3,3-Dimethyl-7a-{3-(1-tosylpiperidin-4-yl)propyl}tetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",13C NMR,"(126 MHz, CDCl3) δ 173.5, 143.4, 133.2, 129.6, 127.7, 102.9, 81.5,
58.0, 46.4, 46.3, 36.3, 36.0, 35.5, 35.2, 32.6, 31.5, 31.5, 26.7, 24.5, 21.5, 21.2",Cc1ccc(S(=O)(=O)N2CCC(CCCC34CCC(=O)N3C(C)(C)CO4)CC2)cc1,1241,0.95,0.95,0.95,0.95,0.9565217391304348
282,"3,3-Dimethyl-7a-{3-(1-tosylpiperidin-4-yl)propyl}tetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",MS,"(ESI) found
[M+H]+ 435.2310, C23H35N2O4S requires 435.2312",Cc1ccc(S(=O)(=O)N2CCC(CCCC34CCC(=O)N3C(C)(C)CO4)CC2)cc1,1242,0.95,1.0,1.0,1.0,0.9565217391304348
283,"Methyl 3-{5'-oxotetrahydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazo)-7a'-
yl)}propanoate",Rf,"(ethyl acetate in petroleum ether, 25%): 0.19",,1243,0.26,1.0,1.0,1.0,
284,"Methyl 3-{5'-oxotetrahydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazo)-7a'-
yl)}propanoate",IR,"(film): 2932, 2860, 1736,
1694, 1452, 1380, 1260, 1175, 1029, 992, 913, 666",,1244,0.26,1.0,1.0,1.0,
285,"Methyl 3-{5'-oxotetrahydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazo)-7a'-
yl)}propanoate",1H NMR,"(500 MHz, CDCl3) δ 4.26 (d, J = 9.2 Hz,
1H, H-9), 4.00 (dd, J = 9.2, 2.0 Hz, 1H, H-9), 3.72 (s, 3H, H-1), 2.77 – 2.64 (m, 2H, H-7 and H-11), 2.59
– 2.34 (m, 3H, H-7 and H-3), 2.32 – 2.23 (m, 1H, H-4), 2.22 – 2.08 (m, 2H, H-6 and H-11), 2.02 – 1.90
(m, 2H, H-4 and H-6), 1.88 – 1.71 (m, 3H, H-11, H-12 and H-13), 1.65 – 1.59 (m, 1H, H-12), 1.46 (d, J =
12.2 Hz, 1H, H-11), 1.35 – 1.18 (m, 2H, H-12), 1.10 – 0.99 (m, 1H, H-13)",,1245,0.26,1.0,1.0,1.0,
286,"Methyl 3-{5'-oxotetrahydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazo)-7a'-
yl)}propanoate",13C NMR,"(126 MHz, CDCl3)
δ 173.4, 172.7, 101.6, 77.6, 61.7, 51.9, 36.7, 35.9, 32.4, 30.9, 30.6, 29.3, 24.5, 24.4, 23.7",,1246,0.26,1.0,1.0,1.0,
287,"Methyl 3-{5'-oxotetrahydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazo)-7a'-
yl)}propanoate",MS,"(ESI) found [M+H]+ 282.1704, C15H24NO4 requires 282.1700",,1247,0.26,1.0,1.0,1.0,
288,"Methyl 3-(3,3-dimethyl-5-oxohexahydropyrrolo[2,1-b]oxazol-7a-yl)propanoate",Rf,"(ethyl acetate in petroleum ether, 25%): 0.17",COC(=O)CCC12CCC(=O)N1C(C)(C)CO2,1248,1.0,1.0,1.0,1.0,0.96875
289,"Methyl 3-(3,3-dimethyl-5-oxohexahydropyrrolo[2,1-b]oxazol-7a-yl)propanoate",IR,"(film): 2973, 1735, 1697,
1438, 1367, 1261, 1195, 1174, 1033, 1002, 809, 670",COC(=O)CCC12CCC(=O)N1C(C)(C)CO2,1249,1.0,1.0,1.0,1.0,0.96875
290,"Methyl 3-(3,3-dimethyl-5-oxohexahydropyrrolo[2,1-b]oxazol-7a-yl)propanoate",1H NMR,"(500 MHz, CDCl3) δ 4.02 (dd, J = 8.9, 0.5 Hz, 1H, H-9), 3.94 (d, J = 8.9 Hz, 1H, H-9), 3.69 (s, 3H, H-1), 2.67 (ddd, J = 17.0, 12.2, 8.0 Hz, 1H, H-
7), 2.55 – 2.34 (m, 3H, H-3 and H-7), 2.30 – 2.22 (m, 1H, H-4), 2.18 (ddd, J = 12.4, 8.0, 0.8 Hz, 1H, H-
6), 2.00 – 1.90 (m, 2H, H-4 and H-6), 1.55 (s, 3H, H-11), 1.42 (s, 3H, H-11)",COC(=O)CCC12CCC(=O)N1C(C)(C)CO2,1250,1.0,1.0,1.0,1.0,0.96875
291,"Methyl 3-(3,3-dimethyl-5-oxohexahydropyrrolo[2,1-b]oxazol-7a-yl)propanoate",13C NMR,"(126 MHz,
CDCl3) δ 173.4, 173.3, 102.2, 81.7, 58.2, 51.9, 35.3, 32.4, 30.4, 29.2, 26.5, 24.6",COC(=O)CCC12CCC(=O)N1C(C)(C)CO2,1251,1.0,1.0,1.0,1.0,0.96875
292,"Methyl 3-(3,3-dimethyl-5-oxohexahydropyrrolo[2,1-b]oxazol-7a-yl)propanoate",MS,"(ESI) found
[M+H]+ 242.1387, C12H20NO4 requires 242.1387",COC(=O)CCC12CCC(=O)N1C(C)(C)CO2,1252,1.0,1.0,1.0,1.0,0.96875
293,"7a'-(2-Hydroxypropan-2-yl)dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-
5'(6'H)-one",Rf,"(ethyl acetate in petroleum ether, 50%): 0.21",CC(C)(O)C12CCC(=O)N1C1(CCCCC1)CO2,1253,0.21,1.0,1.0,1.0,
294,"7a'-(2-Hydroxypropan-2-yl)dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-
5'(6'H)-one",IR,"(film): 3409 (br), 2932,
1705, 1456, 1358, 1168, 1019, 876, 812",CC(C)(O)C12CCC(=O)N1C1(CCCCC1)CO2,1254,0.21,1.0,0.11,0.2,
295,"7a'-(2-Hydroxypropan-2-yl)dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-
5'(6'H)-one",1H NMR,"(500 MHz, CDCl3) δ 4.30 (dd, J = 8.1, 2.0 Hz, 1H, H-
7), 4.21 (d, J = 8.1 Hz, 1H, H-7), 2.78 – 2.70 (m, 1H, H-9), 2.69 (ddd, J = 16.1, 11.8, 6.5 Hz, 1H, H-5),
2.52 (ddd, J = 16.8, 9.6, 0.9 Hz 1H, H-5), 2.29 (ddd, J = 13.0, 8.3, 0.9 Hz, 1H, H-4), 2.09 – 2.02 (m, 2H,
H-9), 1.95 – 1.80 (m, 2H, H-4 and H-10), 1.75 – 1.68 (m, 1H, H-11), 1.53 (s, 1H, H-10), 1.36 (s, 3H, H-
1), 1.34 – 1.31 (m, 1H, H-9), 1.29 (s, 3H, H-1), 1.27 – 1.20 (m, 2H H-10), 1.02 – 0.93 (m, 1H, H-11)",CC(C)(O)C12CCC(=O)N1C1(CCCCC1)CO2,1255,0.21,1.0,1.0,1.0,
296,"7a'-(2-Hydroxypropan-2-yl)dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-
5'(6'H)-one",13C NMR,"(126 MHz, CDCl3) δ 177.8, 106.3, 79.8, 64.2, 36.9, 35.1, 33.1, 32.8, 32.0, 25.9, 25.0, 24.9, 24.5,
24.1",CC(C)(O)C12CCC(=O)N1C1(CCCCC1)CO2,1256,0.21,1.0,1.0,1.0,
297,"7a'-(2-Hydroxypropan-2-yl)dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-
5'(6'H)-one",MS,"(ESI) found [M+H]+ 254.1751, C14H24NO3 requires 254.1751",CC(C)(O)C12CCC(=O)N1C1(CCCCC1)CO2,1257,0.21,1.0,1.0,1.0,
298,"(E)-7a'-(Hept-5-en-1-yl)dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-
one",Rf,"(ethyl acetate in petroleum ether, 25%): 0.35",C/C=C/CCCCC12CCC(=O)N1C1(CCCCC1)CO2,1258,0.99,1.0,1.0,1.0,
299,"(E)-7a'-(Hept-5-en-1-yl)dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-
one",IR,"(film): 2929, 2858, 1694,
1454, 1378, 1087, 1030, 966, 899, 730",C/C=C/CCCCC12CCC(=O)N1C1(CCCCC1)CO2,1259,0.99,1.0,1.0,1.0,
300,"(E)-7a'-(Hept-5-en-1-yl)dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-
one",1H NMR,"(500 MHz, CDCl3) δ 5.51 – 5.32 (m, 2H, H-2 and H-3), 4.23 (d, J = 9.1 Hz, 1H, H-12), 3.95 (dd, J = 9.1, 2.0 Hz, 1H, H-12), 2.75 – 2.68 (m, 1H, H-14), 2.65 (ddd,
J = 16.5, 12.2, 7.4 Hz, 1H, H-10), 2.49 (ddd, J = 16.5, 8.0, 0.8 Hz 1H, H-10), 2.20 (ddd, J = 12.2, 8.0, 0.8
Hz, 1H, H-9), 2.15 – 2.05 (m, 1H, H-14), 2.05 – 1.96 (m, 2H, H-4), 1.96 – 1.49 (m, 10H, H-1, H-7, H-9
and H-14, H-15 and H-16), 1.49 – 1.18 (m, 6H, H-5, H-6, H-14, H-15), 1.10 – 0.99 (m, 1H, H-16)",C/C=C/CCCCC12CCC(=O)N1C1(CCCCC1)CO2,1260,0.99,0.79,0.79,0.79,
301,"(E)-7a'-(Hept-5-en-1-yl)dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-
one",13C NMR,"(126 MHz, CDCl3) δ 172.9, 131.0, 125.2, 102.6, 77.4, 61.4, 36.8, 36.1, 35.9, 32.6, 32.4, 30.9, 29.6,
24.5, 24.5, 23.7, 23.5, 17.9",C/C=C/CCCCC12CCC(=O)N1C1(CCCCC1)CO2,1261,0.99,0.94,0.94,0.94,
302,"(E)-7a'-(Hept-5-en-1-yl)dihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-
one",MS,"(ESI) found [M+H]+ 292.2274, C18H30NO2 requires 292.2276",C/C=C/CCCCC12CCC(=O)N1C1(CCCCC1)CO2,1262,0.99,1.0,1.0,1.0,
303,"(E)-7a-(Hept-5-en-1-yl)-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",Rf,"(ethyl acetate in petroleum ether, 25%): 0.27",C/C=C/CCCCC12CCC(=O)N1C(C)(C)CO2,1263,0.94,1.0,1.0,1.0,0.967741935483871
304,"(E)-7a-(Hept-5-en-1-yl)-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",IR,"(film): 2934, 1698, 1457,
1366, 1270, 1230, 1041, 1002, 965, 841, 711, 666",C/C=C/CCCCC12CCC(=O)N1C(C)(C)CO2,1264,0.94,1.0,1.0,1.0,0.967741935483871
305,"(E)-7a-(Hept-5-en-1-yl)-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",1H NMR,"(500 MHz, CDCl3) δ 5.57 – 5.29 (m, 2H, H-
2 and H-3), 3.99 (d, J = 8.8 Hz, 1H, H-12), 3.95 (d, J = 8.8 Hz, 1H, H-12), 2.65 (ddd, J = 17.0, 12.3, 8.1
Hz, 1H, H-10), 2.48 (ddd, J = 17.0, 9.7, 0.8 Hz, 1H, H-10), 2.22 (ddd, J = 12.3, 8.1, 0.8 Hz, 1H, H-9),
2.05 – 1.89 (m, 3H, H-4 and H-9), 1.85 – 1.76 (m, 1H, H-7), 1.70 – 1.59 (m, 4H, H-4 and H-7), 1.56 (s,
3H, H-14), 1.41 (s, 3H, H-14), 1.47 – 1.30 (m, 4H, H-5 and H-6)",C/C=C/CCCCC12CCC(=O)N1C(C)(C)CO2,1265,0.94,1.0,1.0,1.0,0.967741935483871
306,"(E)-7a-(Hept-5-en-1-yl)-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",13C NMR,"(126 MHz, CDCl3) δ 173.6,
130.9, 125.2, 103.1, 81.6, 57.9, 35.7, 35.6, 32.6, 32.4, 29.6, 26.7, 24.6, 23.5, 17.9",C/C=C/CCCCC12CCC(=O)N1C(C)(C)CO2,1266,0.94,1.0,1.0,1.0,0.967741935483871
307,"(E)-7a-(Hept-5-en-1-yl)-3,3-dimethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",MS,"(ESI)
found [M+H]+ 252.1955, C15H26NO2 requires 252.1958",C/C=C/CCCCC12CCC(=O)N1C(C)(C)CO2,1267,0.94,1.0,1.0,1.0,0.967741935483871
308,"9b'-Ethyl-2'H-spiro(cyclohexane-1,3'-oxazolo[2,3-a]isoindol)-5'(9b'H)-one",Rf,"(ethyl acetate in petroleum ether, 25%): 0.31",CCC12OCC3(CCCCC3)N1C(=O)c1ccccc12,1268,1.0,1.0,1.0,1.0,1.0
309,"9b'-Ethyl-2'H-spiro(cyclohexane-1,3'-oxazolo[2,3-a]isoindol)-5'(9b'H)-one",IR,"(film): 2928, 2358, 1706,
1455, 1369, 1087, 1030, 662",CCC12OCC3(CCCCC3)N1C(=O)c1ccccc12,1269,1.0,1.0,1.0,1.0,1.0
310,"9b'-Ethyl-2'H-spiro(cyclohexane-1,3'-oxazolo[2,3-a]isoindol)-5'(9b'H)-one",1H NMR,"(500 MHz, CDCl3) δ 7.74 – 7.70 (m, 1H, H-8), 7.54 (dd, J = 7.4,
1.2 Hz, 1H, H-6), 7.50 – 7.43 (m, 2H, H-5 and H-8), 4.37 (d, J = 8.8 Hz, 1H, H-11), 4.28 (dd, J = 8.8, 1.8 Hz, 1H, H-11), 2.94 – 2.78 (m, 1H, H-13), 2.25 – 2.04 (m, 3H, H-2 and H-13), 1.99 – 1.91 (m, 1H, H-13),
1.91 – 1.84 (m, 1H, H-14), 1.84 – 1.74 (m, 1H, H-15), 1.68 – 1.59 (m, 1H, H-14), 1.47 – 1.38 (m, 1H, H-
13), 1.36 – 1.23 (m, 2H, H-14), 1.22 – 1.08 (m, 1H, H-15), 0.64 (t, J = 7.4 Hz, 3H, H-1)",CCC12OCC3(CCCCC3)N1C(=O)c1ccccc12,1270,1.0,0.92,0.92,0.92,1.0
311,"9b'-Ethyl-2'H-spiro(cyclohexane-1,3'-oxazolo[2,3-a]isoindol)-5'(9b'H)-one",13C NMR,"(126
MHz, CDCl3) δ 170.2, 145.3, 134.8, 132.4, 129.8, 123.7, 121.6, 102.6, 79.5, 63.1, 37.9, 31.1, 28.9, 24.7,
24.4, 23.9, 8.0",CCC12OCC3(CCCCC3)N1C(=O)c1ccccc12,1271,1.0,1.0,1.0,1.0,1.0
312,"9b'-Ethyl-2'H-spiro(cyclohexane-1,3'-oxazolo[2,3-a]isoindol)-5'(9b'H)-one",MS,"(ESI) found [M+H]+ 272.1641, C17H22NO2 requires 272.1645",CCC12OCC3(CCCCC3)N1C(=O)c1ccccc12,1272,1.0,1.0,1.0,1.0,1.0
313,"7a'-Phenethyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",Rf,"(ethyl acetate in petroleum ether, 25%): 0.23",O=C1CCC2(CCc3ccccc3)OCC3(CCCCC3)N12,1273,1.0,1.0,1.0,1.0,1.0
314,"7a'-Phenethyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",IR,"(film): 2932, 2859, 2250,
1684, 1455, 1384, 1262, 1087, 1028, 907, 804, 729, 698",O=C1CCC2(CCc3ccccc3)OCC3(CCCCC3)N12,1274,1.0,1.0,1.0,1.0,1.0
315,"7a'-Phenethyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",1H NMR,"(500 MHz, CDCl3) δ 7.30 (t, J = 7.5
Hz, 2H, H-3), 7.24 – 7.18 (m, 3H, H-1 and H-2), 4.28 (d, J = 9.1 Hz, 1H, H-11), 3.99 (dd, J = 9.1, 1.9 Hz,
1H, H-11), 2.81 – 2.62 (m, 4H, H-5, H-9 and H-13), 2.54 (dd, J = 17.1, 9.6 Hz, 1H, H-9), 2.27 (dd, J =
12.4, 7.9 Hz, 1H, H-8), 2.19 – 2.06 (m, 2H, H-6 and H-13), 2.04 – 1.92 (m, 2H, H-6 and H-8), 1.89 – 1.80
(m, 1H, H-14), 1.79 – 1.65 (m, 2H, H-13 and H-15), 1.60 (d, J = 11.9 Hz, 1H, H-14), 1.47 (d, J = 12.7
Hz, 1H, H-13), 1.36 – 1.18 (m, 2H, H-14), 1.09 – 0.98 (m, 1H, H-15)",O=C1CCC2(CCc3ccccc3)OCC3(CCCCC3)N12,1275,1.0,1.0,1.0,1.0,1.0
316,"7a'-Phenethyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",13C NMR,"(126 MHz, CDCl3) δ
172.9, 141.2, 128.6, 128.2, 126.1, 102.2, 61.6, 37.8, 36.8, 36.1, 32.6, 30.9, 30.5, 29.7, 24.6, 24.5, 23.7",O=C1CCC2(CCc3ccccc3)OCC3(CCCCC3)N12,1276,1.0,1.0,1.0,1.0,1.0
317,"7a'-Phenethyldihydro-2'H-spiro(cyclohexane-1,3'-pyrrolo[2,1-b]oxazol)-5'(6'H)-one",MS,"(ESI) found [M+H]+ 300.1956, C19H26NO2 requires 300.1958",O=C1CCC2(CCc3ccccc3)OCC3(CCCCC3)N12,1277,1.0,1.0,1.0,1.0,1.0
318,"3,3-Dimethyl-7a-phenethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",Rf,"(ethyl acetate in petroleum ether, 20%): 0.14",CC1(C)COC2(CCc3ccccc3)CCC(=O)N12,1278,0.93,1.0,1.0,1.0,
319,"3,3-Dimethyl-7a-phenethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",IR,"(film): 2949, 2156, 1698,
1455, 1374, 1367, 1230, 1030, 749, 701, 665",CC1(C)COC2(CCc3ccccc3)CCC(=O)N12,1279,0.93,1.0,1.0,1.0,
320,"3,3-Dimethyl-7a-phenethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",1H NMR,"(500 MHz, CDCl3) δ 7.35 – 7.30 (m, 2H, Ar-H),
7.25 – 7.20 (m, 3H, Ar-H), 4.05 (d, J = 8.9 Hz, 1H, H-11), 4.01 (d, J = 8.9 Hz, 1H, H-11), 2.83 – 2.65 (m, 3H, H-5 and H-9), 2.54 (ddd, J = 17.0, 9.7, 0.8 Hz, 1H, H-9), 2.31 (ddd, J = 12.5, 8.1, 0.8 Hz, 1H, H-8),
2.21 – 2.13 (m, 1H, H-6), 2.08 – 1.95 (m, 2H, H-6 and H-8), 1.61 (s, 3H, H-13), 1.44 (s, 3H, H-13)",CC1(C)COC2(CCc3ccccc3)CCC(=O)N12,1280,0.93,1.0,1.0,1.0,
321,"3,3-Dimethyl-7a-phenethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",13C NMR,"(126 MHz, CDCl3) δ 173.6, 141.2, 128.6, 128.2, 126.1, 102.8, 81.6, 58.1, 37.6, 35.5, 32.6, 30.4,
26.7, 24.6",CC1(C)COC2(CCc3ccccc3)CCC(=O)N12,1281,0.93,1.0,1.0,1.0,
322,"3,3-Dimethyl-7a-phenethyltetrahydropyrrolo[2,1-b]oxazol-5(6H)-one",MS,"(ESI) found [M+H]+ 260.1639, C16H22NO2 requires 260.1643",CC1(C)COC2(CCc3ccccc3)CCC(=O)N12,1282,0.93,1.0,1.0,1.0,
323,4-Oxohexanoic acid,Rf,"(dichloromethane in methanol, 5%): 0.15",CCC(=O)CCC(=O)O,1293,0.16,1.0,1.0,1.0,0.8333333333333334
324,4-Oxohexanoic acid,IR,"(film): 3200 (br), 2980, 1706, 1563, 1405, 1368, 1203, 1165, 1116, 953, 830",CCC(=O)CCC(=O)O,1294,0.16,1.0,0.09,0.17,0.8333333333333334
325,4-Oxohexanoic acid,1H NMR,"(400
MHz, CDCl3) δ 2.73 (t, J = 9.5 Hz, 2H, H-3), 2.64 (t, J = 9.5 Hz, 2H, H-5), 2.48 (q, J = 7.3 Hz, 2H, H-2),
1.08 (t, J = 7.3 Hz, 3H, H-6)",CCC(=O)CCC(=O)O,1295,0.16,1.0,1.0,1.0,0.8333333333333334
326,4-Oxohexanoic acid,13C NMR,"(400 MHz, CDCl3) δ 209.7, 177.9, 36.8, 36.3, 28.0, 8.1",CCC(=O)CCC(=O)O,1296,0.16,1.0,1.0,1.0,0.8333333333333334
327,4-Cyclohexyl-4-oxobutanoic acid,Rf,"(dichloromethane in methanol, 5%): 0.23",O=C(O)CCC(=O)C1CCCCC1,1297,0.24,1.0,1.0,1.0,1.0
328,4-Cyclohexyl-4-oxobutanoic acid,IR,"(film): 3210-2530 (v.
br), 2934, 2851, 1686, 1411, 1317, 1222, 1187, 1145, 1102, 921, 890, 801, 779",O=C(O)CCC(=O)C1CCCCC1,1298,0.24,1.0,0.13,0.23,1.0
329,4-Cyclohexyl-4-oxobutanoic acid,1H NMR,"(400 MHz,
CDCl3) δ 2.75 (t, J = 6.4 Hz, 2H, H-3), 2.62 (t, J = 6.4 Hz, 2H, H-2), 2.42 – 2.30 (m, 1H, H-5), 1.95 –
1.53 (m, 4H, H-6), 1.44 – 1.12 (m, 6H, H-7 and H-8)",O=C(O)CCC(=O)C1CCCCC1,1299,0.24,1.0,1.0,1.0,1.0
330,4-Cyclohexyl-4-oxobutanoic acid,13C NMR,"(101 MHz, CDCl3) δ 211.9, 178.1, 50.7,
34.8, 28.5, 27.7, 25.8, 25.6",O=C(O)CCC(=O)C1CCCCC1,1300,0.24,1.0,1.0,1.0,1.0
331,5-(Benzyloxy)-4-oxopentanoic acid,Rf,"(dichloromethane in methanol, 5%)",O=C(O)CCC(=O)COCc1ccccc1,1306,0.32,1.0,1.0,1.0,1.0
332,5-(Benzyloxy)-4-oxopentanoic acid,IR,"(film): 3300-2630 (v. br), 1709, 1398, 1206, 1151, 1090, 1028, 912, 740, 699",O=C(O)CCC(=O)COCc1ccccc1,1307,0.32,1.0,0.18,0.31,1.0
333,5-(Benzyloxy)-4-oxopentanoic acid,1H NMR,"(500 MHz,
MeOD) δ 7.49 – 7.22 (m, 5H, H-8, H-9 and H-10), 4.58 (s, 2H, H-6), 4.12 (s, 2H, H-5), 2.73 (t, J = 6.3
Hz, 2H, H-3), 2.57 (t, J = 6.3 Hz, 2H, H-2)",O=C(O)CCC(=O)COCc1ccccc1,1308,0.32,1.0,1.0,1.0,1.0
334,5-(Benzyloxy)-4-oxopentanoic acid,13C NMR,"(126 MHz, MeOD) δ 209.4, 176.4, 138.9, 129.5,
129.1, 128.9, 75.8, 74.3, 34.4, 28.4",O=C(O)CCC(=O)COCc1ccccc1,1309,0.32,1.0,1.0,1.0,1.0
335,5-(Benzyloxy)-4-oxopentanoic acid,MS,"(ESI) found [M-H]- 221.0816, C12H13O4 requires
221.0819",O=C(O)CCC(=O)COCc1ccccc1,1310,0.32,0.5,1.0,0.67,1.0
336,"(6'R, 7a'S)-7a'-Ethyl-6'-methyldihydro-2'H-spiro[cyclohexane-1,3'-pyrrolo[2,1-b]oxazol]-
5'(6'H)-one (±)",Rf,"(ethyl acetate in petroleum ether, 25%): 0.35",,1311,0.06,1.0,1.0,1.0,
337,"(6'R, 7a'S)-7a'-Ethyl-6'-methyldihydro-2'H-spiro[cyclohexane-1,3'-pyrrolo[2,1-b]oxazol]-
5'(6'H)-one (±)",IR,"(film): 2933, 2860, 1696, 1454, 1382, 1264,
1107, 1028, 968, 900, 848, 736, 697",,1312,0.06,1.0,1.0,1.0,
338,"(6'R, 7a'S)-7a'-Ethyl-6'-methyldihydro-2'H-spiro[cyclohexane-1,3'-pyrrolo[2,1-b]oxazol]-
5'(6'H)-one (±)",1H NMR,"(500 MHz, CDCl3) δ 4.22 (d, J = 9.0 Hz, 1H, H-8), 3.93
(dd, J = 9.0, 2.0 Hz, 1H, H-8), 2.84 – 2.67 (m, 2H, H-5 and H-10), 2.42 (dd, J = 12.1, 7.3 Hz, 1H, H-4),
2.11 (ddd, J = 15.6, 8.7, 2.8 Hz, 1H, H-10), 1.89 – 1.77 (m, 2H, H-2 and H-11), 1.76 – 1.48 (m, 5H, H-2,
H-4, H-10, H-11 and H-12), 1.44 – 1.37 (m, 1H, H-10), 1.34 – 1.18 (m, 2H, H-11), 1.17 (d, J = 7.1 Hz,
3H, H-6), 1.08 – 0.99 (m, 1H, H-12), 0.96 (t, J = 7.5 Hz, 3H, H-1)",,1313,0.06,1.0,1.0,1.0,
339,"(6'R, 7a'S)-7a'-Ethyl-6'-methyldihydro-2'H-spiro[cyclohexane-1,3'-pyrrolo[2,1-b]oxazol]-
5'(6'H)-one (±)",13C NMR,"(126 MHz, CDCl3) δ 175.4,
100.1, 77.0, 61.4, 41.5, 41.1, 36.7, 31.0, 28.6, 24.6, 24.5, 23.7, 16.0, 8.5",,1314,0.06,1.0,1.0,1.0,
340,"(6'R, 7a'S)-7a'-Ethyl-6'-methyldihydro-2'H-spiro[cyclohexane-1,3'-pyrrolo[2,1-b]oxazol]-
5'(6'H)-one (±)",MS,"(ESI) found
[M+H]+, 238.1801, C14H24NO2 requires 238.1802",,1315,0.06,1.0,1.0,1.0,
341,N-{1-(Hydroxymethyl)cyclohexyl}-4-oxohexanamide,Rf,"(ethyl acetate in petroleum ether, 20%): 0.31",CCC(=O)CCC(=O)NC1(CO)CCCCC1,1316,0.27,1.0,1.0,1.0,1.0
342,N-{1-(Hydroxymethyl)cyclohexyl}-4-oxohexanamide,IR,"(film): 3510 (br), 2992, 2930, 1770,
1692, 1272, 1240, 1003, 998, 912, 907, 865, 792",CCC(=O)CCC(=O)NC1(CO)CCCCC1,1317,0.27,1.0,0.08,0.15,1.0
343,N-{1-(Hydroxymethyl)cyclohexyl}-4-oxohexanamide,1H NMR,"(500 MHz, CDCl3) δ 3.95 (s, 2H, H-11), 2.78
(t, J = 7.5 Hz, 2H, H-4), 2.59 (t, J = 7.5 Hz, 2H, H-5), 2.48 (q, J = 7.3 Hz, 2H, H-2), 1.84 – 1.46 (m, 7H,
H-8, H-9 and H-10), 1.38 – 1.21 (m, 3H, H-8 and H-10), 1.08 (t, J = 7.3 Hz, 3H, H-1)",CCC(=O)CCC(=O)NC1(CO)CCCCC1,1318,0.27,1.0,1.0,1.0,1.0
344,N-{1-(Hydroxymethyl)cyclohexyl}-4-oxohexanamide,13C NMR,"(126
MHz, CDCl3) δ 209.6, 164.9, 70.6, 66.3, 38.2, 37.5, 36.0, 25.1, 23.0, 22.2, 7.8",CCC(=O)CCC(=O)NC1(CO)CCCCC1,1319,0.27,1.0,1.0,1.0,1.0
345,N-{1-(Hydroxymethyl)cyclohexyl}-4-oxohexanamide,MS,"(ESI) found
[M+H]+, 224.1674, C13H24NO3 requires 242.1678",CCC(=O)CCC(=O)NC1(CO)CCCCC1,1320,0.27,1.0,1.0,1.0,1.0
346,5-Ethyl-1-{1-(hydroxymethyl)cyclohexyl}-1H-pyrrol-2(5H)-one,Rf,"(ethyl acetate in petroleum ether, 20%): 0.22",CCC1C=CC(=O)N1C1(CO)CCCCC1,1321,0.43,1.0,1.0,1.0,0.9285714285714286
347,5-Ethyl-1-{1-(hydroxymethyl)cyclohexyl}-1H-pyrrol-2(5H)-one,IR,"(film): 3365 (br), 2933, 2864, 1654, 1448, 1385, 1215, 1059, 910, 828, 808, 733",CCC1C=CC(=O)N1C1(CO)CCCCC1,1322,0.43,1.0,0.08,0.15,0.9285714285714286
348,5-Ethyl-1-{1-(hydroxymethyl)cyclohexyl}-1H-pyrrol-2(5H)-one,1H NMR,"(500
MHz, CDCl3) δ 6.97 (dd, J = 5.9, 1.9 Hz, 1H, H-4), 6.07 (dd, J = 5.9, 1.4 Hz, 1H, H-5), 5.49 (s, 1H, H-9),
4.38 (ddd, J = 6.2, 2.9, 1.4 Hz, 1H, H-3), 3.99 – 3.77 (m, 2H, H-8), 2.20 – 1.91 (m, 3H, H-2, H-10 and H-
11), 1.75 – 1.48 (m, 9H, H-2, H-10 and H-11), 1.34 – 1.18 (m, 2H, H-12), 0.84 (t, J = 7.4 Hz, 3H, H-1)",CCC1C=CC(=O)N1C1(CO)CCCCC1,1323,0.43,1.0,1.0,1.0,0.9285714285714286
349,5-Ethyl-1-{1-(hydroxymethyl)cyclohexyl}-1H-pyrrol-2(5H)-one,13C NMR,"(126 MHz, CDCl3) δ 174.2, 148.5, 127.6, 66.9, 63.6, 62.9, 31.8, 30.5, 26.7, 25.2, 22.9, 22.6,
8.2",CCC1C=CC(=O)N1C1(CO)CCCCC1,1324,0.43,1.0,1.0,1.0,0.9285714285714286
350,5-Ethyl-1-{1-(hydroxymethyl)cyclohexyl}-1H-pyrrol-2(5H)-one,MS,"(ESI) found [M+H]+, 224.1645, C13H22NO2 requires 224.1645",CCC1C=CC(=O)N1C1(CO)CCCCC1,1325,0.43,1.0,1.0,1.0,0.9285714285714286
351,"1-(4-Fluorobenzyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1H-benzo[d]imidazol-2-amine",Rf,"(methanol in
dichloromethane, 20%): 0.19",CC1(C)CC(Nc2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1326,0.29,1.0,1.0,1.0,1.0
352,"1-(4-Fluorobenzyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1H-benzo[d]imidazol-2-amine",IR,"2972, 1604, 1572, 1533, 1363, 1220, 1156, 1080,
1025, 953, 846, 734",CC1(C)CC(Nc2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1327,0.29,1.0,1.0,1.0,1.0
353,"1-(4-Fluorobenzyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1H-benzo[d]imidazol-2-amine",1H NMR,"(500 MHz, CDCl3) δ 7.52 (d, J = 7.9 Hz, 1H, H-13), 7.17 – 7.07 (m, 3H,
H-10 and H-18), 7.06 – 6.99 (m, 4H, H-11, H-12 and H-17), 5.05 (s, 2H, H-15), 4.30 (tt, J = 8.5, 6.0 Hz
1H, H-6), 3.60 (d, J = 7.4 Hz, 1H, H-7), 2.07 (dd, J = 12.6, 3.9 Hz, 2H, H-5eq), 1.31 (s, 6H, H-3 or H-4),
1.14 (s, 6H, H-3 or H-4), 0.86 (t, J = 11.6 Hz, 2H, H-5ax)",CC1(C)CC(Nc2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1328,0.29,1.0,1.0,1.0,1.0
354,"1-(4-Fluorobenzyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1H-benzo[d]imidazol-2-amine",13C NMR,"(126 MHz, CDCl3) δ 162.4 (d, 1J C-F
= 247.2 Hz), 153.3, 142.5, 134.6, 131.2, 128.1 (d, 3J C-F = 8.1 Hz), 121.5, 119.8, 116.2 (d, 2J C-F = 21.8
Hz), 116.1, 107.1, 51.6, 46.3, 45.8, 45.0, 34.7, 28.5",CC1(C)CC(Nc2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1329,0.29,0.0,0.0,0.0,1.0
355,"1-(4-Fluorobenzyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1H-benzo[d]imidazol-2-amine",19F NMR,"(376 MHz, CDCl3) δ -113.73",CC1(C)CC(Nc2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1330,0.29,1.0,1.0,1.0,1.0
356,"1-(4-Fluorobenzyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1H-benzo[d]imidazol-2-amine",MS,"(ESI) found [M+H]+ 381.2454, C23H30F N4 requires 381.2454",CC1(C)CC(Nc2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1331,0.29,1.0,1.0,1.0,1.0
357,"1-(4-Fluorobenzyl)-N-(4-methoxyphenethyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1Hbenzo[
d]imidazol-2-amine",Rf,"(methanol
in dichloromethane, 20%): 0.34;",COc1ccc(CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)C2CC(C)(C)NC(C)(C)C2)cc1,1332,0.18,1.0,1.0,1.0,0.7101449275362319
358,"1-(4-Fluorobenzyl)-N-(4-methoxyphenethyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1Hbenzo[
d]imidazol-2-amine",IR,"(film): 2916, 1656, 1611, 1511, 1499, 1363, 1247, 1225,
1157, 1036, 908, 812, 731",COc1ccc(CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)C2CC(C)(C)NC(C)(C)C2)cc1,1333,0.18,1.0,1.0,1.0,0.7101449275362319
359,"1-(4-Fluorobenzyl)-N-(4-methoxyphenethyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1Hbenzo[
d]imidazol-2-amine",1H NMR,"(500 MHz, CDCl3) δ 7.20 (dd, J = 8.5, 5.3 Hz, 2H, H-23), 7.10 (d, J
= 8.6 Hz, 2H, H-10), 7.03 (t, J = 8.7 Hz, 2H, H-24), 6.95 (t, J = 7.5 Hz, 1H, H-17), 6.87 (t, J = 7.5 Hz,
1H, H-18), 6.81 (d, J = 8.6 Hz, 2H, H-11), 6.78 (d, J = 7.6 Hz, 1H, H-19), 6.63 (d, J = 7.5 Hz, 1H, H-16),
5.04 (s, 2H, H-21) 4.20 – 4.05 (m, 2H, H-7), 4.00 – 3.86 (m, 1H, H-6), 3.78 (s, 3H, H-13), 3.04 – 2.92
(m, 2H, H-8), 1.62 (dd, J = 13.0, 3.3 Hz, 2H, H-5eq), 1.31 – 1.18 (m, 2H, H-5ax), 1.13 (s, 6H, H-3 or H-
4), 0.98 (s, 6H, H-3 or H-4)",COc1ccc(CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)C2CC(C)(C)NC(C)(C)C2)cc1,1334,0.18,1.0,1.0,1.0,0.7101449275362319
360,"1-(4-Fluorobenzyl)-N-(4-methoxyphenethyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1Hbenzo[
d]imidazol-2-amine",13C NMR,"(126 MHz, CDCl3) δ 162.1 (d, 1J C-F = 245.8 Hz), 158.3, 144.7,
133.0, 132.8, 132.5, 130.6, 129.9, 127.8 (d, 3J C-F = 4.9 Hz), 120.8, 120.2, 115.7 (d, 2J C-F = 21.6 Hz),
114.0, 106.1, 55.2, 51.4, 48.3, 46.6, 44.4, 34.5, 33.1, 28.2",COc1ccc(CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)C2CC(C)(C)NC(C)(C)C2)cc1,1335,0.18,0.0,0.0,0.0,0.7101449275362319
361,"1-(4-Fluorobenzyl)-N-(4-methoxyphenethyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1Hbenzo[
d]imidazol-2-amine",19F NMR,"(376 MHz, CDCl3) δ -115.16",COc1ccc(CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)C2CC(C)(C)NC(C)(C)C2)cc1,1336,0.18,1.0,1.0,1.0,0.7101449275362319
362,"1-(4-Fluorobenzyl)-N-(4-methoxyphenethyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1Hbenzo[
d]imidazol-2-amine",MS,"(ESI) found [M+H]+ 515.3186, C32H40FN4O requires 515.3181",COc1ccc(CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)C2CC(C)(C)NC(C)(C)C2)cc1,1337,0.18,1.0,1.0,1.0,0.7101449275362319
363,"Tert-butyl (1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)(2,2,6,6-tetramethylpiperidin-4-
yl)carbamate",Rf,"(methanol in
dichloromethane, 5%): 0.28",CC1(C)CC(N(C(=O)OC(C)(C)C)c2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1338,0.62,1.0,1.0,1.0,1.0
364,"Tert-butyl (1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)(2,2,6,6-tetramethylpiperidin-4-
yl)carbamate",IR,"(film): 2940, 1733, 1670, 1603, 1488, 1342, 1246, 1219, 1149,
1082, 853, 749, 672",CC1(C)CC(N(C(=O)OC(C)(C)C)c2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1339,0.62,1.0,1.0,1.0,1.0
365,"Tert-butyl (1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)(2,2,6,6-tetramethylpiperidin-4-
yl)carbamate",1H NMR,"(400 MHz, CDCl3) δ 7.45 (d, J = 7.8 Hz, 1H, H-15), 7.30 (dd, J = 8.6, 5.4
Hz, 2H, H-19), 7.03 – 6.93 (m, 3H, H-13 and H-20), 6.87 (t, J = 7.8 Hz, 1H, H-14), 6.62 (d, J = 7.7 Hz,
1H, H-12), 4.93 (s, 2H, H-17), 4.04 (tt, J = 11.5, 3.9 Hz, 1H, H-6), 2.53 (s, 1H, H-1) 1.82 (dd, J = 12.7,
3.8 Hz, 2H, H-5eq), 1.65 (s, 9H, H-9), 1.24 (s, 6H, H-3 or H-4), 1.13 (s, 6H, H-3 or H-4), 1.08 – 1.01 (m,
2H, H-5ax)",CC1(C)CC(N(C(=O)OC(C)(C)C)c2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1340,0.62,1.0,1.0,1.0,1.0
366,"Tert-butyl (1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)(2,2,6,6-tetramethylpiperidin-4-
yl)carbamate",13C NMR,"(126 MHz, CDCl3) δ 162.0 (d, 1J C-F = 245.0 Hz), 150.2, 140.7, 134.0, 132.9, 129.2
(d, 3J C-F = 7.5 Hz), 129.1, 124.0, 119.6, 115.3 (d, 2J C-F = 21.4 Hz), 113.9, 106.5, 84.1, 51.0, 49.9, 46.9,
44.7, 35.1, 28.7, 28.2",CC1(C)CC(N(C(=O)OC(C)(C)C)c2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1341,0.62,0.0,0.0,0.0,1.0
367,"Tert-butyl (1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)(2,2,6,6-tetramethylpiperidin-4-
yl)carbamate",19F NMR,"(376 MHz, CDCl3) δ -115.60",CC1(C)CC(N(C(=O)OC(C)(C)C)c2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1342,0.62,1.0,1.0,1.0,1.0
368,"Tert-butyl (1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)(2,2,6,6-tetramethylpiperidin-4-
yl)carbamate",MS,"(ESI) found [M+H]+
481.2975, C26H38FN4O2 requires 481.2973",CC1(C)CC(N(C(=O)OC(C)(C)C)c2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1343,0.62,1.0,1.0,1.0,1.0
369,"Benzyl (1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)(2,2,6,6-tetramethylpiperidin-4-
yl)carbamate",Rf,"(methanol in dichloromethane, 2%): 0.27",CC1(C)CC(N(C(=O)OCc2ccccc2)c2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1344,0.61,1.0,1.0,1.0,0.6861313868613139
370,"Benzyl (1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)(2,2,6,6-tetramethylpiperidin-4-
yl)carbamate",IR,"(film): 294058, 1675, 1583,
1423, 1300, 1289, 1226, 1082, 821, 711",CC1(C)CC(N(C(=O)OCc2ccccc2)c2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1345,0.61,1.0,1.0,1.0,0.6861313868613139
371,"Benzyl (1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)(2,2,6,6-tetramethylpiperidin-4-
yl)carbamate",1H NMR,"(400 MHz, CDCl3) δ 7.93 (d, J = 7.5 Hz, 2H, H-8),
7.67 (dd, J = 6.8, 2.1 Hz, 1H, H-14), 7.54 (dd, J = 6.9, 2.2 Hz, 1H, H-17), 7.38 (d, J = 7.3 Hz, 2H, H-9),
7.30 – 7.20 (m, 4H, H-15, H-16 and H-21), 6.97 (t, J = 7.8 Hz, 2H, H-22), 5.12 (s, 2H, H-19), 4.27 – 4.08, (m, 1H, H-6), 2.36 (s, 3H, H-11), 1.87 (dd, J = 12.4, 3.1 Hz, 2H, H-5eq), 1.50 (dd, J = 12.4, 7.5 Hz, 2H,
H-5ax), 1.22 (s, 6H, H-3 or H-4), 1.16 (s, 6H, H-3 or H-4)",CC1(C)CC(N(C(=O)OCc2ccccc2)c2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1346,0.61,1.0,0.94,0.97,0.6861313868613139
372,"Benzyl (1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)(2,2,6,6-tetramethylpiperidin-4-
yl)carbamate",13C NMR,"(125 MHz, CDCl3) δ 163.0 (d, 1J C-F
= 262.3 Hz), 156.6, 142.7, 140.5, 138.6, 136.5, 131.5, 130.6 (d, 3J C-F = 6.7 Hz), 129.8, 128.1, 122.8,
121.5, 116.1, 115.0 (d, 2J C-F = 26.7 Hz), 111.5, 50.0, 49.9, 47.2, 42.7, 30.2, 21.1, 19.4",CC1(C)CC(N(C(=O)OCc2ccccc2)c2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1347,0.61,0.0,0.0,0.0,0.6861313868613139
373,"Benzyl (1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)(2,2,6,6-tetramethylpiperidin-4-
yl)carbamate",19F NMR,"(376
MHz, CDCl3) δ -111.30",CC1(C)CC(N(C(=O)OCc2ccccc2)c2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1348,0.61,1.0,1.0,1.0,0.6861313868613139
374,"Benzyl (1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)(2,2,6,6-tetramethylpiperidin-4-
yl)carbamate",MS,"(ESI) found [M+H]+ 535.6876, C30H36FN4O2S requires 535.6879",CC1(C)CC(N(C(=O)OCc2ccccc2)c2nc3ccccc3n2Cc2ccc(F)cc2)CC(C)(C)N1,1349,0.61,1.0,1.0,1.0,0.6861313868613139
375,"2-(2,2,6,6-Tetramethylpiperidin-4-yl)isoindoline-1,3-dione",IR,"(film): 2972,
1701, 1626, 1373, 1364, 1098, 1087, 865, 712",CC1(C)CC(N2C(=O)c3ccccc3C2=O)CC(C)(C)N1,1350,0.46,1.0,1.0,1.0,1.0
376,"2-(2,2,6,6-Tetramethylpiperidin-4-yl)isoindoline-1,3-dione",1H NMR,"(400 MHz, CDCl3) δ 7.81 (dd, J = 5.4, 3.1 Hz,
2H, H-8), 7.69 (dd, J = 5.4, 3.0 Hz, 2H, H-9), 5.54 (s, 1H, H-1), 4.66 (tt, J = 12.8, 3.5 Hz, 1H, H-5), 2.26
(t, J = 12.8 Hz, 2H, H-4ax), 1.64 (dd, J = 12.8, 3.4 Hz, 2H, H-4eq), 1.36 (s, 6H, H-2), 1.26 (s, 6H, H-2)",CC1(C)CC(N2C(=O)c3ccccc3C2=O)CC(C)(C)N1,1351,0.46,1.0,1.0,1.0,1.0
377,"2-(2,2,6,6-Tetramethylpiperidin-4-yl)isoindoline-1,3-dione",13C NMR,"(126 MHz, CDCl3) δ 168.5, 133.9, 132.0, 123.0, 51.4, 44.8, 41.2, 34.7, 28.0",CC1(C)CC(N2C(=O)c3ccccc3C2=O)CC(C)(C)N1,1352,0.46,1.0,1.0,1.0,1.0
378,"2-(1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl)isoindoline-1,3-dione",Rf,"(dichloromethane in methanol, 5%): 0.21",COc1ccc(CCN2C(C)(C)CC(N3C(=O)c4ccccc4C3=O)CC2(C)C)cc1,1353,0.64,1.0,1.0,1.0,0.36363636363636365
379,"2-(1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl)isoindoline-1,3-dione",IR,"(film): 2966,
1708, 1512, 1375, 1244, 1176, 1086, 1035, 912, 719",COc1ccc(CCN2C(C)(C)CC(N3C(=O)c4ccccc4C3=O)CC2(C)C)cc1,1354,0.64,1.0,1.0,1.0,0.36363636363636365
380,"2-(1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl)isoindoline-1,3-dione",1H NMR,"(500 MHz, CDCl3) δ 7.82 (dd, J = 5.5, 3.0
Hz, 2H, H-14), 7.70 (dd, J = 5.5, 3.0 Hz, 2H, H-15), 7.11 (d, J = 8.6 Hz, 2H, H-4), 6.85 (d, J = 8.6 Hz,
2H, H-3), 4.59 (ddd, J = 13.0, 8.3, 3.5 Hz, 1H, H-11), 2.73 – 2.62 (m, 2H, H-7), 2.60 – 2.57 (m, 2H, H-6),
2.47 (t, J = 12.4 Hz, 2H, H-10ax), 1.54 (dd, J = 12.4, 3.5 Hz, 1H, H-10eq), 1.28 (s, 6H, H-8), 1.12 (s, 6H,
H-8)",COc1ccc(CCN2C(C)(C)CC(N3C(=O)c4ccccc4C3=O)CC2(C)C)cc1,1355,0.64,1.0,1.0,1.0,0.36363636363636365
381,"2-(1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl)isoindoline-1,3-dione",13C NMR,"(126 MHz, CDCl3) δ 168.6, 157.9, 133.8, 133.3, 132.0, 129.4, 123.0, 113.8, 56.0, 55.3,
47.4, 44.1, 43.4, 41.3, 34.1, 21.4",COc1ccc(CCN2C(C)(C)CC(N3C(=O)c4ccccc4C3=O)CC2(C)C)cc1,1356,0.64,1.0,1.0,1.0,0.36363636363636365
382,"2-(1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl)isoindoline-1,3-dione",MS,"(ESI) found [M+H]+ 421.2483, C26H33N2O3 requires
421.2486",COc1ccc(CCN2C(C)(C)CC(N3C(=O)c4ccccc4C3=O)CC2(C)C)cc1,1357,0.64,1.0,1.0,1.0,0.36363636363636365
383,"1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-amine",IR,"(film): 2938, 2835, 1611, 1583, 1511, 1464, 1378,
1366, 1243, 1175, 1111, 1036, 961, 853, 821, 743",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)C)cc1,1358,0.71,1.0,1.0,1.0,0.7954545454545454
384,"1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-amine",1H NMR,"(500 MHz, CDCl3) δ 7.10 (d, J = 8.6 Hz,
2H, H-4), 6.84 (d, J = 8.6 Hz, 2H, H-3), 3.79 (s, 3H, H-1), 3.01 (ddd, J = 11.7, 8.3, 3.6 Hz, 1H, H-12),
2.70 – 2.47 (m, 4H, H-6 and H-7), 1.69 (dd, J = 12.2, 3.1 Hz, 2H, H-11eq), 1.44 (br. s, 2H, H-13), 1.43 (s,
6H, H-8 or H-9), 1.22 (s, 6H, H-8 or H-9), 1.28 – 1.15 (m, 2H, H-11ax)",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)C)cc1,1359,0.71,1.0,1.0,1.0,0.7954545454545454
385,"1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-amine",13C NMR,"(126 MHz, CDCl3) δ
157.9, 133.2, 129.4, 113.8, 55.7, 55.3, 51.5, 47.3, 42.5, 41.4, 34.3, 21.9",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)C)cc1,1360,0.71,1.0,1.0,1.0,0.7954545454545454
386,"1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-amine",MS,"(ESI) found [M+H]+
291.2433, C18H30N2O requires 291.2431",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)C)cc1,1361,0.71,1.0,1.0,1.0,0.7954545454545454
387,"1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-amine",Rf,"(ethyl acetate in petroleum ether, 30% - on
triethylamine-pretreated silica plate): 0.22",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)C)cc1,1400,,,,,
388,"1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-amine",IR,"(film): 2938, 2835, 1611, 1583, 1511, 1464,
1378, 1366, 1243, 1175, 1111, 1036, 961, 853, 821, 743",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)C)cc1,1401,0.71,1.0,1.0,1.0,0.7954545454545454
389,"1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-amine",1H NMR,"(500 MHz, CDCl3) δ 7.10 (d, J = 8.6
Hz, 2H, H-4), 6.84 (d, J = 8.6 Hz, 2H, H-3), 3.79 (s, 3H, H-1), 3.05 – 2.95 (m, 1H, H-12), 2.70 – 2.47 (m,
4H, H-6 and H-7), 1.69 (dd, J = 12.2, 3.1 Hz, 2H, H-11eq), 1.44 (br. s, 2H, H-12), 1.43 (s, 6H, H-8 or H-
9), 1.22 (s, 6H, H-8 o H-9), 1.28 – 1.15 (m, 2H, H-11ax)",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)C)cc1,1402,0.71,0.92,0.85,0.88,0.7954545454545454
390,"1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-amine",13C NMR,"(126 MHz, CDCl3) δ 157.9, 133.2,
129.4, 113.8, 55.7, 55.3, 51.5, 47.3, 42.5, 41.4, 34.3, 21.8",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)C)cc1,1403,0.71,0.92,0.92,0.92,0.7954545454545454
391,"1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-amine",MS,"(ESI) found [M+H]+ 291.2433,
C18H30N2O requires 291.2431",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)C)cc1,1404,0.71,1.0,1.0,1.0,0.7954545454545454
392,"2-(1-Heptyl-2,2,6,6-tetramethylpiperidin-4-yl)isoindoline-1,3-dione",Rf,"(ethyl acetate in petroleum ether, 10%): 0.36",CCCCCCCN1C(C)(C)CC(N2C(=O)c3ccccc3C2=O)CC1(C)C,1362,0.7,1.0,1.0,1.0,0.7446808510638298
393,"2-(1-Heptyl-2,2,6,6-tetramethylpiperidin-4-yl)isoindoline-1,3-dione",IR,"(film): 2926, 2855, 1769, 1710, 1467, 1374, 1336, 1177, 1086, 943, 869, 717",CCCCCCCN1C(C)(C)CC(N2C(=O)c3ccccc3C2=O)CC1(C)C,1363,0.7,1.0,1.0,1.0,0.7446808510638298
394,"2-(1-Heptyl-2,2,6,6-tetramethylpiperidin-4-yl)isoindoline-1,3-dione",1H NMR,"(500 MHz,
CDCl3) δ 7.83 (dd, J = 5.4, 3.0 Hz, 2H, H-15), 7.71 (dd, J = 5.4, 3.0 Hz, 2H, H-16), 4.60 (tt, J = 13.0, 3.5
Hz, 1H, H-12), 2.52 – 2.33 (m, 4H, H-7 and H-11ax), 1.52 (dd, J = 12.3, 3.5 Hz, 2H, H-11eq), 1.50 – 1.41
(m, 2H, H-6), 1.36 – 1.21 (m, 8H, H-2, H-3, H-4 and H-5), 1.17 (s, 6H, H-8 or H-9), 1.14 (s, 6H, H-8 or
H-9), 0.92 (t, J = 6.1 Hz, 3H, H-1)",CCCCCCCN1C(C)(C)CC(N2C(=O)c3ccccc3C2=O)CC1(C)C,1364,0.7,1.0,1.0,1.0,0.7446808510638298
395,"2-(1-Heptyl-2,2,6,6-tetramethylpiperidin-4-yl)isoindoline-1,3-dione",13C NMR,"(126 MHz, CDCl3) δ 168.6, 133.8, 132.0, 123.0, 55.8, 44.6,
44.2, 43.5, 35.7, 34.1, 32.1, 29.3, 27.5, 22.7, 21.2, 14.1",CCCCCCCN1C(C)(C)CC(N2C(=O)c3ccccc3C2=O)CC1(C)C,1365,0.7,1.0,1.0,1.0,0.7446808510638298
396,"2-(1-Heptyl-2,2,6,6-tetramethylpiperidin-4-yl)isoindoline-1,3-dione",MS,"(ESI) found [M+H]+ 385.2856,
C24H37N2O2 requires 385.2855",CCCCCCCN1C(C)(C)CC(N2C(=O)c3ccccc3C2=O)CC1(C)C,1366,0.7,1.0,1.0,1.0,0.7446808510638298
397,"8-Heptyl-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane",Rf,"(ethyl acetate in petroleum ether, 10% -
on triethylamine-pretreated silica plate): 0.34",CCCCCCCN1C(C)(C)CC2(CC1(C)C)OCCO2,1375,0.64,1.0,1.0,1.0,0.9850746268656716
398,"8-Heptyl-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane",IR,"(film): 2949, 2874, 1467, 1361, 1259, 1189,
1082, 1013, 959, 841, 798, 733, 702",CCCCCCCN1C(C)(C)CC2(CC1(C)C)OCCO2,1376,0.64,1.0,1.0,1.0,0.9850746268656716
399,"8-Heptyl-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane",1H NMR,"(500 MHz, CDCl3) δ 3.94 (s, 4H, H-12), 2.46 – 2.37 (m,
2H, H-7), 1.66 (s, 4H, H-10), 1.49 – 1.38 (m, 2H, H-6), 1.37 – 1.17 (m, 8H, H-2, H-3, H-4 and H-5), 1.14
(s, 12H, H-8), 0.90 (t, J = 6.9 Hz, 3H, H-1)",CCCCCCCN1C(C)(C)CC2(CC1(C)C)OCCO2,1377,0.64,1.0,1.0,1.0,0.9850746268656716
400,"8-Heptyl-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane",13C NMR,"(126 MHz, CDCl3) δ 107.8, 63.6, 55.7, 47.6, 44.2,
35.9, 32.0, 29.3, 27.5, 23.0, 22.7, 14.1",CCCCCCCN1C(C)(C)CC2(CC1(C)C)OCCO2,1378,0.64,1.0,1.0,1.0,0.9850746268656716
401,"8-Heptyl-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane",MS,"(ESI) found [M+H]+ 334.2376, C20H32NO3 requires
334.2377",CCCCCCCN1C(C)(C)CC2(CC1(C)C)OCCO2,1379,0.64,1.0,1.0,1.0,0.9850746268656716
402,"1-Heptyl-2,2,6,6-tetramethylpiperidin-4-one",Rf,"(ethyl acetate in petroleum ether, 10% - on triethylamine-pretreated silica plate): 0.29",CCCCCCCN1C(C)(C)CC(=O)CC1(C)C,1380,0.38,1.0,1.0,1.0,0.9830508474576272
403,"1-Heptyl-2,2,6,6-tetramethylpiperidin-4-one",IR,"(film): 2957, 2926, 2854, 1675, 1615, 1444, 1378, 1359, 1219, 1112, 1032, 868, 770, 724",CCCCCCCN1C(C)(C)CC(=O)CC1(C)C,1381,0.38,1.0,1.0,1.0,0.9830508474576272
404,"1-Heptyl-2,2,6,6-tetramethylpiperidin-4-one",1H NMR,"(500
MHz, CDCl3) δ 2.50 (t, J = 10.0 Hz, 2H, H-7), 2.15 (s, 4H, H-10), 1.51 – 1.43 (m, 2H, H-6), 1.36 – 1.25
(m, 8H, H-2, H-3, H-4 and H-5), 1.15 (s, 12H, H-8), 0.89 (t, J = 7.0 Hz, 3H, H-1)",CCCCCCCN1C(C)(C)CC(=O)CC1(C)C,1382,0.38,1.0,1.0,1.0,0.9830508474576272
405,"1-Heptyl-2,2,6,6-tetramethylpiperidin-4-one",13C NMR,"(126 MHz,
CDCl3) δ 200.9, 52.9, 52.4, 42.5, 31.8, 30.9, 29.3, 27.6, 27.5, 22.6, 14.1",CCCCCCCN1C(C)(C)CC(=O)CC1(C)C,1383,0.38,1.0,1.0,1.0,0.9830508474576272
406,"1-Heptyl-2,2,6,6-tetramethylpiperidin-4-one",MS,"(ESI) found [M+H]+
254.2481, C16H32NO requires 254.2478",CCCCCCCN1C(C)(C)CC(=O)CC1(C)C,1384,0.38,1.0,1.0,1.0,0.9830508474576272
407,"1-Heptyl-2,2,6,6-tetramethylpiperidin-4-amine",IR,"(film): 2920, 2872, 1577, 1464, 1378, 1330, 1260, 1214, 1187,
1112, 1013, 913, 839, 722",CCCCCCCN1C(C)(C)CC(N)CC1(C)C,1367,1.0,1.0,1.0,1.0,1.0
408,"1-Heptyl-2,2,6,6-tetramethylpiperidin-4-amine",1H NMR,"(400 MHz, CDCl3) δ 3.04 – 2.91 (m, 1H, H-12), 2.40 – 2.27 (m, 2H,
H-7), 1.65 (dd, J = 12.4, 3.7 Hz, 2H, H-11eq), 1.46 – 1.32 (m, 2H, H-6), 1.34 – 1.12 (m, 10H, H-2, H-3,
H-4, H-5 and H-11ax), 1.08 (s, 6H, H-8 or H-9), 1.01 (s, 6H, H-8 or H-9), 0.88 (t, J = 6.8 Hz, 3H, H-1)",CCCCCCCN1C(C)(C)CC(N)CC1(C)C,1368,1.0,1.0,1.0,1.0,1.0
409,"1-Heptyl-2,2,6,6-tetramethylpiperidin-4-amine",13C NMR,"(126 MHz, CDCl3) δ 55.5, 51.7, 44.6, 42.5, 35.8, 34.2, 32.0, 29.3, 27.5, 22.7, 21.7, 14.1",CCCCCCCN1C(C)(C)CC(N)CC1(C)C,1369,1.0,1.0,1.0,1.0,1.0
410,"1-Heptyl-2,2,6,6-tetramethylpiperidin-4-amine",MS,"(ESI) found [M+H]+ 255.2795, C16H35N2 requires 255.2795",CCCCCCCN1C(C)(C)CC(N)CC1(C)C,1370,1.0,1.0,1.0,1.0,1.0
411,"1-Heptyl-2,2,6,6-tetramethylpiperidin-4-amine",Rf,"(ethyl acetate in petroleum ether, 30% -
on triethylamine-pretreated silica plate): 0.25",CCCCCCCN1C(C)(C)CC(N)CC1(C)C,1385,1.0,1.0,1.0,1.0,1.0
412,"1-Heptyl-2,2,6,6-tetramethylpiperidin-4-amine",IR,"(film): 2920, 2872, 1577, 1464, 1378, 1330,
1260, 1214, 1187, 1112, 1013, 913, 839, 722",CCCCCCCN1C(C)(C)CC(N)CC1(C)C,1386,1.0,1.0,1.0,1.0,1.0
413,"1-Heptyl-2,2,6,6-tetramethylpiperidin-4-amine",1H NMR,"(400 MHz, CDCl3) δ 3.04 – 2.91 (m, 1H, H-12),
2.40 – 2.27 (m, 2H, H-7), 1.65 (dd, J = 12.4, 3.7 Hz, 2H, H-11eq), 1.46 – 1.32 (m, 2H, H-6), 1.34 – 1.12
(m, 10H, H-2, H-3, H-4, H-5 and H-11ax), 1.08 (s, 6H, H-8 or H-9), 1.01 (s, 6H, H-8 or H-9), 0.88 (t, J =
6.8 Hz, 3H, H-1)",CCCCCCCN1C(C)(C)CC(N)CC1(C)C,1387,1.0,1.0,1.0,1.0,1.0
414,"1-Heptyl-2,2,6,6-tetramethylpiperidin-4-amine",13C NMR,"(126 MHz, CDCl3) δ 55.5, 51.7, 44.6, 42.5, 35.8, 34.2, 32.0, 29.3, 27.5, 22.7,
21.7, 14.1",CCCCCCCN1C(C)(C)CC(N)CC1(C)C,1388,1.0,1.0,1.0,1.0,1.0
415,"1-Heptyl-2,2,6,6-tetramethylpiperidin-4-amine",MS,"(ESI) found [M+H]+ 255.2795, C16H35N2 requires 255.2795",CCCCCCCN1C(C)(C)CC(N)CC1(C)C,1389,1.0,1.0,1.0,1.0,1.0
416,"8-(4-Methoxyphenethyl)-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane",Rf,"(ethyl acetate in petroleum ether, 10% - on triethylamine-pretreated silica plate): 0.31",COc1ccc(CCN2C(C)(C)CC3(CC2(C)C)OCCO3)cc1,1390,0.61,1.0,1.0,1.0,1.0
417,"8-(4-Methoxyphenethyl)-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane",IR,"(film): 2953, 2880, 1611, 1511, 1364, 1243, 1188, 1080, 1037, 1011, 959, 854, 821, 730, 572, 560",COc1ccc(CCN2C(C)(C)CC3(CC2(C)C)OCCO3)cc1,1391,0.61,1.0,1.0,1.0,1.0
418,"8-(4-Methoxyphenethyl)-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane",1H NMR,"(500 MHz, CDCl3) δ 7.10 (d, J = 8.7 Hz, 2H, H-4), 6.84 (d, J = 8.7 Hz, 2H, H-3), 3.93 (s, 4H, H-
12), 3.79 (s, 3H, H-1), 2.66 – 2.62 (m, 4H, H6 and H-7), 1.68 (s, 4H, H-10), 1.18 (s, 12H, H-8)",COc1ccc(CCN2C(C)(C)CC3(CC2(C)C)OCCO3)cc1,1392,,,,,
419,"8-(4-Methoxyphenethyl)-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane",13C NMR,"(126 MHz, CDCl3) δ 157.8, 133.3, 129.4, 113.8, 107.7, 63.6, 55.9, 55.3, 47.5, 46.9, 41.4, 28.0",COc1ccc(CCN2C(C)(C)CC3(CC2(C)C)OCCO3)cc1,1393,0.61,1.0,1.0,1.0,1.0
420,"8-(4-Methoxyphenethyl)-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane",MS,"(ESI) found [M+H]+ 334.2376, C20H32NO3 requires 334.2377",COc1ccc(CCN2C(C)(C)CC3(CC2(C)C)OCCO3)cc1,1394,0.61,1.0,1.0,1.0,1.0
421,"1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-one",Rf,"(ethyl acetate in petroleum ether, 10% - on triethylamine-pretreated silica plate): 0.39",COc1ccc(CCN2C(C)(C)CC(=O)CC2(C)C)cc1,1395,0.52,1.0,1.0,1.0,
422,"1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-one",IR,"(film): 2969, 2835, 1712, 1611, 1511, 1464, 1302, 1245, 1177, 1143, 1092, 1036, 1012, 855,
822",COc1ccc(CCN2C(C)(C)CC(=O)CC2(C)C)cc1,1396,0.52,1.0,1.0,1.0,
423,"1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-one",1H NMR,"(500 MHz, CDCl3) δ 7.13 (d, J = 8.6 Hz, 2H, H-4), 6.86 (d, J = 8.7 Hz, 2H, H-3), 3.81 (s,
3H, H-1), 2.78 – 2.72 (m, 2H, H-7), 2.72 – 2.66 (m, 2H, H-6), 2.39 (s, 4H, H-10), 1.20 (s, 12H, H-8)",COc1ccc(CCN2C(C)(C)CC(=O)CC2(C)C)cc1,1397,0.52,0.89,0.89,0.89,
424,"1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-one",13C NMR,"(126 MHz, CDCl3) δ 209.9, 158.0, 132.6, 129.4, 113.9, 60.0, 55.8, 55.3, 47.3, 41.1, 28.4",COc1ccc(CCN2C(C)(C)CC(=O)CC2(C)C)cc1,1398,0.52,1.0,1.0,1.0,
425,"1-(4-Methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-one",MS,"(ESI) found [M+H]+ 290.2116, C18H28NO2 requires 290.2115",COc1ccc(CCN2C(C)(C)CC(=O)CC2(C)C)cc1,1399,0.52,1.0,1.0,1.0,
426,"1-(4-Fluorobenzyl)-N-{1-(4-methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl}-1Hbenzo[
d]imidazol-2-amine",Rf,"(ethyl acetate in petroleum ether, 15% - on triethylamine-pretreated silica plate): 0.32",COc1ccc(CCN2C(C)(C)CC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2(C)C)cc1,1405,0.36,1.0,1.0,1.0,0.7256637168141593
427,"1-(4-Fluorobenzyl)-N-{1-(4-methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl}-1Hbenzo[
d]imidazol-2-amine",IR,"(film): 2929, 2875, 1618, 1602, 1558, 1509, 1464, 1390, 1360, 1249, 1224, 1158, 1080, 1015, 963, 846,
820, 737, 703",COc1ccc(CCN2C(C)(C)CC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2(C)C)cc1,1406,0.36,1.0,1.0,1.0,0.7256637168141593
428,"1-(4-Fluorobenzyl)-N-{1-(4-methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl}-1Hbenzo[
d]imidazol-2-amine",1H NMR,"(500 MHz, CDCl3) δ 7.54 (d, J = 7.8 Hz, 1H, H-19), 7.18 – 7.11 (m, 3H, H-18
and H-23), 7.08 – 7.02 (m, 4H, H-16, H-17 and H-24), 5.05 (s, 2H, H-21), 4.31 – 4.16 (m, 1H, H-12),
3.56 (d, J = 8.3 Hz, 1H, H-13), 2.45 – 2.34 (m, 2H, H-7), 1.96 (dd, J = 11.7, 3.2 Hz, 2H, H-11eq), 1.46 –
1.35 (m, 2H, H-6), 1.36 – 1.17 (m, 10H, H-2, H-3, H-4 and H-5, H-11 ax), 1.14 (s, 6H, H-8 or H-9), 1.10
(s, 6H, H-8 or H-9), 0.90 (t, J = 7.0 Hz, 3H, H-1)",COc1ccc(CCN2C(C)(C)CC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2(C)C)cc1,1407,0.36,1.0,1.0,1.0,0.7256637168141593
429,"1-(4-Fluorobenzyl)-N-{1-(4-methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl}-1Hbenzo[
d]imidazol-2-amine",13C NMR,"(126 MHz, CDCl3) δ 162.4 (d, 1J C-F = 247.2
Hz), 153.5, 142.6, 134.6, 131.2, 128.09 (d, 3J C-F = 8.2 Hz), 121.4, 119.6, 116.8, 116.2 (d, 2J C-F = 21.7
Hz), 107.0, 55.6, 48.1, 45.4, 45.0, 44.5, 35.8, 34.1, 32.0, 29.2, 27.4, 22.6, 21.7, 14.1",COc1ccc(CCN2C(C)(C)CC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2(C)C)cc1,1408,0.36,0.0,0.0,0.0,0.7256637168141593
430,"1-(4-Fluorobenzyl)-N-{1-(4-methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl}-1Hbenzo[
d]imidazol-2-amine",19F NMR,"(376
MHz, CDCl3) δ -113.77",COc1ccc(CCN2C(C)(C)CC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2(C)C)cc1,1409,0.36,1.0,1.0,1.0,0.7256637168141593
431,"1-(4-Fluorobenzyl)-N-{1-(4-methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl}-1Hbenzo[
d]imidazol-2-amine",MS,"(ESI) found [M+H]+ 479.3532, C30H44FN4 requires 479.3531",COc1ccc(CCN2C(C)(C)CC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2(C)C)cc1,1410,0.36,1.0,1.0,1.0,0.7256637168141593
432,"1-(4-Fluorobenzyl)-N-{1-(4-methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl}-1Hbenzo[
d]imidazol-2-amine",Rf,"(ethyl acetate in petroleum ether, 20% - on triethylamine-pretreated silica
plate): 0.31",COc1ccc(CCN2C(C)(C)CC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2(C)C)cc1,1411,0.36,0.0,0.0,0.0,0.7256637168141593
433,"1-(4-Fluorobenzyl)-N-{1-(4-methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl}-1Hbenzo[
d]imidazol-2-amine",IR,"(film): 2963, 1605, 1563, 1510, 1245, 1027, 908, 821, 731",COc1ccc(CCN2C(C)(C)CC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2(C)C)cc1,1412,0.36,0.0,0.0,0.0,0.7256637168141593
434,"1-(4-Fluorobenzyl)-N-{1-(4-methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl}-1Hbenzo[
d]imidazol-2-amine",1H NMR,"(400
MHz, CDCl3) δ 7.52 (d, J = 7.8 Hz, 1H, H-19), 7.18 – 6.95 (m, 9H, H-4, H-16, H-17, H-18, H-23 and H-
24), 6.84 (d, J = 8.6 Hz, 2H, H-3), 5.05 (s, 2H, H-21), 4.39 – 4.13 (m, 1H, H-12), 3.79 (s, 3H, H-1), 3.57
(d, J = 8.0 Hz, 1H, H-13), 2.62 (s, 4H, H-6 and H-7), 1.98 (dd, J = 12.1, 3.5 Hz, 2H, H-11eq), 1.21 (s, 6H,
H-8 or H-9), 1.19 – 1.14 (m, 2H, H-11ax), 1.12 (s, 6H, H-8 or H-9)",COc1ccc(CCN2C(C)(C)CC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2(C)C)cc1,1413,0.36,0.21,0.27,0.24,0.7256637168141593
435,"1-(4-Fluorobenzyl)-N-{1-(4-methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl}-1Hbenzo[
d]imidazol-2-amine",13C NMR,"(101 MHz, CDCl3) δ 162.5
(d, 1J C-F = 247.1 Hz), 157.9, 153.5, 142.6, 134.6, 133.0, 131.2, 129.4, 128.1 (d, 3J C-F = 8.2 Hz), 121.5,
119.7, 116.8, 116.2 (d, 2J C-F = 21.8 Hz), 113.9, 107.0, 55.8, 55.3, 48.0, 47.2, 45.4, 45.0, 41.3, 34.2, 21.8",COc1ccc(CCN2C(C)(C)CC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2(C)C)cc1,1414,0.36,0.0,0.0,0.0,0.7256637168141593
436,"1-(4-Fluorobenzyl)-N-{1-(4-methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl}-1Hbenzo[
d]imidazol-2-amine",19F NMR,"(377 MHz, CDCl3) δ -113.72",COc1ccc(CCN2C(C)(C)CC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2(C)C)cc1,1415,0.36,0.5,0.5,0.5,0.7256637168141593
437,"1-(4-Fluorobenzyl)-N-{1-(4-methoxyphenethyl)-2,2,6,6-tetramethylpiperidin-4-yl}-1Hbenzo[
d]imidazol-2-amine",MS,"(ESI) found [M+H]+ 515.3168, C32H40 FN4O
requires 515.3167",COc1ccc(CCN2C(C)(C)CC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2(C)C)cc1,1416,0.36,0.0,0.0,0.0,0.7256637168141593
438,"(7,9,9-Trimethyl-1,4-dioxa-8-azaspiro[4.5]decan-7-yl)methanol",Rf,"(methanol in dichloromethane, 5% - on triethylamine-pretreated silica plate): 0.28",CC1(C)CC2(CC(C)(CO)N1)OCCO2,1417,0.6,1.0,1.0,1.0,0.9818181818181818
439,"(7,9,9-Trimethyl-1,4-dioxa-8-azaspiro[4.5]decan-7-yl)methanol",IR,"(film): 3320-3168(br), 2958, 1662, 1479, 1355, 1219, 1078, 1016, 949, 776",CC1(C)CC2(CC(C)(CO)N1)OCCO2,1418,0.6,1.0,0.18,0.31,0.9818181818181818
440,"(7,9,9-Trimethyl-1,4-dioxa-8-azaspiro[4.5]decan-7-yl)methanol",1H NMR,"(500
MHz, CDCl3) δ 4.01 – 3.84 (m, 4H, H-6 and H-7), 3.47 (d, J = 10.3 Hz, 1H, H-12), 3.07 (d, J = 10.3 Hz,
1H, H-12), 1.77 (dd, J = 13.8, 0.9 Hz, 1H, H-4), 1.59 (dd, J = 13.5, 0.9 Hz, 1H, H-8), 1.53 (dd, J = 13.5,
1.5 Hz, 1H, H-8), 1.44 (dd, J = 13.8, 1.5 Hz, 1H, H-4), 1.27 (s, 3H, H-10 or H-11), 1.19 (s, 3H, H-10 or
H-11), 1.19 (s, 3H, H-2)",CC1(C)CC2(CC(C)(CO)N1)OCCO2,1419,0.6,0.91,0.91,0.91,0.9818181818181818
441,"(7,9,9-Trimethyl-1,4-dioxa-8-azaspiro[4.5]decan-7-yl)methanol",13C NMR,"(126 MHz, CDCl3) δ 108.6, 68.4, 63.9, 63.8, 54.7, 51.2, 44.8, 39.9,
32.2, 32.0, 27.7",CC1(C)CC2(CC(C)(CO)N1)OCCO2,1420,0.6,1.0,1.0,1.0,0.9818181818181818
442,"(7,9,9-Trimethyl-1,4-dioxa-8-azaspiro[4.5]decan-7-yl)methanol",MS,"(ESI) found [M+H]+ 216.1592, C11H22NO3 requires 215.1594",CC1(C)CC2(CC(C)(CO)N1)OCCO2,1421,0.6,1.0,1.0,1.0,0.9818181818181818
443,"7-{(Benzyloxy)methyl}-8-(4-methoxyphenethyl)-7,9,9-trimethyl-1,4-dioxa-8-
azaspiro[4.5]decane",Rf,"(ethyl
acetate in petroleum ether, 20%): 0.25;",COc1ccc(CCN2C(C)(C)CC3(CC2(C)COCc2ccccc2)OCCO3)cc1,1427,0.7,1.0,1.0,1.0,0.8623853211009175
444,"7-{(Benzyloxy)methyl}-8-(4-methoxyphenethyl)-7,9,9-trimethyl-1,4-dioxa-8-
azaspiro[4.5]decane",IR,"(film): 2951, 2880, 1611, 1511, 1365, 1244, 1177,
1079, 1037, 1037, 1011, 960, 822, 733, 699",COc1ccc(CCN2C(C)(C)CC3(CC2(C)COCc2ccccc2)OCCO3)cc1,1428,0.7,0.93,0.93,0.93,0.8623853211009175
445,"7-{(Benzyloxy)methyl}-8-(4-methoxyphenethyl)-7,9,9-trimethyl-1,4-dioxa-8-
azaspiro[4.5]decane",1H NMR,"(500 MHz, CDCl3) δ 7.37 – 7.26 (m, 5H, H-21, H-
22 and H-23), 7.02 (d, J = 8.6 Hz, 2H, H-4), 6.80 (d, J = 8.6 Hz, 2H, H-3), 4.54 (d, J = 12.2 Hz, 1H, H-
19), 4.51 (d, J = 12.2 Hz, 1H, H-19), 3.99 – 3.86 (m, 4H, H-12 and H-13), 3.79 (s, 3H, H-1), 3.58 (d, J =
8.7 Hz, 1H, H-18), 3.33 (d, J = 8.7 Hz, 1H, H-18), 2.86– 2.72 (m, 1H, H-7), 2.71 – 2.40 (m, 3H, H-6 and
H-7), 1.96 (d, J = 13.5 Hz, 1H, H-10), 1.70 (s, 2H, H-14), 1.62 (d, J = 13.5 Hz, 1H, H-10), 1.24 (s, 3H, H-
16 or H-17), 1.20 (s, 3H, H-16 or H-17), 1.18 (s, 3H, H-8)",COc1ccc(CCN2C(C)(C)CC3(CC2(C)COCc2ccccc2)OCCO3)cc1,1429,0.7,1.0,1.0,1.0,0.8623853211009175
446,"7-{(Benzyloxy)methyl}-8-(4-methoxyphenethyl)-7,9,9-trimethyl-1,4-dioxa-8-
azaspiro[4.5]decane",13C NMR,"(126 MHz, CDCl3) δ 157.8, 138.8,
133.2, 129.5, 128.3, 127.5, 127.4, 113.8, 107.6, 73.4, 63.7, 63.6, 58.9, 56.0, 55.3, 47.5, 47.0, 42.5, 40.9,
29.71, 29.37, 27.56, 22.24",COc1ccc(CCN2C(C)(C)CC3(CC2(C)COCc2ccccc2)OCCO3)cc1,1430,0.7,1.0,1.0,1.0,0.8623853211009175
447,"7-{(Benzyloxy)methyl}-8-(4-methoxyphenethyl)-7,9,9-trimethyl-1,4-dioxa-8-
azaspiro[4.5]decane",MS,"(ESI) found [M+H]+ 440.2788, C27H38NO4 requires 440.2792",COc1ccc(CCN2C(C)(C)CC3(CC2(C)COCc2ccccc2)OCCO3)cc1,1431,0.7,1.0,1.0,1.0,0.8623853211009175
448,"2-{(Benzyloxy)methyl}-2,6,6-trimethylpiperidin-4-one",Rf,"(ethyl acetate in petroleum ether, 20% - on triethylamine-pretreated silica plate): 0.20",CC1(C)CC(=O)CC(C)(COCc2ccccc2)N1,1432,0.49,1.0,1.0,1.0,0.9696969696969697
449,"2-{(Benzyloxy)methyl}-2,6,6-trimethylpiperidin-4-one",IR,"(film): 2967, 2861, 1705, 1454, 1296, 1095, 1027, 737, 698",CC1(C)CC(=O)CC(C)(COCc2ccccc2)N1,1433,0.49,1.0,1.0,1.0,0.9696969696969697
450,"2-{(Benzyloxy)methyl}-2,6,6-trimethylpiperidin-4-one",1H NMR,"(500 MHz, CDCl3) δ
7.39 – 7.27 (m, 5H, Ar-Hs), 4.59 (d, J = 12.0 Hz, 1H, H-10), 4.53 (d, J = 12.0 Hz, 1H, H-10), 3.33 (d, J =
8.9 Hz, 1H, H-9), 3.17 (d, J = 8.9 Hz, 1H, H-9), 2.63 (dd, J = 13.3, 0.6 Hz, 1H, H-4), 2.31 (dd, J = 13.1,
1.6 Hz, 1H, H-6), 2.22 (dd, J = 13.1, 0.6 Hz, 1H, H-6), 2.11 (dd, J = 13.3, 1.6 Hz, 1H, H-4), 1.26 (s, 3H,
H-7 or H-8), 1.21 (s, 3H, H-7 or H-8), 1.14 (s, 3H, H-2)",CC1(C)CC(=O)CC(C)(COCc2ccccc2)N1,1434,0.49,1.0,1.0,1.0,0.9696969696969697
451,"2-{(Benzyloxy)methyl}-2,6,6-trimethylpiperidin-4-one",13C NMR,"(126 MHz, CDCl3) δ 211.3, 137.9,
128.5, 127.8, 127.7, 77.9, 73.3, 57.9, 55.1, 54.1, 48.7, 33.3, 30.4, 26.6",CC1(C)CC(=O)CC(C)(COCc2ccccc2)N1,1435,0.49,1.0,1.0,1.0,0.9696969696969697
452,"2-{(Benzyloxy)methyl}-2,6,6-trimethylpiperidin-4-one",MS,"(ESI) found [M+H]+
262.1797, C16H24NO2 requires 262.1802",CC1(C)CC(=O)CC(C)(COCc2ccccc2)N1,1436,0.49,1.0,1.0,1.0,0.9696969696969697
453,"2-{(Benzyloxy)methyl}-2,6,6-trimethylpiperidin-4-ol",IR,"(film): 3319 (br.), 2958, 2858, 1454, 1366, 1191, 1098, 1075,
1051, 738, 698",CC1(C)CC(O)CC(C)(COCc2ccccc2)N1,1437,0.69,1.0,1.0,1.0,0.8493150684931506
454,"2-{(Benzyloxy)methyl}-2,6,6-trimethylpiperidin-4-ol",MS,"(ESI) found [M+H]+ 264.1957, C16H26NO2 requires 264.1958",CC1(C)CC(O)CC(C)(COCc2ccccc2)N1,1438,0.69,1.0,1.0,1.0,0.8493150684931506
455,"2-{(Benzyloxy)methyl}-2,6,6-trimethylpiperidin-4-ol",1H NMR,"(500 MHz, CDCl3) δ 7.41 – 7.30 (m, 5H, Ar-Hs), 4.57 (d, J = 12.3 Hz, 1H, H-
10), 4.50 (d, J = 12.3 Hz, 1H, H-10), 4.01 – 3.88 (m, 1H, H-5), 3.36 (d, J = 8.9 Hz, 1H, H-9), 3.31 (d, J =
8.9 Hz, 1H, H-9), 2.04 (ddd, J = 12.6, 4.3, 2.0 Hz, 1H, H-4), 1.85 (ddd, J = 12.3, 4.1, 2.0 Hz, 1H, H-6),
1.19 (s, 3H, H-2), 1.18 (s, 3H, H-7 or H-8), 1.15 (d, J = 9.1 Hz, 1H, H-6), 1.14 (s, 3H, H-7 or H-8), 1.08
(dd, J = 12.5, 11.3 Hz, 1H, H-4)",CC1(C)CC(O)CC(C)(COCc2ccccc2)N1,1439,0.69,1.0,1.0,1.0,0.8493150684931506
456,"2-{(Benzyloxy)methyl}-2,6,6-trimethylpiperidin-4-ol",13C NMR,"(126 MHz, CDCl3) δ 138.4, 128.3, 127.7, 127.5, 76.0, 73.2,
64.8, 54.4, 51.2, 47.3, 43.3, 34.9, 30.4, 29.5",CC1(C)CC(O)CC(C)(COCc2ccccc2)N1,1440,0.69,0.14,0.14,0.14,0.8493150684931506
457,"2-{(Benzyloxy)methyl}-2,6,6-trimethylpiperidin-4-ol",1H NMR,"(500 MHz, CDCl3) δ 7.46
– 7.31 (m, 5H, H-12, H-13 and H-14), 4.59 (d, J = 12.8 Hz, 1H, H-10), 4.55 (d, J = 12.8 Hz, 1H, H-10),
4.14-1.10 (m, 1H, H-5), 3.27 (d, J = 8.7 Hz, 1H, H-9), 3.19 (d, J = 8.7 Hz, 1H, H-9), 1.96 (ddd, J = 12.2,
4.2, 1.8 Hz, 1H, H-4), 1.74 (ddd, J = 12.0, 4.3, 1.8 Hz, 1H, H-6), 1.50 – 1.36 (m, 1H, H-6), 1.23 (s, 3H,
H-7 or H-8), 1.19 (s, 3H, H-7 or H-8), 1.16 (s, 3H, H-2), 1.07 – 1.00 (m, 1H, H-4)",CC1(C)CC(O)CC(C)(COCc2ccccc2)N1,1441,0.69,0.13,0.12,0.12,0.8493150684931506
458,"2-{(Benzyloxy)methyl}-2,6,6-trimethylpiperidin-4-ol",13C NMR,"(126 MHz,
CDCl3) δ 138.3, 128.4, 127.6, 127.5, 79.6, 76.0, 64.9, 53.4, 51.5, 47.9, 42.0, 34.6, 29.1, 25.3",CC1(C)CC(O)CC(C)(COCc2ccccc2)N1,1442,0.69,1.0,1.0,1.0,0.8493150684931506
459,"2-{(Benzyloxy)methyl}-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-one",Rf,"(ethyl acetate in petroleum ether, 20%): 0.26",COc1ccc(CCN2C(C)(C)CC(=O)CC2(C)COCc2ccccc2)cc1,1450,0.57,1.0,1.0,1.0,0.7435897435897436
460,"2-{(Benzyloxy)methyl}-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-one",IR,"(film): 2966, 1713,
1511, 1301, 1244, 1093, 1034, 822, 737, 699",COc1ccc(CCN2C(C)(C)CC(=O)CC2(C)COCc2ccccc2)cc1,1451,0.57,1.0,1.0,1.0,0.7435897435897436
461,"2-{(Benzyloxy)methyl}-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-one",1H NMR,"(500 MHz, CDCl3) δ 7.41 – 7.30 (m, 5H, H-19,
H-20 and H-21), 7.05 (d, J = 8.5 Hz, 2H, H-4), 6.84 (d, J = 8.5 Hz, 2H, H-3), 4.59 (d, J = 12.1 Hz, 1H, H-
17), 4.55 (d, J = 12.1 Hz, 1H, H-17), 3.82 (s, 3H, H-1), 3.45 (d, J = 9.2 Hz, 1H, H-16), 3.29 (d, J = 9.2
Hz, 1H, H-16), 2.87 – 2.67 (m, 5H, H-6, H-7 and H-10), 2.52 (d, J = 13.0 Hz, 1H, H-12), 2.36 – 2.25 (m, 2H, H-10 and H-12), 1.29 (s, 3H, H-14 or H-15), 1.18 (s, 3H, H-8), 1.17 (s, 3H, H-14 or H-15);",COc1ccc(CCN2C(C)(C)CC(=O)CC2(C)COCc2ccccc2)cc1,1452,0.57,1.0,1.0,1.0,0.7435897435897436
462,"2-{(Benzyloxy)methyl}-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-one",13C NMR,"(126 MHz, CDCl3) δ 210.1, 158.0, 138.1, 132.6, 129.5, 129.6, 129.4, 128.4, 127.6, 113.9, 76.8, 73.4,
62.4, 59.6, 55.5, 55.3, 51.1, 47.3, 40.3, 30.8, 26.7, 22.3",COc1ccc(CCN2C(C)(C)CC(=O)CC2(C)COCc2ccccc2)cc1,1453,0.57,1.0,1.0,1.0,0.7435897435897436
463,"2-{(Benzyloxy)methyl}-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-one",MS,"(ESI) found [M+H]+ 396.2529,
C25H34NO3 requires 396.2533",COc1ccc(CCN2C(C)(C)CC(=O)CC2(C)COCc2ccccc2)cc1,1454,0.57,1.0,1.0,1.0,0.7435897435897436
464,"2-{(Benzyloxy)methyl}-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-amine",Rf,"(methanol in dichloromethane, 5% - on triethylamine-pretreated silica gel): 0.21",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)COCc2ccccc2)cc1,1455,0.84,1.0,1.0,1.0,0.8155339805825242
465,"2-{(Benzyloxy)methyl}-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-amine",IR,"(film): 3392, 3381, 2942, 1513, 1432, 1247, 1202, 1133, 1030, 835, 722",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)COCc2ccccc2)cc1,1456,0.84,1.0,1.0,1.0,0.8155339805825242
466,"2-{(Benzyloxy)methyl}-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-amine",MS,"(ESI) found
[M+H]+ 397.2846, C25H37N2O2 requires 397.2850",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)COCc2ccccc2)cc1,1457,0.84,1.0,1.0,1.0,0.8155339805825242
467,"2-{(Benzyloxy)methyl}-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-amine",1H NMR,"(400 MHz, CDCl3)
δ 7.42 – 7.30 (m, 5H, H-20, H-21 and H-22), 7.10 (d, J = 8.6 Hz, 2H, H-4), 6.85 (d, J = 8.6 Hz, 2H, H-3),
4.52 (d, J = 12.2 Hz, 1H, H-18), 4.44 (d, J = 12.2 Hz, 1H, H-18), 3.81 (s, 3H, H-1), 3.38 (d, J = 8.5 Hz,
1H, H-17), 3.36 (d, J = 8.5 Hz, 1H, H-17), 3.19 – 3.06 (m, 1H, H-11), 2.98 – 2.79 (m, 1H, H-7), 2.73 –
2.56 (m, 3H, H-6 and H-7), 2.18 – 2.10 (m, 1H, H-10), 1.79 – 1.68 (m, 1H, H-13), 1.36 (s, 3H, H-8), 1.34
– 1.28 (m, 1H, H-13), 1.26 (s, 3H, H-15), 1.02 (t, J = 6.1 Hz, 1H, H-10), 0.98 (s, 3H, H-16)",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)COCc2ccccc2)cc1,1458,0.84,0.26,0.24,0.25,0.8155339805825242
468,"2-{(Benzyloxy)methyl}-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-amine",13C NMR,"(126 MHz, CDCl3) δ 157.9, 138.8, 133.1, 129.4, 128.3, 127.7, 127.4, 113.8, 80.8, 73.3, 72.2, 58.9, 55.3,
51.0, 47.2, 46.5, 42.1, 41.4, 34.5, 28.3, 23.5",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)COCc2ccccc2)cc1,1459,0.84,0.19,0.19,0.19,0.8155339805825242
469,"2-{(Benzyloxy)methyl}-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-amine",1H NMR,"(400 MHz, CDCl3) δ 7.41
– 7.29 (m, 5H, H-20, H-21 and H-22), 6.99 (d, J = 8.6 Hz, 2H, H-4), 6.80 (d, J = 8.6 Hz, 2H, H-3), 4.62
(d, J = 12.2 Hz, 1H, H-18), 4.58 (d, J = 12.2 Hz, 1H, H-18), 3.80 (s, 3H, H-1), 3.48 (d, J = 9.1 Hz, 1H, H 17), 3.32 (d, J = 9.1 Hz, 1H, H-17), 2.99 – 2.80 (m, 2H, H-7 and H-11), 2.72 – 2.54 (m, 3H, H-6 and H-
7), 1.95 – 1.84 (m, 1H, H-10), 1.79 – 1.67 (m, 1H, H-13), 1.34 – 1.29 (m, 1H, H-13), 1.25 (s, 3H, H-8),
1.20 (dd, J = 9.0, 5.7 Hz, 1H), 1.07 (s, 3H, H-15), 1.06 (s, 3H, H-16)",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)COCc2ccccc2)cc1,1460,0.84,1.0,1.0,1.0,0.8155339805825242
470,"2-{(Benzyloxy)methyl}-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-amine",13C NMR,"(126 MHz, CDCl3) δ
158.0, 138.5, 133.1, 129.5, 128.4, 127.5, 127.4, 113.8, 75.9, 73.5, 72.2, 58.7, 55.4, 51.1, 47.5, 46.9, 43.2,
40.5, 33.9, 22.3, 18.1",COc1ccc(CCN2C(C)(C)CC(N)CC2(C)COCc2ccccc2)cc1,1461,0.84,1.0,1.0,1.0,0.8155339805825242
471,"N-{(2R,4R)-2-((Benzyloxy)methyl)-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-yl}-
1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-amine",Rf,"(ethyl acetate in
petroleum ether, 25%): 0.23",COc1ccc(CCN2C(C)(C)C[C@@H](Nc3nc4ccccc4n3Cc3ccc(F)cc3)C[C@]2(C)COCc2ccccc2)cc1,1462,0.17,1.0,1.0,1.0,0.896969696969697
472,"N-{(2R,4R)-2-((Benzyloxy)methyl)-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-yl}-
1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-amine",IR,"(film): 2924, 1604, 1563, 1510, 1368, 1245, 1175, 1077, 908,
822, 730",COc1ccc(CCN2C(C)(C)C[C@@H](Nc3nc4ccccc4n3Cc3ccc(F)cc3)C[C@]2(C)COCc2ccccc2)cc1,1463,0.17,1.0,1.0,1.0,0.896969696969697
473,"N-{(2R,4R)-2-((Benzyloxy)methyl)-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-yl}-
1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-amine",1H NMR,"(400 MHz, CDCl3) δ 7.48 (d, J = 7.8 Hz, 1H, H-21), 7.39 – 7.19 (m, 5H, H-15, H-22,
H-23, and H-29), 7.15 – 6.96 (m, 9H, H-4, H-13, H-14, H-24 and H-28), 6.82 (d, J = 8.3 Hz, 2H, H-3),
5.04 (s, 2H, H-26), 4.56 (d, J = 12.0 Hz, 1H, H-11), 4.49 (d, J = 12.0 Hz, 1H, H-11), 4.25 – 4.10 (m, 1H,
H-17), 3.78 (s, 3H, H-1), 3.63 (d, J = 9.2 Hz, 1H, H-10), 3.56 (d, J = 7.7 Hz, 1H, NH), 3.46 (d, J = 9.2
Hz, 1H, H-10), 2.96 – 2.84 (m, 1H, H-7), 2.69 – 2.56 (m, 3H, H-6 and H-7), 2.35 (d, J = 12.0 Hz, 1H, H-
16), 2.03 (d, J = 9.4 Hz, 1H, H-3), 1.31 (s, 3H, H-9), 1.22 (s, 3H, H-33), 1.19 – 1.12 (m, 1H, H-31), 1.10
(s, 3H, H-34), 1.04 – 0.93 (m, 1H, H-16)",COc1ccc(CCN2C(C)(C)C[C@@H](Nc3nc4ccccc4n3Cc3ccc(F)cc3)C[C@]2(C)COCc2ccccc2)cc1,1464,0.17,1.0,1.0,1.0,0.896969696969697
474,"N-{(2R,4R)-2-((Benzyloxy)methyl)-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-yl}-
1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-amine",13C NMR,"(101 MHz, CDCl3) δ 162.5 (d, 1JC-F = 247.1 Hz),
157.9, 153.4, 142.6, 138.9, 134.6, 132.96, 131.2, 129.4, 128.3, 128.1 (d, 3JC-F = 8.2 Hz), 127.4, 127.3,
121.5, 119.7, 116.8, 116.2 (d, 2JC-F = 21.7 Hz), 113.8, 107.1, 73.5, 72.6, 59.1, 55.6, 55.3, 47.7, 47.2, 45.2, 45.1, 43.1, 41.4, 34.4, 28.2, 23.4",COc1ccc(CCN2C(C)(C)C[C@@H](Nc3nc4ccccc4n3Cc3ccc(F)cc3)C[C@]2(C)COCc2ccccc2)cc1,1465,0.17,0.0,0.0,0.0,0.896969696969697
475,"N-{(2R,4R)-2-((Benzyloxy)methyl)-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-yl}-
1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-amine",19F NMR,"(376 MHz, MeOD) δ -113.75",COc1ccc(CCN2C(C)(C)C[C@@H](Nc3nc4ccccc4n3Cc3ccc(F)cc3)C[C@]2(C)COCc2ccccc2)cc1,1466,0.17,1.0,1.0,1.0,0.896969696969697
476,"N-{(2R,4R)-2-((Benzyloxy)methyl)-1-(4-methoxyphenethyl)-2,6,6-trimethylpiperidin-4-yl}-
1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-amine",MS,"(ESI) found
[M+H]+ 621.3596, C39H46FN4O2 requires 621.3599",COc1ccc(CCN2C(C)(C)C[C@@H](Nc3nc4ccccc4n3Cc3ccc(F)cc3)C[C@]2(C)COCc2ccccc2)cc1,1467,0.17,1.0,1.0,1.0,0.896969696969697
477,"{(2R,4R)-4-((1-(4-Fluorobenzyl)-1H-benzo[d]imidazol-2-yl)amino)-1-(4-methoxyphenethyl)-
2,6,6-trimethylpiperidin-2-yl}methanol",Rf,"(methanol in dichloromethane, 5%): 0.26",COc1ccc(CCN2C(C)(C)C[C@@H](Nc3nc4ccccc4n3Cc3ccc(F)cc3)C[C@]2(C)CO)cc1,1468,0.5,1.0,1.0,1.0,0.9305555555555556
478,"{(2R,4R)-4-((1-(4-Fluorobenzyl)-1H-benzo[d]imidazol-2-yl)amino)-1-(4-methoxyphenethyl)-
2,6,6-trimethylpiperidin-2-yl}methanol",IR,"(film): 3280 (br.), 2939, 1605, 1567, 1509, 1244, 1158, 1078, 1030, 821, 737, 700",COc1ccc(CCN2C(C)(C)C[C@@H](Nc3nc4ccccc4n3Cc3ccc(F)cc3)C[C@]2(C)CO)cc1,1469,0.5,1.0,0.08,0.15,0.9305555555555556
479,"{(2R,4R)-4-((1-(4-Fluorobenzyl)-1H-benzo[d]imidazol-2-yl)amino)-1-(4-methoxyphenethyl)-
2,6,6-trimethylpiperidin-2-yl}methanol",1H NMR,"(500 MHz,
MeOD) δ 7.33 (d, J = 7.6 Hz, 1H, H-16), 7.25 – 7.16 (m, 3H, H-18 and H-24), 7.12 – 7.04 (m, 5H, H-4,
H-19 and H-23), 6.99 – 6.95 (m, 1H, H-17), 6.85 (d, J = 8.7 Hz, 2H, H-3), 5.28 (s, 2H, H-21), 4.23 – 4.12
(m, 1H, H-12), 3.88 (d, J = 11.4 Hz, 1H, H-10), 3.78 (s, 3H, H-1), 3.48 (d, J = 11.4 Hz, 1H, H-10), 2.95 –
2.87 (m, 1H, H-7), 2.76 – 2.62 (m, 3H, H-6 and H-7), 2.32 – 2.25 (m, 1H, H-11), 1.87 (d, J = 12.2 Hz,
1H, H-25), 1.56 – 1.48 (m, 1H, H-25), 1.31 (s, 3H, H-28), 1.31 (s, 3H, H-9), 1.22 – 1.15 (m, 1H, H-11),
1.19 (s, 3H, H-29)",COc1ccc(CCN2C(C)(C)C[C@@H](Nc3nc4ccccc4n3Cc3ccc(F)cc3)C[C@]2(C)CO)cc1,1470,0.5,0.96,0.96,0.96,0.9305555555555556
480,"{(2R,4R)-4-((1-(4-Fluorobenzyl)-1H-benzo[d]imidazol-2-yl)amino)-1-(4-methoxyphenethyl)-
2,6,6-trimethylpiperidin-2-yl}methanol",13C NMR,"(126 MHz, MeOD) δ 162.2 (d, 1JC-F = 244.4 Hz), 158.1, 154.0, 141.4,
133.9, 132.6, 132.4, 129.0, 128.2 (d, 3JC-F = 8.2 Hz), 121.1, 119.4, 115.0 (d, 2JC-F = 21.9 Hz), 114.5, 113.5, 107.7, 62.3, 60.0, 55.6, 54.2, 46.8, 44.5, 43.8, 41.2, 41.0, 33.5, 26.5, 22.5, 20.1",COc1ccc(CCN2C(C)(C)C[C@@H](Nc3nc4ccccc4n3Cc3ccc(F)cc3)C[C@]2(C)CO)cc1,1471,0.5,0.0,0.0,0.0,0.9305555555555556
481,"{(2R,4R)-4-((1-(4-Fluorobenzyl)-1H-benzo[d]imidazol-2-yl)amino)-1-(4-methoxyphenethyl)-
2,6,6-trimethylpiperidin-2-yl}methanol",19F NMR,"(376
MHz, MeOD) δ -117.20",COc1ccc(CCN2C(C)(C)C[C@@H](Nc3nc4ccccc4n3Cc3ccc(F)cc3)C[C@]2(C)CO)cc1,1472,0.5,1.0,1.0,1.0,0.9305555555555556
482,"{(2R,4R)-4-((1-(4-Fluorobenzyl)-1H-benzo[d]imidazol-2-yl)amino)-1-(4-methoxyphenethyl)-
2,6,6-trimethylpiperidin-2-yl}methanol",MS,"HRMS (ESI) found [M+H]+ 531.3126, C32H40FN4O2 requires 531.3130",COc1ccc(CCN2C(C)(C)C[C@@H](Nc3nc4ccccc4n3Cc3ccc(F)cc3)C[C@]2(C)CO)cc1,1473,0.5,1.0,1.0,1.0,0.9305555555555556
483,"2,2,6-Trimethyl-1-azaspiro[bicyclo[4.2.0]octane-4,2'-[1,3]dioxolan]-8-one",Rf,"(diethyl
ether in dichloromethane, 10%): 0.26",CC1(C)CC2(CC3(C)CC(=O)N13)OCCO2,1474,1.0,1.0,1.0,1.0,0.34
484,"2,2,6-Trimethyl-1-azaspiro[bicyclo[4.2.0]octane-4,2'-[1,3]dioxolan]-8-one",IR,"(film): 2971, 1737, 1326, 1094, 667",CC1(C)CC2(CC3(C)CC(=O)N13)OCCO2,1475,1.0,1.0,1.0,1.0,0.34
485,"2,2,6-Trimethyl-1-azaspiro[bicyclo[4.2.0]octane-4,2'-[1,3]dioxolan]-8-one",1H NMR,"(500
MHz, CDCl3) δ 4.01 (2H, td, J = 6.0 Hz, 0.4 Hz, H-7 or H-8), 3.93-3.86 (2H, m, H-7 or H-8), 2.68 (2H,
d, J = 14.4 Hz, H-2), 2.00 (1H, dd, J = 13.2, 1.6 Hz, H-5), 1.71-1.65 (3H, m, H-5 and H-9), 1.63 (3H, s,
H-11 or H-12), 1.54 (3H, s, H-3), 1.32 (3H, s, H-11 or H-12)",CC1(C)CC2(CC3(C)CC(=O)N13)OCCO2,1476,1.0,1.0,1.0,1.0,0.34
486,"2,2,6-Trimethyl-1-azaspiro[bicyclo[4.2.0]octane-4,2'-[1,3]dioxolan]-8-one",13C NMR,"(126 MHz, CDCl3) δ 165.4,
108.1, 64.9, 63.3, 55.0, 53.3, 52.6, 46.0, 42.8, 29.2, 27.2, 25.4",CC1(C)CC2(CC3(C)CC(=O)N13)OCCO2,1477,1.0,1.0,1.0,1.0,0.34
487,"2,2,6-Trimethyl-1-azaspiro[bicyclo[4.2.0]octane-4,2'-[1,3]dioxolan]-8-one",MS,"(ESI) found [M+H]+
226.1437, C12H20NO3 requires 226.1438",CC1(C)CC2(CC3(C)CC(=O)N13)OCCO2,1478,1.0,1.0,1.0,1.0,0.34
488,"2,2,6-Trimethyl-1-azaspiro(bicyclo[4.2.0]octane-4,2'-[1,3]dioxolane)",Rf,"(methanol in dichloromethane, 5% - on triethylamine-pretreated silica plate): 0.40",CC1(C)CC2(CC3(C)CCN13)OCCO2,1484,0.47,1.0,1.0,1.0,0.38596491228070173
489,"2,2,6-Trimethyl-1-azaspiro(bicyclo[4.2.0]octane-4,2'-[1,3]dioxolane)",IR,"(film):
1641, 1454, 1361, 1189, 1086, 1032, 895, 805, 735, 698",CC1(C)CC2(CC3(C)CCN13)OCCO2,1485,0.47,1.0,1.0,1.0,0.38596491228070173
490,"2,2,6-Trimethyl-1-azaspiro(bicyclo[4.2.0]octane-4,2'-[1,3]dioxolane)",1H NMR,"(500 MHz, CDCl3) δ 4.04 – 3.95 (m,
2H, H-7 or H-8), 3.92 – 3.82 (m, 2H, H-7 or H-8), 3.22 (dt, J = 9.2, 6.9 Hz, 1H, H-1), 3.16 – 3.05 (m, 1H,
H-1), 2.01 (dd, J = 17.2, 9.4 Hz, 1H, H-2), 1.92 (d, J = 13.7 Hz, 1H, H-5), 1.67 – 1.54 (m, 3H, H-2, H-5
and H-9), 1.42 (dd, J = 13.7, 2.3 Hz, 1H, H-9), 1.36 (s, 3H, H-4), 1.18 (s, 3H, H-11 or H-12), 0.96 (s, 3H, H-11 or H-12)",CC1(C)CC2(CC3(C)CCN13)OCCO2,1486,0.47,1.0,1.0,1.0,0.38596491228070173
491,"2,2,6-Trimethyl-1-azaspiro(bicyclo[4.2.0]octane-4,2'-[1,3]dioxolane)",13C NMR,"(126 MHz, CDCl3) δ 108.9, 64.7, 63.5, 62.9, 53.1, 43.3, 38.7, 37.8, 32.9, 29.9,
29.2, 28.1",CC1(C)CC2(CC3(C)CCN13)OCCO2,1487,0.47,1.0,1.0,1.0,0.38596491228070173
492,"2,2,6-Trimethyl-1-azaspiro(bicyclo[4.2.0]octane-4,2'-[1,3]dioxolane)",MS,"(ESI) found [M+H]+ 212.1575, C12H22NO2 requires 212.1752",CC1(C)CC2(CC3(C)CCN13)OCCO2,1488,0.47,1.0,1.0,1.0,0.38596491228070173
493,"2-{(Benzyloxy)ethyl}-2,6,6-trimethylpiperidin-4-one",Rf,"(ethyl acetate
in petroleum ether, 50%): 0.19",CC1(C)CC(=O)CC(C)(CCOCc2ccccc2)N1,1494,0.48,1.0,1.0,1.0,0.6956521739130435
494,"2-{(Benzyloxy)ethyl}-2,6,6-trimethylpiperidin-4-one",IR,"(film): 2965, 2864, 1703, 1454, 1365, 1292, 1215, 1098,
736, 697",CC1(C)CC(=O)CC(C)(CCOCc2ccccc2)N1,1495,0.48,1.0,1.0,1.0,0.6956521739130435
495,"2-{(Benzyloxy)ethyl}-2,6,6-trimethylpiperidin-4-one",1H NMR,"(500 MHz, CDCl3) δ 7.39 – 7.29 (m, 5H, Ar-Hs), 4.51 (s, 2H, H-11), 3.72 – 3.57 (m,
2H, H-10), 2.42 (d, J = 13.2 Hz, 1H, H-4 ), 2.28 (d, J = 13.3 Hz, 1H, H-6), 2.25 (d, J = 13.3 Hz, 1H, H-6),
2.21 (dd, J = 13.2, 1.0 Hz, 1H, H-4), 1.82 (t, J = 6.4 Hz, 2H, H-9), 1.23 (s, 3H, H-2), 1.22 (s, 3H, H-7 or
H-8), 1.20 (s, 3H, H-7 or H-8)",CC1(C)CC(=O)CC(C)(CCOCc2ccccc2)N1,1496,0.48,1.0,1.0,1.0,0.6956521739130435
496,"2-{(Benzyloxy)ethyl}-2,6,6-trimethylpiperidin-4-one",13C NMR,"(126 MHz, CDCl3) δ 211.1, 138.2, 128.4, 127.8, 127.7, 73.2,
66.9, 57.0, 54.9, 54.2, 52.5, 43.4, 32.9, 31.5, 29.8",CC1(C)CC(=O)CC(C)(CCOCc2ccccc2)N1,1497,0.48,1.0,1.0,1.0,0.6956521739130435
497,"2-{(Benzyloxy)ethyl}-2,6,6-trimethylpiperidin-4-one",MS,"(ESI) found [M+H]+ 276.1957, C17H26NO2
requires 276.1958",CC1(C)CC(=O)CC(C)(CCOCc2ccccc2)N1,1498,0.48,1.0,1.0,1.0,0.6956521739130435
498,"2-{2-(Benzyloxy)ethyl}-2,6,6-trimethyl-4-{(triisopropylsilyl)oxy}piperidine",Rf,"(ethyl acetate in petroleum ether, 20% - on triethylaminepretreated
silica plate): 0.32",CC(C)[Si](OC1CC(C)(C)NC(C)(CCOCc2ccccc2)C1)(C(C)C)C(C)C,1505,0.53,0.1,1.0,0.18,0.5853658536585366
499,"2-{2-(Benzyloxy)ethyl}-2,6,6-trimethyl-4-{(triisopropylsilyl)oxy}piperidine",IR,"(film): 2938, 2865, 1455, 1363, 1223, 1089, 1014, 882, 733,
636",CC(C)[Si](OC1CC(C)(C)NC(C)(CCOCc2ccccc2)C1)(C(C)C)C(C)C,1506,0.53,1.0,1.0,1.0,0.5853658536585366
500,"2-{2-(Benzyloxy)ethyl}-2,6,6-trimethyl-4-{(triisopropylsilyl)oxy}piperidine",MS,"(ESI) found [M+H]+ 434.3446, C26H48NO2Si requires 434.3449",CC(C)[Si](OC1CC(C)(C)NC(C)(CCOCc2ccccc2)C1)(C(C)C)C(C)C,1507,0.53,1.0,1.0,1.0,0.5853658536585366
501,"2-{2-(Benzyloxy)ethyl}-2,6,6-trimethyl-4-{(triisopropylsilyl)oxy}piperidine",1H NMR,"(500 MHz, CDCl3) δ 7.38 – 7.29 (m, 5H, Ar-Hs), 4.53 (d, J = 12.0 Hz, 1H, H-
12), 4.51 (d, J = 12.0 Hz, 1H, H-12), 4.14 (tt, J = 11.0, 4.1 Hz, 1H, H-5), 3.68 – 3.57 (m, 2H, H-13), 2.07
– 1.81 (m, 3H, H-4, H-8 and H-12), 1.75 – 1.66 (m, 1H, H-12), 1.16 (s, 3H, H-10 or H-11), 1.13 (s, 3H,
H10 or H-11), 1.12 (s, 3H, H-2), 1.10 – 0.98 (m, 25H, H-4, H-6, H-7 and H-8)",CC(C)[Si](OC1CC(C)(C)NC(C)(CCOCc2ccccc2)C1)(C(C)C)C(C)C,1508,0.53,0.86,0.75,0.8,0.5853658536585366
502,"2-{2-(Benzyloxy)ethyl}-2,6,6-trimethyl-4-{(triisopropylsilyl)oxy}piperidine",13C NMR,"(126 MHz,
CDCl3) δ 138.6, 128.4, 127.7, 127.5, 73.2, 67.6, 65.1, 53.2, 51.5, 48.8, 48.7, 39.5, 35.0, 31.8, 28.7, 18.1,
12.3",CC(C)[Si](OC1CC(C)(C)NC(C)(CCOCc2ccccc2)C1)(C(C)C)C(C)C,1509,0.53,0.41,0.41,0.41,0.5853658536585366
503,"2-{2-(Benzyloxy)ethyl}-2,6,6-trimethyl-4-{(triisopropylsilyl)oxy}piperidine",1H NMR,"(500 MHz, CDCl3) δ 7.38 – 7.29 (m, 5H, Ar-Hs), 4.53 (d, J =
12.0 Hz, 1H, H-12), 4.51 (d, J = 12.0 Hz, 1H, H-12), 4.10 – 4.05 (m, 1H, H-5), 3.68 – 3.57 (m, 2H, H-
13), 2.07 – 1.81 (m, 3H, H-4, H-8 and H-12), 1.75 – 1.66 (m, 1H, H-12), 1.10 – 0.98 (m, 34H, H-2, H-4,
H-6, H-7, H-8, H-10 and H-11)",CC(C)[Si](OC1CC(C)(C)NC(C)(CCOCc2ccccc2)C1)(C(C)C)C(C)C,1510,0.53,1.0,1.0,1.0,0.5853658536585366
504,"2-{2-(Benzyloxy)ethyl}-2,6,6-trimethyl-4-{(triisopropylsilyl)oxy}piperidine",13C NMR,"(126 MHz, CDCl3) δ 138.6, 128.4, 127.7, 127.5, 73.0, 66.8,
65.4, 53.6, 51.3, 46.3, 45.7, 39.5, 35.0, 31.8, 28.1, 18.2, 12.4",CC(C)[Si](OC1CC(C)(C)NC(C)(CCOCc2ccccc2)C1)(C(C)C)C(C)C,1511,0.53,1.0,1.0,1.0,0.5853658536585366
505,"2-{2-(Benzyloxy)ethyl)-2,6,6-trimethyl-4-((triisopropylsilyl)oxy}piperidine",Rf,"(ethyl acetate in petroleum ether, 20%): 0.30",CC(C)[Si](OC1CC(C)(C)NC(C)(CCOCc2ccccc2)C1)(C(C)C)C(C)C,1512,0.5,1.0,1.0,1.0,0.4946236559139785
506,"2-{2-(Benzyloxy)ethyl)-2,6,6-trimethyl-4-((triisopropylsilyl)oxy}piperidine",IR,"(film): 2966, 1714,
1611, 1511, 1364, 1245, 1176, 1094, 1034, 822, 698",CC(C)[Si](OC1CC(C)(C)NC(C)(CCOCc2ccccc2)C1)(C(C)C)C(C)C,1513,0.5,1.0,1.0,1.0,0.4946236559139785
507,"2-{2-(Benzyloxy)ethyl)-2,6,6-trimethyl-4-((triisopropylsilyl)oxy}piperidine",1H NMR,"(500 MHz, CDCl3) δ 7.39 – 7.29 (m, 5H,
H-20, H-21 and H-22), 7.12 (d, J = 8.7 Hz, 2H, H-4), 6.87 (d, J = 8.7 Hz, 2H, H-3), 4.51 (s, 2H, H-18),
3.82 (s, 3H, H-18), 3.61 (t, J = 6.6 Hz, 2H, H-17), 2.78 – 2.66 (m, 4H, H-6 and H-7), 2.59 (dd, J = 13.0, 1.5 Hz, 1H, H-10), 2.42 (dd, J = 12.7, 1.5 Hz, 1H, H-12), 2.34 (dd, J = 12.7, 1.8 Hz, 1H, H-12), 2.29 (dd,
J = 13.0, 1.8 Hz, 1H, H-10), 2.03 – 1.94 (m, 2H, H-16), 1.89 – 1.79 (m, 1H, H-16), 1.26 (s, 3H, H-14 or
H-15), 1.20 (s, 6H, H-8, and H-14 or H-15)",CC(C)[Si](OC1CC(C)(C)NC(C)(CCOCc2ccccc2)C1)(C(C)C)C(C)C,1514,0.5,1.0,1.0,1.0,0.4946236559139785
508,"2-{2-(Benzyloxy)ethyl)-2,6,6-trimethyl-4-((triisopropylsilyl)oxy}piperidine",13C NMR,"(126 MHz, CDCl3) δ 210.0, 158.0, 138.2, 132.6,
129.4, 128.4, 127.7, 127.6, 113.9, 73.1, 67.2, 61.9, 59.9, 55.7, 55.3, 52.6, 47.4, 40.5, 40.1, 30.0, 27.6,
25.6",CC(C)[Si](OC1CC(C)(C)NC(C)(CCOCc2ccccc2)C1)(C(C)C)C(C)C,1515,0.5,1.0,1.0,1.0,0.4946236559139785
509,"2-{2-(Benzyloxy)ethyl)-2,6,6-trimethyl-4-((triisopropylsilyl)oxy}piperidine",MS,"(ESI) found [M+H]+ 410.2692, C26H36NO3 requires 410.2690",CC(C)[Si](OC1CC(C)(C)NC(C)(CCOCc2ccccc2)C1)(C(C)C)C(C)C,1516,0.5,1.0,1.0,1.0,0.4946236559139785
510,"2-(4-Methoxyphenyl)-1-(7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl)ethanone",Rf,"(ethyl acetate in
petroleum ether, 30% - on triethylamine-pretreated silica plate): 0.30",COc1ccc(CC(=O)N2C(C)(C)CC3(CC2(C)C)OCCO3)cc1,1517,0.58,1.0,1.0,1.0,1.0
511,"2-(4-Methoxyphenyl)-1-(7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl)ethanone",IR,"(film): 2962, 1728,
1666, 1516, 1251, 1164, 1144, 809, 763, 694",COc1ccc(CC(=O)N2C(C)(C)CC3(CC2(C)C)OCCO3)cc1,1518,0.58,1.0,1.0,1.0,1.0
512,"2-(4-Methoxyphenyl)-1-(7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl)ethanone",1H NMR,"(500 MHz, CDCl3) δ 7.21 (d, J = 8.8 Hz, 2H, H-
4), 6.86 (d, J = 8.7 Hz, 2H, H-3), 4.34 (dd, J = 5.4, 4.3 Hz, 2H, H-13 or H-14), 3.92 – 3.83 (m, 2H, H-13
or H-14), 3.79 (s, 3H, H-1), 3.60 (s, 2H, H-6), 1.91 (s, 4H, H-11), 1.21 (s, 6H, H-9 or H-10), 1.18 (s, 6H,
H-9 or H-10)",COc1ccc(CC(=O)N2C(C)(C)CC3(CC2(C)C)OCCO3)cc1,1519,0.58,1.0,1.0,1.0,1.0
513,"2-(4-Methoxyphenyl)-1-(7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl)ethanone",13C NMR,"(126 MHz, CDCl3) δ 171.9, 158.7, 151.0, 130.3, 125.9, 114.0, 102.7, 64.1, 63.1,
55.3, 40.4, 40.3, 32.8, 30.3",COc1ccc(CC(=O)N2C(C)(C)CC3(CC2(C)C)OCCO3)cc1,1520,0.58,1.0,1.0,1.0,1.0
514,"2-(4-Methoxyphenyl)-1-(7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl)ethanone",MS,"(ESI) found [M+H]+ 348.2170, C20H30NO4 requires 348.2169",COc1ccc(CC(=O)N2C(C)(C)CC3(CC2(C)C)OCCO3)cc1,1521,0.58,1.0,1.0,1.0,1.0
515,"2,2,6,6-Tetramethylpiperidin-1-yl benzoate",Rf,"(ethyl acetate in petroleum ether, 10%): 0.27",CC1(C)CCCC(C)(C)N1OC(=O)c1ccccc1,1522,1.0,1.0,1.0,1.0,1.0
516,"2,2,6,6-Tetramethylpiperidin-1-yl benzoate",IR,"(film): 2978, 1741, 1449, 1363, 1249, 104, 906, 717",CC1(C)CCCC(C)(C)N1OC(=O)c1ccccc1,1523,1.0,1.0,1.0,1.0,1.0
517,"2,2,6,6-Tetramethylpiperidin-1-yl benzoate",1H NMR,"(400 MHz, CDCl3) δ 8.10 (d,
J = 7.1 Hz, 2H, H-3), 7.59 (t, J = 7.4 Hz, 1H, H-1), 7.48 (t, J = 7.6 Hz, 2H, H-2), 1.94 – 1.41 (m, 6H, H-9
and H-10), 1.30 (s, 6H, H-7 or H-8), 1.14 (s, 6H, H-7 or H-8)",CC1(C)CCCC(C)(C)N1OC(=O)c1ccccc1,1524,1.0,1.0,1.0,1.0,1.0
518,"2,2,6,6-Tetramethylpiperidin-1-yl benzoate",13C NMR,"(101 MHz, CDCl3) δ 166.4,
132.8, 129.8, 129.6, 128.4, 60.4, 39.1, 32.0, 20.9, 17.0",CC1(C)CCCC(C)(C)N1OC(=O)c1ccccc1,1525,1.0,1.0,1.0,1.0,1.0
519,"8-Ethyl-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane",Rf,"(ethyl acetate in
petroleum ether, 10% - on triethylamine-pretreated silica plate): 0.33",CCN1C(C)(C)CC2(CC1(C)C)OCCO2,1526,0.65,1.0,1.0,1.0,1.0
520,"8-Ethyl-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane",IR,"(film): 2969, 2884,
1478, 1356, 1185, 1086, 947, 796, 726",CCN1C(C)(C)CC2(CC1(C)C)OCCO2,1527,0.65,1.0,1.0,1.0,1.0
521,"8-Ethyl-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane",1H NMR,"(400 MHz, CDCl3) δ 3.94 (s, 4H, H-7), 2.56 (q, J = 7.1
Hz, 2H, H-2), 1.66 (s, 4H, H-5), 1.14 (s, 12H, H-4), 1.05 (t, J = 7.1 Hz, 3H, H-1)",CCN1C(C)(C)CC2(CC1(C)C)OCCO2,1528,0.65,1.0,1.0,1.0,1.0
522,"8-Ethyl-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane",13C NMR,"(101 MHz, CDCl3) δ 107.8, 63.6, 55.8, 47.6, 37.3, 27.9, 20.9",CCN1C(C)(C)CC2(CC1(C)C)OCCO2,1529,0.65,0.0,0.0,0.0,1.0
523,"8-Ethyl-7,7,9,9-tetramethyl-1,4-dioxa-8-azaspiro[4.5]decane",MS,"(ESI) found [M+H]+ 228.1956, C13H26NO2
requires 228.1958",CCN1C(C)(C)CC2(CC1(C)C)OCCO2,1530,0.65,0.03,1.0,0.06,1.0
